ÌåäÓíèâåð - MedUniver.com Âñå ðàçäåëû ñàéòà Âèäåî ïî ìåäèöèíå Êíèãè ïî ìåäèöèíå Ôîðóì êîíñóëüòàöèé âðà÷åé  
Ðåêîìåíäóåì:
Ïåäèàòðèÿ:
Ïåäèàòðèÿ
Ãåíåòèêà â ïåäèàòðèè
Äåòñêàÿ àëëåðãîëîãèÿ è èììóíîëîãèÿ
Äåòñêàÿ ãàñòðîýíòåðîëîãèÿ
Äåòñêàÿ ãåìàòîëîãèÿ
Äåòñêàÿ ãèíåêîëîãèÿ
Äåòñêàÿ äåðìàòîëîãèÿ
Äåòñêàÿ è ïîäðîñòêîâàÿ ñòîìàòîëîãèÿ
Äåòñêàÿ êàðäèîëîãèÿ
Äåòñêàÿ íåâðîëîãèÿ
Äåòñêàÿ íåôðîëîãèÿ
Äåòñêàÿ îíêîëîãèÿ
Äåòñêàÿ îðòîïåäèÿ
Äåòñêàÿ îòîðèíîëàðèíãîëîãèÿ
Äåòñêàÿ îôòàëüìîëîãèÿ
Äåòñêàÿ ïóëüìîíîëîãèÿ
Äåòñêàÿ ðåàáèëèòàöèÿ
Äåòñêàÿ ðåâìàòîëîãèÿ
Äåòñêàÿ óðîëîãèÿ
Äåòñêàÿ ôàðìàêîëîãèÿ
Äåòñêàÿ ýíäîêðèíîëîãèÿ
Èíôåêöèîííûå áîëåçíè ó äåòåé
Íåîíàòîëîãèÿ
Íåîòëîæíûå ñîñòîÿíèÿ äåòåé
Ïîäðîñòêîâàÿ ìåäèöèíà
Ðîñò è ðàçâèòèå ðåáåíêà
Îðãàíèçàöèÿ ïåäèàòðè÷åñêîé ïîìîùè
Ôîðóì
 

Àâòîðû òðóäîâ (ñòàòåé) èñïîëüçîâàííûå ïðè ïîäãîòîâêå ìàòåðèàëîâ ïî äåòñêîé îðòîïåäèè â ïåäèàòðèè

 ñòàòüÿõ íà ñàéòå èñïîëüçîâàíû ñëåäóþùèå ñîêðàùåíèÿ:

  • °F — òåìïåðàòóðà ïî Ôàðåíãåéòó
  • °C — òåìïåðàòóðà ïî Öåëüñèþ
  • 5-ÍÒ — 5-ãèäðîêñèèíäîëóêñóñíàÿ êèñëîòà ìî÷è
  • ÀÁ — àíòèáèîòèê(è)
  • ÀÁËÀ — àëëåðãè÷åñêèé áðîíõîëåãî÷íûé àñïåðãèëëåç
  • ÀÁÒ — àíòèáàêòåðèàëüíàÿ òåðàïèÿ
  • ÀÂ — àòðèîâåíòðèêóëÿðíûé
  • ÀÃ — àðòåðèàëüíàÿ ãèïåðòåíçèÿ
  • ÀÃí — àíòèãåí
  • ÀÄ — àðòåðèàëüíîå äàâëåíèå
  • ÀÄà — àíòèäèóðåòè÷åñêèé ãîðìîí
  • ÀÄÑ — àíàòîêñèí äèôòåðèéíî-ñòîëáíÿ÷íûé
  • ÀÄÑ-Ì — àíàòîêñèí äèôòåðèéíî-ñòîëáíÿ÷íûé (ìàëûå äîçû)
  • ÀÄÔ — àäåíîçèíäèôîñôîðíàÿ êèñëîòà, àäåíîçèíäèôîñôàò
  • ÀÊÄÑ — àíàòîêñèí êîêëþøíî-äèôòåðèéíî-ñòîëáíÿ÷íûé
  • ÀÊÒÃ — àäðåíîêîðòèêîòðîïíûé ãîðìîí
  • ÀÊØ — àîðòîêîðîíàðíîå øóíòèðîâàíèå
  • ÀËÒ — àëàíèíàìèíîòðàíñôåðàçà
  • àìåð. — àìåðèêàíñêèé
  • ÀÌÊ — àçîò ìî÷åâèíû êðîâè
  • ÀÌÔ — àäåíîçèíìîíîôîñôîðíàÿ êèñëîòà, àäåíîçèíìîíîôîñôàò
  • ÀÍÀ — àíòèíóêëåàðíûå àíòèòåëà
  • àíàò. — àíàòîìè÷åñêèé
  • àíãë. — àíãëèéñêèé
  • ÀÏÔ — àíãèîòåíçèí-ïðåâðàùàþùèé ôåðìåíò
  • ÀÐÂÒ — àíòèðåòðîâèðóñíàÿ òåðàïèÿ
  • ÀÐÏ — àêòèâíîñòü ðåíèíà â ïëàçìå êðîâè
  • ACT — àñïàðòàòàìèíîòðàíñôåðàçà
  • ÀÒë — àíòèòåëî
  • ÀÒÔ — àäåíîçèíòðèôîñôîðíàÿ êèñëîòà, àäåíîçèíòðèôîñôàò
  • ÀóÄ — àóòîñîìíî-äîìèíàíòíûé
  • ÀóÐ — àóòîñîìíî-ðåöåññèâíûé
  • ÀÔÏ — α-ôåòîïðîòåèí
  • ÀÔÑ — àíòèôîñôîëèïèäíûé ñèíäðîì
  • ÀÕÝ — àöåòèëõîëèíýñòåðàçà
  • ÀÖÕ — àöåòèëõîëèí
  • À×Ò — àêòèâèðîâàííîå ÷àñòè÷íîå òðîìáîïëàñòèíîâîå âðåìÿ
  • ÁÀ — áðîíõèàëüíàÿ àñòìà
  • ÁÀÄ — áèîëîãè÷åñêè àêòèâíàÿ äîáàâêà
  • ÁÀË — áðîíõîàëüâåîëÿðíûé ëàâàæ
  • ÁÀÐ — áèïîëÿðíîå àôôåêòèâíîå ðàññòðîéñòâî (I èëè II òèïà)
  • ÁÊÊ — áîëüøîé êðóã êðîâîîáðàùåíèÿ
  • ÁËÄ — áðîíõîëåãî÷íàÿ äèñïëàçèÿ
  • ÁËÍÏà — áëîêàäà ëåâîé íîæêè ïó÷êà Ãèñà
  • ÁÌÑÝ — áþðî ìåäèêî-ñîöèàëüíîé ýêñïåðòèçû
  • ÁÏ — áðþøíàÿ ïîëîñòü
  • ÁÏÍÏà — áëîêàäà ïðàâîé íîæêè ïó÷êà Ãèñà
  • ÁÐÌ — áàçîâûå ðåàíèìàöèîííûå ìåðîïðèÿòèÿ
  • ÁÐÍÑ — áûñòðî ðàçðåøèâøååñÿ íåîáúÿñíèìîå ñîáûòèå
  • ÁÖÆ — áàöèëëà Êàëüìåòòà-Ãåðåíà â ò.÷. — â òîì ÷èñëå
  • ÁÔÏ - áèîôèçè÷åñêèé ïðîôèëü ïëîäà
  • â. — âåê
  • â/ — âíóòðè... â ñëîæíîñîñòàâíûõ ñëîâàõ (íàïð. â/ñîñóäèñòûé, â/÷åðåïíîé è ò.ï.)
  • â/à — âíóòðèàðòåðèàëüíî
  • â/â — âíóòðèâåííî
  • â/ê — âíóòðèêîæíî
  • â/ì — âíóòðèìûøå÷íî
  • ââ. — âåêà
  • â-âî — âåùåñòâî
  • ÂÂÝ — âîåííî-âðà÷åáíàÿ ýêñïåðòèçà
  • ÂÃÄ — âíóòðèãëàçíîå äàâëåíèå
  • ÂÃ× — âèðóñ ãåðïåñà ÷åëîâåêà
  • ÂÄÏ — âåðõíèå äûõàòåëüíûå ïóòè
  • ÂÆÊ — âíóòðèæåëóäî÷êîâîå êðîâîèçëèÿíèå
  • ÂÇÊ — âîñïàëèòåëüíûå çàáîëåâàíèÿ êèøå÷íèêà
  • ÂÇÎÌÒ—âîñïàëèòåëüíûå çàáîëåâàíèÿ îðãàíîâ ìàëîãî òàçà
  • ÂÈÏ — âàçîàêòèâíûé èíòåñòèíàëüíûé ïåïòèä
  • ÂÈ× — âèðóñ èììóíîäåôèöèòà ÷åëîâåêà
  • ÂÌÏ — âûñîêîòåõíîëîãè÷íàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÂÌÑ — âíóòðèìàòî÷íîå ñðåäñòâî (ñïèðàëü)
  • ÂÍ — âèðóñíàÿ íàãðóçêà
  • ÂÍÑ — âåãåòàòèâíàÿ íåðâíàÿ ñèñòåìà
  • ÂΠ— Âåëèêàÿ Îòå÷åñòâåííàÿ âîéíà
  • ÂÎÃÌ — âûñîêîãîðíûé îòåê ãîëîâíîãî ìîçãà
  • ÂÎÇ — Âñåìèðíàÿ îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ
  • ÂÎË — âûñîêîãîðíûé îòåê ëåãêèõ
  • ÂÎÌÊ — âðà÷, îñóùåñòâëÿþùèé ìåäèöèíñêèé êîíòðîëü
  • ÂÎÏ — âðà÷ îáùåé ïðàêòèêè
  • ÂÏÂ — âåðõíÿÿ ïîëàÿ âåíà
  • ÂÏÃ — âèðóñ ïðîñòîãî ãåðïåñà
  • ÂÏÐ — âðîæäåííûå ïîðîêè ðàçâèòèÿ
  • ÂÏÑ — âðîæäåííûé ïîðîê ñåðäöà
  • ÂÏ× — âèðóñ ïàïèëëîìû ÷åëîâåêà
  • ÂÐÒ — âñïîìîãàòåëüíûå ðåïðîäóêòèâíûå òåõíîëîãèè
  • ÂÑÎ — âîäíî-ñîëåâîé îáìåí
  • Â×Ä — âíóòðè÷åðåïíîå äàâëåíèå
  • Â×ÈÂË — âûñîêî÷àñòîòíàÿ èñêóññòâåííàÿ âåíòèëÿöèÿ ëåãêèõ (HFV)
  • ÂÝÁ — âèðóñ Ýïøòåéíà-Áàðð
  • ã — ãðàìì
  • ã. — ãîä
  • Ã-6-ÔÄ — ãëþêîçî-6-ôîñôàòäåãèäðîãåíàçà
  • ÃÀÌÊ — ãàììà-àìèíîìàñëÿíàÿ êèñëîòà
  • ÃÁ — ãèïåðòîíè÷åñêàÿ áîëåçíü
  • ÃÁÍ — ãåìîëèòè÷åñêàÿ áîëåçíü íîâîðîæäåííîãî
  • ÃÁÎ — ãèïåðáàðè÷åñêàÿ îêñèãåíàöèÿ
  • ÃÇÒ — ãèïåð÷óâñòâèòåëüíîñòü çàìåäëåííîãî òèïà
  • ãèñò. — ãèñòîëîãè÷åñêèé
  • ÃÊ — ãðóäíàÿ êëåòêà
  • ÃÊÌÏ — ãèïåðòðîôè÷åñêàÿ êàðäèîìèîïàòèÿ
  • ÃÊÑ — ãëþêîêîðòèêîñòåðîèä(û)
  • ÃËÃ — ãåìîôàãîöèòàðíûé ëèìôîãèñòèîöèòîç
  • ÃËÏÑ — ãåìîððàãè÷åñêàÿ ëèõîðàäêà ñ ïî÷å÷íûì ñèíäðîìîì
  • ÃÌ — ãîëîâíîé ìîçã
  • ÃÌ-ÊÑÔ — ãðàíóëîöèòàðíî-ìàêðîôàãàëüíûé êîëîíèåñòèìóëèðóþùèé ôàêòîð
  • ÃÌÔ — ãóàíîçèíìîíîôîñôàò
  • ÃíÐà — ãîíàäîòðîïèí-ðèëèçèíã-ãîðìîí
  • ÃÍÒ — ãèïåð÷óâñòâèòåëüíîñòü íåìåäëåííîãî òèïà
  • ÃÏÎÄ — ãðûæà ïèùåâîäíîãî îòâåðñòèÿ äèàôðàãìû
  • ÃÐÄÑ — ãèïîêñè÷åñêàÿ ðåàêöèÿ äûõàòåëüíîé ñèñòåìû ãðå÷. — ãðå÷åñêèé
  • ÃÒÔ — ãóàíîçèíòðèôîñôàò
  • ÃÓÑ — ãåìîëèòèêî-óðåìè÷åñêèé ñèíäðîì
  • Ãö — ãåðö
  • ÃÝÁ — ãåìàòîýíöåôàëè÷åñêèé áàðüåð
  • ÃÝÐ — ãàñòðîýçîôàãåàëüíûé ðåôëþêñ
  • ÃÝÐÁ — ãàñòðîýçîôàãåàëüíàÿ ðåôëþêñíàÿ áîëåçíü
  • äÁ — äåöèáåë
  • ÄÂÑ — äèññåìèíèðîâàííîå âíóòðèñîñóäèñòîå ñâåðòûâàíèå
  • ÄÃÒ — äèãèäðîòåñòîñòåðîí
  • ÄÄ — äèôôåðåíöèàëüíàÿ äèàãíîñòèêà, äèôôåðåíöèàëüíî-äèàãíîñòè÷åñêèé
  • ÄÄÁÀ — äëèòåëüíîäåéñòâóþùèå β2-àãîíèñòû
  • ÄÄÊ — äèôôåðåíöèàëüíî-äèàãíîñòè÷åñêèé êðèòåðèé (êðèòåðèè)
  • ÄÄÐÌ - äîïóñòèìûé äèàïàçîí ðàñïðåäåëåíèÿ ìàêðîíóòðèåíòîâ
  • ÄÈ — äîâåðèòåëüíûé èíòåðâàë
  • ÄÊ — äèàãíîñòè÷åñêèé êðèòåðèé
  • ÄÊÀ — äèàáåòè÷åñêèé êåòîàöèäîç
  • ÄÊÌÏ — äèëàòàöèîííàÿ êàðäèîìèîïàòèÿ
  • ÄÌÆÏ — äåôåêò ìåææåëóäî÷êîâîé ïåðåãîðîäêè
  • ÄÌÏÏ — äåôåêò ìåæïðåäñåðäíîé ïåðåãîðîäêè
  • ÄÌÑ — äîáðîâîëüíîå ìåäèöèíñêîå ñòðàõîâàíèå
  • ÄÍ — äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • ÄÍÊ — äåçîêñèðèáîíóêëåèíîâàÿ êèñëîòà
  • ÄÍÒ — äåôåêòû íåðâíîé òðóáêè
  • ÄÎ - äûõàòåëüíûé îáúåì
  • ÄÎÔÀ — äèãèäðîêñèôåíèëàëàíèí
  • ÄÏ — äûõàòåëüíûå ïóòè
  • ÄÏÊ — äâåíàäöàòèïåðñòíàÿ êèøêà
  • ÄÏÌ — äàòà ïîñëåäíåé ìåíñòðóàöèè
  • ÄÏÏ - äîïóñòèìûé ïðåäåë ïîòðåáëåíèÿ
  • äð. — äðóãèå
  • ÄÒÏ — äîðîæíî-òðàíñïîðòíîå ïðîèñøåñòâèå
  • ÄÖÏ — äåòñêèé öåðåáðàëüíûé ïàðàëè÷
  • ÅÄ — åäèíèöà äåéñòâèÿ, åäèíèöà
  • ÆÂÏ — æåë÷åâûâîäÿùèå ïóòè
  • ÆÄÀ — æåëåçîäåôèöèòíàÿ àíåìèÿ
  • ÆÅË — æèçíåííàÿ åìêîñòü ëåãêèõ
  • ÆÊÁ — æåë÷åêàìåííàÿ áîëåçíü
  • ÆÊÊ — æåëóäî÷íî-êèøå÷íîå êðîâîòå÷åíèå
  • ÆÊÒ — æåëóäî÷íî-êèøå÷íûé òðàêò
  • ÆÍÂËÏ — æèçíåííî íåîáõîäèìûå è âàæíûå ëåêàðñòâåííûå ïðåïàðàòû (ñïèñîê, ïåðå÷åíü)
  • ÇÂÓÐ — çàäåðæêà âíóòðèóòðîáíîãî ðàçâèòèÿ
  • ÇË — çäîðîâûå ëþäè (ëèöà)
  • ÇÍÎ — çëîêà÷åñòâåííîå íîâîîáðàçîâàíèå
  • ÇÎ — çäðàâîîõðàíåíèå
  • ÇÎÆ — çäîðîâûé îáðàç æèçíè
  • ÇÑÍ — çàñòîéíàÿ ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • èÀÏÔ — èíãèáèòîðû àíãèîòåíçèí-ïðåâðàùàþùåãî ôåðìåíòà
  • ÈÁÑ — èøåìè÷åñêàÿ áîëåçíü ñåðäöà
  • ÈÂË — èñêóññòâåííàÿ âåíòèëÿöèÿ ëåãêèõ
  • ÈÃÊÑ — èíãàëÿöèîííûå ãëþêîêîðòèêîñòåðîèäû
  • ÈÇË — èíòåðñòèöèàëüíûå çàáîëåâàíèÿ ëåãêèõ
  • ÈÊÏ — èììóíîêîìïðîìåòèðîâàííûå ïàöèåíòû
  • ÈË — èíòåðëåéêèí
  • ÈËÄÁ — èíòåãðèðîâàííîå ëå÷åíèå äåòñêèõ áîëåçíåé
  • ÈÌ — èíôàðêò ìèîêàðäà
  • ÈÌÀÎ — èíãèáèòîð(û) ìîíîàìèíîêñèäàçû
  • ÈÌáïÁÒ — èíôàðêò ìèîêàðäà áåç ïîäúåìà ñåãìåíòà ST
  • ÈÌÏ — èíôåêöèÿ ìî÷åâûõ (ìî÷åâûâîäÿùèõ) ïóòåé
  • ÈÌïÇÒ — èíôàðêò ìèîêàðäà ñ ïîäúåìîì ñåãìåíòà
  • ST ÈÌÒ — èíäåêñ ìàññû òåëà
  • ÈÎË — èíòðàîêóëÿðíàÿ ëèíçà
  • ÈÏÏ — èíãèáèòîðû ïðîòîííîé ïîìïû (ïðîòîííîãî íàñîñà)
  • ÈÏÏÏ — èíôåêöèè, ïåðåäàâàåìûå ïîëîâûì ïóòåì
  • ÈÑÑ — èíäèâèäóàëüíûå ñïàñàòåëüíûå ñðåäñòâà èñòîð. — èñòîðè÷åñêîå èòàë. — èòàëüÿíñêèé
  • ÈÒÏ — èäèîïàòè÷åñêàÿ òðîìáîöèòîïåíè÷åñêàÿ ïóðïóðà
  • ÈÒØ — èíôåêöèîííî-òîêñè÷åñêèé øîê ÈÔÀ — èììóíîôåðìåíòíûé àíàëèç
  • ÊÀ — êîðîíàðíàÿ(ûå) àðòåðèÿ(è)
  • ê — êèëîâîëüò
  • êã — êèëîãðàìì
  • ÊÄÁÀ — êîðîòêîäåéñòâóþùèå β2-àãîíèñòû
  • ÊÄÄ — êîíå÷íî-äèàñòîëè÷åñêîå äàâëåíèå
  • ÊÄÎ — êîíå÷íî-äèàñòîëè÷åñêèé îáúåì
  • ÊÄÐ — êîíå÷íî-äèàñòîëè÷åñêèé ðàçìåð
  • êèò. — êèòàéñêèé
  • êêàë — êèëîêàëîðèÿ
  • êë. — êëåòêè, êëåòîê
  • ÊÌÏ — êà÷åñòâî ìåäèöèíñêîé ïîìîùè
  • ÊîÀ — êîýíçèì À, êîôåðìåíò À
  • ÊÎÅ — êîëîíèåîáðàçóþùàÿ åäèíèöà
  • ÊÎÊ — êîìáèíèðîâàííûå îðàëüíûå êîíòðàöåïòèâû
  • ÊÏÒ — êîãíèòèâíî-ïîâåäåí÷åñêàÿ òåðàïèÿ
  • ÊÐ — êëèíè÷åñêèå ðåêîìåíäàöèè
  • ÊÑÄ — êîíå÷íî-ñèñòîëè÷åñêîå äàâëåíèå
  • ÊÑÎ — êîíå÷íî-ñèñòîëè÷åñêèé îáúåì
  • ÊÑÐ — êîíå÷íî-ñèñòîëè÷åñêèé ðàçìåð
  • ÊÒ — êîìïüþòåðíàÿ òîìîãðàôèÿ
  • ÊÒÂÐ — êîìïüþòåðíàÿ òîìîãðàôèÿ âûñîêîãî ðàçðåøåíèÿ
  • ÊÒÃ — êàðäèîòîêîãðàôèÿ
  • ÊÔÊ — êðåàòèíôîñôîêèíàçà
  • ÊÙÑ — êèñëîòíî-ùåëî÷íîå ñîñòîÿíèå
  • ë — ëèòð
  • ë/î — ëîæíîîòðèöàòåëüíûé
  • ë/ï — ëîæíîïîëîæèòåëüíûé
  • ËÀ — ëåãî÷íàÿ àðòåðèÿ
  • ëàò. — ëàòèíñêèé
  • ËÃ — ëþòåèíèçèðóþùèé ãîðìîí
  • ËÄÃ — ëàêòàòäåãèäðîãåíàçà
  • ËÆ — ëåâûé æåëóäî÷åê
  • ËÎÐ — èìåþùèé îòíîøåíèå ê îòîðèíîëàðèíãîëîãèè (ËÎÐ-âðà÷, ËÎÐ-îðãàíû)
  • ËÏ — ëåêàðñòâåííûé ïðåïàðàò
  • ËÏÂÏ — ëèïîïðîòåèíû âûñîêîé ïëîòíîñòè
  • ËÏÍÏ — ëèïîïðîòåèíû íèçêîé ïëîòíîñòè
  • ËÏÎÍÏ — ëèïîïðîòåèíû î÷åíü íèçêîé ïëîòíîñòè
  • ËÏÓ — ëå÷åáíî-ïðîôèëàêòè÷åñêîå ó÷ðåæäåíèå
  • ËÑ — ëåêàðñòâåííîå ñðåäñòâî
  • ËÓ — ëèìôàòè÷åñêèé óçåë, ëèìôîóçëû
  • ËÔÊ — ëå÷åáíàÿ ôèçêóëüòóðà
  • ì.á. — ìîæåò (ìîã, ìîãóò, ìîãëè) áûòü
  • Ì/Æ — ñîîòíîøåíèå ìóæ÷èí è æåíùèí
  • ìàêñÄ — ìàêñèìàëüíàÿ äîçà
  • ìàêñÍÄ — ìàêñèìàëüíàÿ íà÷àëüíàÿ äîçà
  • ìàêñÐÄ — ìàêñèìàëüíàÿ ðàçîâàÿ äîçà
  • ìàêñÑÄ — ìàêñèìàëüíàÿ ñóòî÷íàÿ äîçà
  • ÌÀÍÊ — ìåòîä àìïëèôèêàöèè íóêëåèíîâûõ êèñëîò
  • ÌÀÎ — ìîíîàìèíîêñèäàçà
  • ÌÂÏ — ìî÷åâûâîäÿùèå ïóòè ìã — ìèëëèãðàìì
  • ÌÄÁ — ìûøå÷íàÿ äèñòðîôèÿ Áåêêåðà
  • ÌÄÄ — ìûøå÷íàÿ äèñòðîôèÿ Äþøåííà
  • ÌÄÌÀ — ìåòèëåíäèîêñèìåòàìôåòàìèí
  • ME — ìåæäóíàðîäíàÿ åäèíèöà
  • ìåä. — ìåäèöèíñêèé
  • ìåñ — ìåñÿö
  • ÌÆ — ìîëî÷íàÿ æåëåçà
  • ÌÆÏ — ìåææåëóäî÷êîâàÿ ïåðåãîðîäêà
  • ÌÇ — ìèíèñòåðñòâî çäðàâîîõðàíåíèÿ
  • ìèí — ìèíóò(à)
  • ìèíÄ — ìèíèìàëüíàÿ äîçà
  • ìèíÑÄ — ìèíèìàëüíàÿ ñóòî÷íàÿ äîçà
  • ÌÊÁ — ìî÷åêàìåííàÿ áîëåçíü
  • ÌÊÁ-10 — Ìåæäóíàðîäíàÿ êëàññèôèêàöèÿ áîëåçíåé 10-ãî ïåðåñìîòðà
  • ÌÊÁ-11 — Ìåæäóíàðîäíàÿ êëàññèôèêàöèÿ áîëåçíåé 11-ãî ïåðåñìîòðà
  • ìê — ìèêðîâîëüò
  • ìêã — ìèêðîãðàìì
  • ÌÊÊ — ìàëûé êðóã êðîâîîáðàùåíèÿ
  • ìêë — ìèêðîëèòð
  • ìë — ìèëëèëèòð
  • ìëí — ìèëëèîí
  • ìëðä — ìèëëèàðä
  • ìì — ìèëëèìåòð
  • ìì ðò.ñò. — ìèëëèìåòð ðòóòíîãî ñòîëáà ììîëü — ìèëëèìîëü
  • ÌÍÍ — ìåæäóíàðîäíîå íåïàòåíòîâàííîå íàèìåíîâàíèå
  • ÌÍÎ — ìåæäóíàðîäíîå íîðìàëèçîâàííîå îòíîøåíèå
  • ÌÎ — ìåäèöèíñêàÿ îðãàíèçàöèÿ
  • ÌÏ — ìåäèöèíñêàÿ ïîìîùü
  • ÌÏÑ — ìî÷åïîëîâàÿ ñèñòåìà
  • ÌÐ — ìàãíèòíî-ðåçîíàíñíûé
  • ÌÐ-âåíîãðàôèÿ — ÌÐÒ âåí è ñèíóñîâ ãîëîâíîãî ìîçãà
  • ÌÐÒ — ìàãíèòíî-ðåçîíàíñíàÿ òîìîãðàôèÿ
  • ìñ — ìèëëèñåêóíäà
  • ÌÑÊÒ — ìóëüòèñïèðàëüíàÿ êîìïüþòåðíàÿ òîìîãðàôèÿ
  • ÌÑÝ — ìåäèêî-ñîöèàëüíàÿ ýêñïåðòèçà
  • ÌÒ — ìàññà òåëà
  • ìòÄÍÊ — ìèòîõîíäðèàëüíàÿ äåçîêñèðèáîíóêëåèíîâàÿ êèñëîòà
  • ÌÒÐ — ìàññà òåëà ïðè ðîæäåíèè
  • ÌÝ - ìèàëãè÷åñêèé ýíöåôàëîìèåëèò
  • í.ý. — íàøåé ýðû
  • ÍÀ — íåðâíàÿ àíîðåêñèÿ
  • ÍÀÄ — íèêîòèíàìèäàäåíèíäèíóêëåîòèä
  • ÍÀÄÍ — íèêîòèíàìèäàäåíèíäèíóêëåîòèä (âîññòàíîâëåííûé)
  • ÍÀÄÔ — íèêîòèíàìèäàäåíèíäèíóêëåîòèäôîñôàò
  • ÍÀÆÁÏ — íåàëêîãîëüíàÿ æèðîâàÿ áîëåçíü ïå÷åíè íàïð. — íàïðèìåð
  • ÍÁ — íåðâíàÿ áóëèìèÿ
  • ÍÄÎ — íåãàòèâíûé äåòñêèé îïûò
  • íåä — íåäåëè
  • íåì. — íåìåöêèé
  • íì — íàíîìåòð
  • ÍÌÈÖ — íàöèîíàëüíûé ìåäèöèíñêèé èññëåäîâàòåëüñêèé öåíòð
  • ÍÌÏ — íåîòëîæíàÿ (ìåäèöèíñêàÿ) ïîìîùü
  • ÍÌÒ — íèçêàÿ ìàññà òåëà
  • ÍÏÀ — íîðìàòèâíî-ïðàâîâîé àêò
  • ÍÏÂ — íèæíÿÿ ïîëàÿ âåíà
  • ÍÏÂÑ — íåñòåðîèäíûå ïðîòèâîâîñïàëèòåëüíûå ñðåäñòâà
  • ÍÑ — íåðâíàÿ ñèñòåìà
  • ÍÑÒ - íåñòðåññîâûé òåñò
  • ÍÐÏ — íîðìû ðàöèîíà ïèòàíèÿ
  • ÍÑÃ — íåéðîñîíîãðàôèÿ
  • ÍÝÊ — íåêðîòè÷åñêèé ýíòåðîêîëèò
  • ÍßÊ — íåñïåöèôè÷åñêèé ÿçâåííûé êîëèò
  • ÎÀÊ — îáùèé àíàëèç êðîâè
  • ÎÀÌ — îáùèé àíàëèç ìî÷è
  • ÎÀÏ — îòêðûòûé àðòåðèàëüíûé ïðîòîê
  • ÎÁÏ — îðãàíû áðþøíîé ïîëîñòè
  • ÎÃÁ — îñòðàÿ ãîðíàÿ áîëåçíü
  • ÎÃÌ — îòåê ãîëîâíîãî ìîçãà
  • ÎÄÍ — îñòðàÿ äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • ÎÆÑÑ — îáùàÿ æåëåçîñâÿçûâàþùàÿ ñïîñîáíîñòü ñûâîðîòêè
  • ÎÇ — îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ
  • îê. — îêîëî
  • ÎÊÐ — îáñåññèâíî-êîìïóëüñèâíîå ðàññòðîéñòâî
  • ÎÊÑ — îñòðûé êîðîíàðíûé ñèíäðîì
  • ÎËË — îñòðûé ëèìôîáëàñòíûé ëåéêîç
  • ÎÌÑ — îáÿçàòåëüíîå ìåäèöèíñêîå ñòðàõîâàíèå
  • ÎÌÒ — îðãàíû ìàëîãî òàçà
  • ÎÍÌÊ — îñòðîå íàðóøåíèå ìîçãîâîãî êðîâîîáðàùåíèÿ
  • ÎÍÌÏ — îòäåëåíèå íåîòëîæíîé (ìåäèöèíñêîé) ïîìîùè
  • ÎÍÌÒ — î÷åíü íèçêàÿ ìàññà òåëà
  • ÎÎÇ — îðãàíû (îðãàíèçàöèè/óïðàâëåíèÿ) çäðàâîîõðàíåíèÿ
  • ÎÎÍ — Îðãàíèçàöèÿ Îáúåäèíåííûõ Íàöèé
  • ÎÏÆ — îæèäàåìàÿ ïðîäîëæèòåëüíîñòü æèçíè
  • ÎÏÍ — îñòðàÿ ïî÷å÷íàÿ íåäîñòàòî÷íîñòü
  • ÎÏÑÑ - îáùåå ïåðèôåðè÷åñêîå ñîñóäèñòîå ñîïðîòèâëåíèå
  • ÎÐÂÈ — îñòðàÿ ðåñïèðàòîðíàÿ âèðóñíàÿ èíôåêöèÿ
  • ÎÐÄÑ — îñòðûé ðåñïèðàòîðíûé äèñòðåññ-ñèíäðîì
  • ÎÐÇ — îñòðîå ðåñïèðàòîðíîå çàáîëåâàíèå
  • ÎÐÈÒ — îòäåëåíèå ðåàíèìàöèè è èíòåíñèâíîé òåðàïèè (ICU)
  • ÎÑÂÎ — îáùåå ñîäåðæàíèå âîäû â îðãàíèçìå
  • ÎÔÂ — îáúåì ôîðñèðîâàííîãî âûäîõà
  • ÎÔÂ1 — îáúåì ôîðñèðîâàííîãî âûäîõà çà 1-þ ñåêóíäó
  • ÎÖÊ — îáúåì öèðêóëèðóþùåé êðîâè
  • ï.ç. — ïîëå çðåíèÿ (ìèêðîñêîïà)
  • ï/ê — ïîäêîæíî
  • ÏÀÂ — ïñèõîàêòèâíûå âåùåñòâà
  • ÏÂ — ïðîòðîìáèíîâîå âðåìÿ
  • ÏÂÊ — ïåðèôåðè÷åñêèé âåíîçíûé êàòåòåð
  • ÏÂË — ïåðèâåíòðèêóëÿðíàÿ ëåéêîìàëÿöèÿ
  • Ïã — ïðîñòàãëàíäèí
  • ÏÃÃ — ïðîãðàììà ãîñóäàðñòâåííûõ ãàðàíòèé îêàçàíèÿ ãðàæäàíàì ÐÔ áåñïëàòíîé ìåäèöèíñêîé ïîìîùè
  • ÏÄÊÂ — ïîëîæèòåëüíîå äàâëåíèå êîíöà âûäîõà (PEEP)
  • ÏÆ — ïðàâûé æåëóäî÷åê
  • ÏÆÆ — ïîäæåëóäî÷íàÿ æåëåçà
  • ÏÆÊ — ïîäêîæíî-æèðîâàÿ êëåò÷àòêà (ãèïîäåðìà)
  • ÏÊÀ — ïî÷å÷íûé êàíàëüöåâûé àöèäîç
  • ÏÊÌÄ — ïîÿñíî-êîíå÷íîñòíàÿ ìûøå÷íàÿ äèñòðîôèÿ
  • ÏËÑÃ — ïÿòíèñòàÿ ëèõîðàäêà Ñêàëèñòûõ ãîð
  • ÏÌÄÐ — ïðåäìåíñòðóàëüíîå äèñôîðè÷åñêîå ðàññòðîéñòâî
  • ÏÌÊ — ïðîëàïñ ìèòðàëüíîãî êëàïàíà
  • ÏÌÑ — ïðåäìåíñòðóàëüíûé ñèíäðîì
  • ÏÌÑÏ — ïåðâè÷íàÿ ìåäèêî-ñàíèòàðíàÿ ïîìîùü
  • ÏÍÆÊ — ïîëèíåíàñûùåííûå æèðíûå êèñëîòû
  • ÏÎÐÈÒ— ïåäèàòðè÷åñêîå îòäåëåíèå ðåàíèìàöèè è èíòåíñèâíîé òåðàïèè
  • ÏÎÒ — ïîñòóðàëüíàÿ îðòîñòàòè÷åñêàÿ òàõèêàðäèÿ
  • ÏÏÂ — ïíåâìîêîêêîâàÿ ïîëèñàõàðèäíàÿ âàêöèíà
  • ÏÏÎÀÊ — ïðÿìûå ïåðîðàëüíûå àíòèêîàãóëÿíòû
  • ÏÏÒ — ïëîùàäü ïîâåðõíîñòè òåëà
  • ÏÑÀ — ïðîñòàòîñïåöèôè÷åñêèé àíòèãåí
  • ÏÑÂ — ïèêîâàÿ ñêîðîñòü âûäîõà
  • ÏÑÂÕ — ïðîãðåññèðóþùèé ñåìåéíûé âíóòðèïå÷åíî÷-íûé õîëåñòàç
  • ÏÒ — ïñèõîòåðàïèÿ
  • ÏÒÂ — ïðîòðîìáèíîâîå âðåìÿ
  • ÏÒÃ — ïàðàòèðåîèäíûé ãîðìîí
  • ÏÒÈ — ïðîòðîìáèíîâûé èíäåêñ
  • ÏÒÑÐ — ïîñòòðàâìàòè÷åñêîå ñòðåññîâîå ðàññòðîéñòâî
  • ÏÔÝ — ïèùåâîé ôîëàòíûé ýêâèâàëåíò
  • ÏÖÐ — ïîëèìåðàçíàÿ öåïíàÿ ðåàêöèÿ
  • ÏØÃ — ïóðïóðà Øåíëåéíà-Ãåíîõà
  • ÏÙÆ — ïàðàùèòîâèäíûå æåëåçû
  • ÏÝÒ — ïîçèòðîííî-ýìèññèîííàÿ òîìîãðàôèÿ ð/ — ðàç â ... (ñ, ìèí, ÷, ñóò è ò.ï.)
  • ÐÀ — ðåâìàòîèäíûé àðòðèò
  • ÐÀÀÑ — ðåíèí-àíãèîòåíçèí-àëüäîñòåðîíîâàÿ ñèñòåìà ðàçã. — ðàçãîâîðíîå ðàçë. — ðàçëè÷íîå
  • ÐÀÑ — ðàññòðîéñòâî àóòèñòè÷åñêîãî ñïåêòðà
  • ÐÄÑ — ðåñïèðàòîðíûé äèñòðåññ-ñèíäðîì ðèì. — ðèìñêèé
  • ÐÈÔ — ðåàêöèÿ èììóíîôëþîðåñöåíöèè
  • ÐÊÈ — ðàíäîìèçèðîâàííûå êëèíè÷åñêèå èññëåäîâàíèÿ
  • ÐÊÌÏ — ðåñòðèêòèâíàÿ êàðäèîìèîïàòèÿ
  • ÐÈÃÀ — ðåàêöèÿ íåïðÿìîé ãåìàããëþòèíàöèè
  • ÐÍ - ðåòèíîïàòèÿ íåäîíîøåííûõ
  • ÐÍÊ — ðèáîíóêëåèíîâàÿ êèñëîòà
  • ÐÍÏ - ðåêîìåíäóåìóþ íîðìó ïîòðåáëåíèÿ
  • ÐÎÃÊ — ðåíòãåíîãðàôèÿ (ðåíòãåíîãðàììà) îðãàíîâ ãðóäíîé êëåòêè
  • ÐÎËÑÍÑ — ðåêîìåíäàöèè ïî îöåíêå è ëå÷åíèþ ïðè ñîðòèðîâêå â íåîòëîæíûõ ñèòóàöèÿõ
  • ÐÏÃÀ — ðåàêöèÿ ïðÿìîé ãåìàããëþòèíàöèè
  • ð-ð — ðàñòâîð
  • ð-ðèòåëü — ðàñòâîðèòåëü
  • ÐÐÊ — ðåöåïòîðû ðåòèíîåâîé êèñëîòû
  • PPM — ðàñøèðåííûå ðåàíèìàöèîííûå ìåðîïðèÿòèÿ
  • ÐÑÂ — ðåñïèðàòîðíî-ñèíöèòèàëüíûé âèðóñ
  • ÐÑÄ — ðàññòðîéñòâî ñòåðåîòèïíûõ äâèæåíèé
  • ÐÑÊ — ðåàêöèÿ ñâÿçûâàíèÿ êîìïëåìåíòà
  • ÐÑÏ - ðàñ÷åòíàÿ ñðåäíÿÿ ïîòðåáíîñòü
  • ÐÒÃÀ — ðåàêöèÿ òîðìîæåíèÿ ãåìàããëþòèíàöèè
  • ÐÒÍÃÀ — ðåàêöèÿ òîðìîæåíèÿ íåïðÿìîé ãåìàããëþòèíàöèè
  • ÐÔ — Ðîññèéñêàÿ Ôåäåðàöèÿ
  • ÐÕÐ — ðåòèíîåâûå Õ-ðåöåïòîðû
  • Ð×À — ðàäèî÷àñòîòíàÿ àáëÿöèÿ
  • ÐÝÑ — ðåòèêóëîýíäîòåëèàëüíàÿ ñèñòåìà
  • ñ — ñåêóíäà
  • ñâ-âî — ñâîéñòâî
  • ÑÀÌ - ñèíäðîì àñïèðàöèè ìåêîíèÿ
  • ÑÂÄÑ — ñèíäðîì âíåçàïíîé äåòñêîé ñìåðòè
  • ÑÃß — ñèíäðîì ãèïåðñòèìóëÿöèè ÿè÷íèêîâ
  • ÑÄ — ñàõàðíûé äèàáåò
  • ÑÄ-1 — ñàõàðíûé äèàáåò 1-ãî òèïà
  • ÑÄ-2 — ñàõàðíûé äèàáåò 2-ãî òèïà
  • ÑÄÂÃ — ñèíäðîì äåôèöèòà âíèìàíèÿ è ãèïåðàêòèâíîñòè
  • ÑÅ — ñóáúåäèíèöà
  • ÑÆÊ — ñâîáîäíûå æèðíûå êèñëîòû
  • ÑÇÄ - ñëóæáà çàùèòû äåòåé
  • ÑÇÑÒ — ñèñòåìíîå(ûå) çàáîëåâàíèå(ÿ) ñîåäèíèòåëüíîé òêàíè
  • ÑÈÇ — ñðåäñòâà èíäèâèäóàëüíîé çàùèòû
  • ÑÈÎÇÑ— ñåëåêòèâíûé èíãèáèòîð îáðàòíîãî çàõâàòà ñåðîòîíèíà
  • ÑÈÎÇÑÍ — ñåëåêòèâíûå èíãèáèòîðû îáðàòíîãî çàõâàòà ñåðîòîíèíà è íîðýïèíåôðèíà
  • ÑÊÀ — ñåðïîâèäíî-êëåòî÷íàÿ àíåìèÿ
  • ÑÊ — ñåðïîâèäíî-êëåòî÷íàÿ áîëåçíü
  • ÑÊ — ñèñòåìíàÿ êðàñíàÿ âîë÷àíêà
  • ÑÊÔ — ñêîðîñòü êëóáî÷êîâîé ôèëüòðàöèè
  • ÑËÐ — ñåðäå÷íî-ëåãî÷íàÿ ðåàíèìàöèÿ
  • ñì — ñàíòèìåòð
  • ñì âîä.ñò. — ñàíòèìåòð âîäÿíîãî ñòîëáà
  • ÑÌÆ — ñïèííîìîçãîâàÿ æèäêîñòü
  • ÑÌÈ — ñðåäñòâà ìàññîâîé èíôîðìàöèè
  • ÑÌÎ — ñòðàõîâàÿ ìåäèöèíñêàÿ îðãàíèçàöèÿ
  • ÑÌÏ — ñêîðàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÑÌÝ — ñóäåáíî-ìåäèöèíñêàÿ ýêñïåðòèçà
  • ÑÍ — ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • ÑÍÑÀÄÃ — ñèíäðîì íåàäåêâàòíîé ñåêðåöèè ÀÄÃ
  • ÑÎÀÑ — ñèíäðîì îáñòðóêòèâíîãî àïíîý ñíà (âî ñíå) ñîâð. — ñîâðåìåííûé
  • ÑÎÝ — ñêîðîñòü îñåäàíèÿ ýðèòðîöèòîâ
  • ÑÏÈÄ — ñèíäðîì ïðèîáðåòåííîãî èììóíîäåôèöèòà
  • ÑÏÊß — ñèíäðîì ïîëèêèñòîçíûõ ÿè÷íèêîâ
  • ÑÏÎÍ — ñèíäðîì ïîëèîðãàííîé íåäîñòàòî÷íîñòè
  • ÑÐÂ — Ñ-ðåàêòèâíûé áåëîê
  • ÑÐÊ — ñèíäðîì ðàçäðàæåííîãî êèøå÷íèêà
  • ÑðÑÄ — ñðåäíÿÿ ñóòî÷íàÿ äîçà
  • ÑÑÂ — ñèíäðîì Ñòåðäæà-Âåáåðà
  • ÑÑÂÐ — ñèíäðîì ñèñòåìíîé âîñïàëèòåëüíîé ðåàêöèè
  • ÑÑÇ — ñåðäå÷íî-ñîñóäèñòûå çàáîëåâàíèÿ
  • ÑÑÑ — ñåðäå÷íî-ñîñóäèñòàÿ ñèñòåìà
  • ÑÑÑÓ — ñèíäðîì ñëàáîñòè ñèíóñîâîãî óçëà
  • ÑÒ — Ñèíäðîì Òóðåòòà
  • ÑÒÃ — ñîìàòîòðîïíûé ãîðìîí
  • ÑÒÐ — ñòîéêîå (õðîíè÷åñêîå) ìîòîðíîå èëè âîêàëüíîå òèêîçíîå ðàññòðîéñòâî
  • ñóò — ñóòêè
  • ÑÕÓ — ñèíäðîì õðîíè÷åñêîé óñòàëîñòè
  • ò.ä. — òàê äàëåå
  • ò.å. — òî åñòü
  • ò.ê. — òàê êàê
  • ò.î. — òàêèì îáðàçîì
  • ò.ï. — òîìó ïîäîáíîå
  • Ò3 — òðèéîäòèðîíèí
  • Ò4 — òèðîêñèí
  • ÒÀÍÊ — òåñò àìïëèôèêàöèè íóêëåèíîâûõ êèñëîò
  • ÒÁÑ — òàçîáåäðåííûé ñóñòàâ
  • ÒÃÂ — òðîìáîç ãëóáîêèõ âåí
  • ÒÃÑÊ — òðàíñïëàíòàöèÿ ãåìîïîýòè÷åñêèõ ñòâîëîâûõ êëåòîê
  • ÒÈÀ — òðàíçèòîðíàÿ èøåìè÷åñêàÿ àòàêà
  • ÒÈÀÁ — òîíêîèãîëüíàÿ àñïèðàöèîííàÿ áèîïñèÿ
  • ÒÌÎ — òâåðäàÿ ìîçãîâàÿ îáîëî÷êà
  • TH — òîðãîâîå íàèìåíîâàíèå ëåêàðñòâåííûõ ñðåäñòâ
  • ÒÏÃÃ — òåððèòîðèàëüíàÿ ïðîãðàììà ãîñóäàðñòâåííûõ ãàðàíòèé îêàçàíèÿ ãðàæäàíàì ÐÔ áåñïëàòíîé ìåäèöèíñêîé ïîìîùè
  • ÒÏÌ — òðàâìàòè÷åñêîå ïîâðåæäåíèå ìîçãà
  • ÒÒ — òåìïåðàòóðà òåëà
  • ÒÒÃ — òèðåîòðîïíûé ãîðìîí
  • ÒÔÐ — òðàíñôîðìèðóþùèé ôàêòîð ðîñòà
  • ÒÖÀ — òðèöèêëè÷åñêèå àíòèäåïðåññàíòû
  • òûñ. — òûñÿ÷à
  • ÒÝÄ —òðàíçèòîðíàÿ ýðèòðîáëàñòîïåíèÿ äåòñêîãî âîçðàñòà
  • ÒÝËÀ — òðîìáîýìáîëèÿ ëåãî÷íîé àðòåðèè
  • ÒÝÎ — òðîìáîýìáîëè÷åñêèå îñëîæíåíèÿ
  • ÓÇÄÑ — óëüòðàçâóêîâîå äóïëåêñíîå ñêàíèðîâàíèå
  • ÓÇÈ — óëüòðàçâóêîâîå èññëåäîâàíèå
  • óñòàð. — óñòàðåâøåå
  • ÓÔ — óëüòðàôèîëåòîâûé
  • ÓÔÎ — óëüòðàôèîëåòîâîå îáëó÷åíèå
  • ÔÀÏ — ôåëüäøåðñêî-àêóøåðñêèé ïóíêò
  • ÔÂ — ôðàêöèÿ âûáðîñà
  • ÔÂÄ — ôóíêöèè âíåøíåãî äûõàíèÿ
  • ÔÆÅË — ôîðñèðîâàííàÿ æèçíåííàÿ åìêîñòü ëåãêèõ
  • ÔÇ — Ôåäåðàëüíûé çàêîí
  • ôèçèîë. — ôèçèîëîãè÷åñêèé
  • ÔÊ — ôóíêöèîíàëüíûé êëàññ
  • ÔÊÑ — ôèáðîêîëîíîñêîïèÿ
  • ÔÊÓ — ôåíèëêåòîíóðèÿ
  • ÔÍ — ôèçè÷åñêàÿ íàãðóçêà
  • ÔÈÎ — ôàêòîð íåêðîçà îïóõîëè
  • ÔÎÌÑ — ôåäåðàëüíûé ôîíä îáÿçàòåëüíîãî ìåäèöèíñêîãî ñòðàõîâàíèÿ
  • ÔÎÑ — ôîñôîðîðãàíè÷åñêèå ñîåäèíåíèÿ
  • ÔÏ — ôèáðèëëÿöèÿ ïðåäñåðäèé
  • ôð. — ôðàíöóçñêèé
  • ÔÑÃ — ôîëëèêóëîñòèìóëèðóþùèé ãîðìîí
  • ÔÝÃÄÑ — ôèáðîýçîôàãîãàñòðîäóîäåíîñêîïèÿ
  • ÕÁÏ — õðîíè÷åñêàÿ áîëåçíü ïî÷åê
  • ÕÃ× — õîðèîíè÷åñêèé ãîíàäîòðîïèí ÷åëîâåêà
  • ÕÄÍ — õðîíè÷åñêàÿ äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • õèì. — õèìè÷åñêàÿ
  • ÕÍÇË —õðîíè÷åñêèå íåñïåöèôè÷åñêèå çàáîëåâàíèÿ ëåãêèõ
  • ÕÎÁË — õðîíè÷åñêàÿ îáñòðóêòèâíàÿ áîëåçíü ëåãêèõ
  • ÕÏÍ — õðîíè÷åñêàÿ ïî÷å÷íàÿ íåäîñòàòî÷íîñòü
  • ÕÑ — õîëåñòåðèí
  • ÕÑÍ — õðîíè÷åñêàÿ ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • XT — õèìèîòåðàïèÿ
  • ÖÂÄ — öåíòðàëüíîå âåíîçíîå äàâëåíèå
  • ÖÂÊ — öåíòðàëüíûé âåíîçíûé êàòåòåð
  • ÖÈÊ — öèðêóëèðóþùèå èììóííûå êîìïëåêñû
  • ÖÌÂ — öèòîìåãàëîâèðóñ
  • ÖÍÑ — öåíòðàëüíàÿ íåðâíàÿ ñèñòåìà
  • ÖÎÃ — öèêëîîêñèãåíàçà
  • ÖÏÄ — öåðåáðàëüíîå ïåðôóçèîííîå äàâëåíèå
  • ÖÑÒÑ — öåðåáðàëüíûé ñîëüòåðÿþùèé ñèíäðîì ÷ — ÷àñ
  • ×Ä — ÷àñòîòà äûõàíèÿ
  • ×ÄÄ — ÷àñòîòà äûõàòåëüíûõ äâèæåíèé
  • ×Ê — ÷ðåñêîæíîå êîðîíàðíîå âìåøàòåëüñòâî
  • ×ÌÍ — ÷åðåïíî-ìîçãîâûå íåðâû
  • ×ÌÒ — ÷åðåïíî-ìîçãîâàÿ òðàâìà
  • ×Í — ÷åðåïíûå íåðâû
  • ×Ñ — ÷óâñòâèòåëüíîñòü/ñïåöèôè÷íîñòü (×Ñ 97%/87%)
  • ×ÑÑ — ÷àñòîòà ñåðäå÷íûõ ñîêðàùåíèé
  • ×ÑÑÏ - ÷àñòîòà ñåðäå÷íûõ ñîêðàùåíèé ïëîäà
  • ×Ò — ÷àñòè÷íîå òðîìáîïëàñòèíîâîå âðåìÿ
  • ØÊÃ — øêàëà êîìû Ãëàçãî
  • ØÎÏ — øåéíûé îòäåë ïîçâîíî÷íèêà
  • ÙÆ — ùèòîâèäíàÿ æåëåçà
  • ÃÖÔ — ùåëî÷íàÿ ôîñôàòàçà
  • ÝÀÐ — ýêâèâàëåíò àêòèâíîñòè ðåòèíîëà
  • ÝÄÒÀ — ýòèëåíäèàìèíòåòðàóêñóñíàÿ êèñëîòà (ýòèëåíäèàìèíòåòðààöåòàò)
  • ÝÊÃ — ýëåêòðîêàðäèîãðàôèÿ
  • ÝÊÌÎ — ýêñòðàêîðïîðàëüíàÿ ìåìáðàííàÿ îêñèãåíàöèÿ
  • ÝÊÎ — ýêñòðàêîðïîðàëüíîå îïëîäîòâîðåíèå
  • ÝÊÑ — ýëåêòðîêàðäèîñòèìóëÿòîð, ýëåêãðîêàðäèîñòèìóëÿöèÿ
  • ÝÌÃ — ýëåêòðîìèîãðàôèÿ
  • ÝÌÊ — ýëåêòðîííàÿ ìåäèöèíñêàÿ êàðòà
  • ÝÌÏ — ýêñòðåííàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÝÍÌÏ — ýêñòðåííàÿ è íåîòëîæíàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÝÍÌÒ — ýêñòðåìàëüíî íèçêàÿ ìàññà òåëà
  • ÝÒÒ — ýíäîòðàõåàëüíàÿ òðóáêà
  • ÝõîÊà — ýõîêàðäèîãðàôèÿ
  • ÝÝÃ — ýëåêòðîýíöåôàëîãðàôèÿ
  • ÞÄÌ — þâåíèëüíûé äåðìàòîìèîçèò
  • ÞÈÀ — þâåíèëüíûé èäèîïàòè÷åñêèé àðòðèò
  • ßÁ — ÿçâåííàÿ áîëåçíü
  • ÀÀ — àìèëîèä A (amyloid À)
  • ÀÀÐ — Àìåðèêàíñêàÿ àêàäåìèÿ ïåäèàòðèè (American Academy of Pediatrics)
  • ABC — àëãîðèòì íåîòëîæíîé ïîìîùè «äûõàòåëüíûå ïóòè-äûõàíèå-êðîâîîáðàùåíèå» (Airways-Breathing-Circulation)
  • ÀÂÑÀ3 — áåëêîâûé ÷ëåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû À3
  • ÀÂÑÂ11— ãåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû, 11-é ÷ëåí ïîäñåìåéñòâà  (ATP-binding cassette, sub-family  member 11)
  • ÀÂÑÂ4 — ãåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû, 4-é ÷ëåí ïîäñåìåéñòâà  (ATP-binding cassette 4 gene)
  • ÀÂÑÑ2 — ãåí, êîäèðóþùèé 2-é ÷ëåí ïîäñåìåéñòâà Ñ ÀÒÔ-ñâÿçûâàþùèõ êàññåò (ATP-binding cassette sub-family Ñ member 2)
  • ABCDE — àëãîðèòì íåîòëîæíîé ïîìîùè «äûõàòåëüíûå ïóòè-äûõàíèå-êðîâîîáðàùåíèå-íåâðîëîãè÷åñêèé ñòàòóñ-âíåøíèé âèä» (Airways-Breathing-Circulation-Disability- Exposure)
  • ABCG5/G8 — ãåòåðîäèìåð ïåðåíîñ÷èêà ÀÒÔ-ñâÿçûâàþùåé êàññåòû ABCG5 è ABCG8 (The heterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
  • AC — äî åäû (ïðè íàçíà÷åíèÿõ) — ante cibum
  • ÀÑÅÐ — Àìåðèêàíñêàÿ êîëëåãèÿ âðà÷åé íåîòëîæíîé ïîìîùè (American College of Emergency Physicians)
  • ACOG — Àìåðèêàíñêàÿ êîëëåãèÿ àêóøåðîâ è ãèíåêîëîãîâ (American College of Obstetricians and Gynecologists)
  • AHA — Àìåðèêàíñêàÿ êàðäèîëîãè÷åñêàÿ àññîöèàöèÿ (American Heart Association)
  • ALTE — î÷åâèäíîå îïàñíîå äëÿ æèçíè ñîáûòèå (apparent life-threatening event)
  • APLS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè, ñïîíñèðóåìûå Àìåðèêàíñêîé àêàäåìèåé ïåäèàòðèè è Àìåðèêàíñêîé êîëëåãèåé âðà÷åé íåîòëîæíîé ïîìîùè (Advanced Pediatric Life Support)
  • ARPKD — àóòîñîìíî-ðåöåññèâíûé ïîëèêèñòîç ïî÷åê
  • ASCVD-ðèñê — ðèñê ðàçâèòèÿ àòåðîñêëåðîòè÷åñêîãî ñåðäå÷íî-ñîñóäèñòîãî çàáîëåâàíèÿ (ArterioSclerotic Cardiovascular Disease, ASCVD)
  • AVPU — øêàëà äëÿ îöåíêè óðîâíÿ ñîçíàíèÿ («â ÿñíîì ñîçíàíèè»; «ðåàêöèÿ íà âåðáàëüíûå ðàçäðàæèòåëè»; «ðåàêöèÿ íà áîëü»; «áåç ñîçíàíèÿ») (alert, verbal, pain, unresponsive)
  • BCS — ìèòîõîíäðèàëüíûé øàïåðîí BCS1 (mitochondrial chaperone BCS1)
  • BIN — áèíîìèíàëüíàÿ íîìåíêëàòóðà «æèâîé» ïðèðîäû
  • BiPAP — ðåæèì èñêóññòâåííîé âåíòèëÿöèè ëåãêèõ ñ äâóìÿ óðîâíÿìè ïîëîæèòåëüíîãî äàâëåíèÿ (bilevel positive airway pressure) = ÂÐÀÐ
  • BNP — íàòðèéóðåòè÷åñêèé ïåïòèä Â-òèïà — ìîçãîâîé ( (brain)-type natriuretic peptide)
  • BRUE — áûñòðî ðàçðåøèâøèåñÿ íåîáúÿñíèìûå ñîáûòèÿ (Brief resolved unexplained events)
  • BSEP — íàñîñ âûâåäåíèÿ ñîëåé æåë÷íûõ êèñëîò
  • CADASIL — öåðåáðàëüíàÿ àóòîñîìíî-äîìèíàíòíàÿ àðòåðèîïàòèÿ ñ ïîäêîðêîâûìè èíôàðêòàìè è ëåéêîýíöåôàëîïàòèåé (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
  • CAPS — êðèîïèðèí-àññîöèèðîâàííûé ïåðèîäè÷åñêèé ñèíäðîì (cryopyrin-associated periodic syndrome)
  • CBIT — êîìïëåêñíîå ïîâåäåí÷åñêîå âîçäåéñòâèå ïðè òèêàõ (Comprehensive behavioral intervention for tics)
  • CD — êëàñòåðû äèôôåðåíöèðîâêè (clusters of differentiation)
  • CDC — Öåíòð ïî êîíòðîëþ è ïðîôèëàêòèêå çàáîëåâàíèé, ÑØÀ (Center for Disease Control and Prevention)
  • CDG — âðîæäåííûå íàðóøåíèÿ ãëèêîçèëèðîâàíèÿ (Congenital Disorder of Glycosylation)
  • CFTR — òðàíñìåìáðàííûé ðåãóëÿòîð ìóêîâèñöèäîçà (cystic fibrosis transmembrane regulator)
  • CH — ãåìîëèòè÷åñêèé êîìïëåìåíò (hemolytic complement)
  • CLLS — øêàëà îöåíêè îñòðîé ãîðíîé áîëåçíè îçåðà Ëóèç ó äåòåé (Childrens Lake Louise Score)
  • CMT — Øàðêî-Ìàðè-Òóòà áîëåçíü (Charcot-Marie-Tooth disease)
  • ÑÐÀÐ — ïîñòîÿííîå ïîëîæèòåëüíîå äàâëåíèå â äûõàòåëüíûõ ïóòÿõ (Constant Positive Airway Pressure)
  • CYP — öèòîõðîì îáùèé
  • DAF — ôàêòîð óñêîðåíèÿ ðàñïàäà (decay-accelerating factor)
  • DGAT1 —äèàöèëãëèöåðèí-1-àöèëòðàíñôåðàçà (diacylglycerol acyltransferase 1)
  • DHR — äèãèäðîðîäàìèí (dihydrorhodamine)
  • DSM — Äèàãíîñòè÷åñêîå è ñòàòèñòè÷åñêîå ðóêîâîäñòâî ïî ïñèõè÷åñêèì ðàññòðîéñòâàì (Diagnostic and Statistical Manual of Mental Disorders)
  • EAST syndrome — ýïèëåïñèÿ, àòàêñèÿ, ñåíñîíåâðàëüíàÿ òóãîóõîñòü è òóáóëîïàòèÿ (epilepsy, ataxia, sensorineural hearing loss, and tubulopath)
  • EBM — äîêàçàòåëüíàÿ ìåäèöèíà (Evidence based medicine)
  • EPCAM— ìîëåêóëà àäãåçèè ýïèòåëèàëüíûõ êëåòîê (epithelial cell adhesion molecule)
  • ESC — Åâðîïåéñêîå îáùåñòâî êàðäèîëîãèè (European Society of Cardiology)
  • EXIT — ëå÷åíèå âíå ìàòêè âî âðåìÿ ðîäîâ (Ex utero intrapartum treatment)
  • FAST — ñôîêóñèðîâàííàÿ ñîíîãðàôèÿ áðþøíîé ïîëîñòè ïðè òðàâìå (focused assessment with sonography in trauma)
  • FDA — Êîìèòåò ïî êîíòðîëþ çà ëåêàðñòâåííûìè âåùåñòâàìè è ïèùåâûìè äîáàâêàìè, ÑØÀ (Food and Drug Administration)
  • FFR — ôðàêöèîííûé ðåçåðâ êðîâîòîêà (Fractional Flow Reserve)
  • FGF-23 — ôàêòîð ðîñòà ôèáðîáëàñòîâ-23 (Fibroblast growth factor-23)
  • FIC 1 —ñåìåéíûé âíóòðèïå÷åíî÷íûé õîëåñòàç 1-ãî òèïà, áîëåçíü Áàéëåðà (familial intrahepatic cholestasis)
  • FiO2 — ôðàêöèÿ êèñëîðîäà (âî âäûõàåìîì âîçäóõå, ãàçîâîé ñìåñè)
  • FISH — ôëóîðåñöåíòíàÿ in situ ãèáðèäèçàöèÿ (fluorescence in situ hybridization)
  • FLAIR — âîññòàíîâëåíèå èíâåðñèè ñ îñëàáëåíèåì æèäêîñòè (fluid-attenuated inversion recovery)
  • FMF — ñåìåéíàÿ ñðåäèçåìíîìîðñêàÿ ëèõîðàäêà (Familial Mediterranean fever)
  • GATA — gata-ñâÿçûâàþùèé áåëîê
  • HADH — ãèäðîêñèëàöèë-ÊîÀ-äåãèäðîãåíàçà (Hydro-xyacyl-Coenzyme A dehydrogenase)
  • HAV — âèðóñ ãåïàòèòà Â (hepatitis A virus)
  • Hb — ãåìîãëîáèí
  • HBcAg — ñåðäöåâèííûé àíòèãåí âèðóñà ãåïàòèòà Â
  • HBeAg — àíòèãåí âèðóñà ãåïàòèòà Â
  • HBsAg — ïîâåðõíîñòíûé àíòèãåí âèðóñà ãåïàòèòà Â
  • HBV — âèðóñ ãåïàòèòà  (hepatitis  virus)
  • HCV — âèðóñ ãåïàòèòà Ñ (hepatitis Ñ virus)
  • HDV — âèðóñ ãåïàòèòà D (hepatitis D virus)
  • HFNC — íàçàëüíûå êàíþëè âûñîêîãî ïîòîêà (heated, high-flow nasal cannula)
  • Hib — ãåìîôèëüíàÿ ïàëî÷êà òèïà  (Haemophilus influenzae  type)
  • HLA — ëåéêîöèòàðíûå àíòèãåíû (ãëàâíîãî êîìïëåêñà ãèñòîñîâìåñòèìîñòè) ÷åëîâåêà (human leukocyte antigens)
  • HR — îòíîøåíèå ðèñêîâ (hazard ratio)
  • HRT — òåðàïèÿ îòìåíû ïðèâû÷êè (Habit reversal therapy)
  • Ht — ãåìàòîêðèò
  • HTLV — Ò-ëèìôîòðîïíûé âèðóñ ÷åëîâåêà (human T-lymphotropic virus)
  • Ig — èììóíîãëîáóëèí
  • IgA — èììóíîãëîáóëèí A
  • IgE — èììóíîãëîáóëèí E
  • IgG — èììóíîãëîáóëèí G
  • IgM — èììóíîãëîáóëèí M
  • IL — èíòåðëåéêèí
  • IPEX — Õ-ñöåïëåííûé ñèíäðîì èììóííîé äèñðå-ãóëÿöèè, ïîëèýíäîêðèíîïàòèè è ýíòåðîïàòèè (Immunedysregulation polyendocrinopathy enteropathy, X-linked)
  • IQ — êîýôôèöèåíò óìñòâåííîãî ðàçâèòèÿ (intelligence quotient)
  • JAK — ÿíóñ-êèíàçà (Janus kinase)
  • LFA — àíòèãåí, àêòèâèðóþùèé ôóíêöèþ ëåéêîöèòîâ (Lymphocyte function-associated antigen)
  • LT — ëåéêîòðèåí
  • MALT — ëèìôîèäíàÿ òêàíü ñëèçèñòîé îáîëî÷êè (mucosa-associated lymphoid tissue)
  • MASP — ÌÑË-àññîöèèðîâàííàÿ ñåðèíîâàÿ ïðîòåàçà (MBL-associated serine protease)
  • MBL — ìàííîçî-ñâÿçûâàþùèé ëåêòèí (mannose-
  • binding lectin)
  • MCP — ìåìáðàííûé áåëîê-êîôàêòîð (membrane cofactor protein)
  • MDR3 — áåëîê ìíîæåñòâåííîé ëåêàðñòâåííîé óñòîé÷èâîñòè 3 (multidrug resistance protein 3)
  • MELAS — ìèòîõîíäðèàëüíàÿ ýíöåôàëîïàòèÿ, ëàêòîàöèäîç è èíñóëüòîïîäîáíûå ýïèçîäû (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)
  • MERRF — ìèîêëîíè÷åñêàÿ ýïèëåïñèÿ ñ ðâàíûìè êðàñíûìè âîëîêíàìè (Myoclonic epilepsy with ragged red fibers)
  • Mr — êàæóùàÿñÿ ìîëåêóëÿðíàÿ ìàññà
  • MRP — áåëîê ñ ìíîæåñòâåííîé ëåêàðñòâåííîé óñòîé÷èâîñòüþ (multidrug-resistant protein)
  • MRSA — ìåòèöèëëèíðåçèñòåíòíûé çîëîòèñòûé ñòàôèëîêîêê
  • MSSA — ìåòèöèëëèí÷óâñòâèòåëüíûé çîëîòèñòûé ñòàôèëîêîêê
  • NB! — âàæíî, îáðàòèòü âíèìàíèå (Nota bene)
  • NICE — Íàöèîíàëüíûé èíñòèòóò çäîðîâüÿ è êëèíè÷åñêîãî ñîâåðøåíñòâîâàíèÿ (êà÷åñòâà ìåäèöèíñêîé ïîìîùè) Âåëèêîáðèòàíèè (National Institute for Health and Clinical Excellence)
  • NK — åñòåñòâåííûå êëåòêè-êèëëåðû (natural killer)
  • NMDA — N-ìåòèë-D-àñïàðòàò (N-methyl-D-aspartate)
  • NMDA — N-ìåòèë-D-àñïàðòàòíûå ðåöåïòîðû
  • NNT — ÷èñëî áîëüíûõ, êîòîðûõ íåîáõîäèìî ïðîëå÷èòü, ÷òîáû äîñòè÷ü êàêîãî-òî óêàçàííîãî ýôôåêòà (Number Need to Treatment)
  • OR — îòíîøåíèå øàíñîâ (odds ratio)
  • paCO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà â àðòåðèàëüíîé êðîâè
  • PALS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè (Pediatric Advanced Life Support)
  • PANDAS — àóòîèììóííîå íåéðîïñèõèàòðè÷åñêîå ðàññòðîéñòâî â äåòñêîì âîçðàñòå, àññîöèèðîâàííîå ñî ñòðåïòîêîêêîâîé èíôåêöèåé (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
  • PANS — îñòðûé íåéðîïñèõèàòðè÷åñêèé ñèíäðîì â äåòñêîì âîçðàñòå (Pediatric acute-onset neuropsychiatric syndrome)
  • paO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà â àðòåðèàëüíîé êðîâè
  • PAS — ôóêñèíñåðíèñòàÿ êèñëîòà, ðåàêòèâ Øèôôà (periodic acid-Shiff)
  • PC — ïîñëå åäû (ïðè íàçíà÷åíèÿõ) — post cibum ðÑO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà
  • PCSK-9 — ïðîïðîòåèíîâàÿ êîíâåðòàçà ñóáòèëèçèí-êåêñè-íîâîãî òèïà 9 (proprotein convertase subtilisin/ kexin type 9)
  • PFAPA — ïåðèîäè÷åñêàÿ ëèõîðàäêà ñ àôòîçíûì ñòîìàòèòîì, ôàðèíãèòîì è ëèìôàäåíèòîì (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
  • PFIC — ñåìåéíûé âíóòðèïå÷åíî÷íûé õîëåñòàç (familial intrahepatic cholestasis)
  • Pg — ïðîñòàãëàíäèí
  • pH — âîäîðîäíûé ïîêàçàòåëü
  • PIM — ïîêàçàòåëü ëåòàëüíîãî èñõîäà ó äåòåé (Pediatric Index of Mortality)
  • piO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà âî âäûõàåìîì
  • âîçäóõå
  • ðO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà
  • POLG — ñóáúåäèíèöà ÄÍÊ-ïîëèìåðàçû ó
  • PRISA II — îöåíêà ðèñêà ãîñïèòàëèçàöèè ó äåòåé II (Pediatric Risk of Admission)
  • PRISM — ðèñê ëåòàëüíîãî èñõîäà ó äåòåé (Pediatric Risk of Mortality)
  • PRN — ïðè (ïî) íåîáõîäèìîñòè (Pro re nata — ïðè âîçíèêíîâåíèè îáñòîÿòåëüñòâ)
  • PRSS — ãåí ñåðèíîâîé ïðîòåàçû
  • PS. — ïðèìå÷àíèå (Post scriptum)
  • PUVA-òåðàïèÿ — ïñîðàëåí-óëüòðàôèîëåò À-òåðàïèÿ (psoralen and ultraviolet À)
  • Q#H — êàæäûå # ÷àñîâ (ïðè íàçíà÷åíèÿõ) — quaque ... hora
  • QAM — êàæäîå óòðî (ïðè íàçíà÷åíèÿõ) — quaque ante meridiem
  • QPM — êàæäûé âå÷åð (ïðè íàçíà÷åíèÿõ) — quaque post meridiem
  • RAG — ãåí, àêòèâèðóþùèé ðåêîìáèíàçó
  • RePEAT— ïåðåñìîòðåííûé èíñòðóìåíò äëÿ îöåíêè ïåäèàòðè÷åñêîé íåîòëîæíîé ìåäèöèíñêîé ïîìîùè (Revised Pediatric Emergency Assessment Tool)
  • RF — ðåâìàòîèäíûé ôàêòîð
  • Rh — ðåçóñ(-ôàêòîð)
  • Rh«-» — ðåçóñ-îòðèöàòåëüí(ûé)
  • Rh«+» — ðåçóñ-ïîëîæèòåëüí(ûé)
  • ROHHAD — áûñòðî ðàçâèâàþùååñÿ îæèðåíèå ñ äèñôóíêöèåé ãèïîòàëàìóñà, ãèïîâåíòèëÿöèåé è ñïîíòàííîé äèñðåãóëÿöèåé (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
  • RR — îòíîñèòåëüíûé ðèñê (relative risk èëè risk ratio) RW — ðåàêöèÿ Âàññåðìàíà (reaction of Wassermann)
  • SaO2 — ñàòóðàöèÿ àðòåðèàëüíîé êðîâè êèñëîðîäîì SatO2 — íàñûùåíèå êðîâè êèñëîðîäîì
  • ScvO2 — íàñûùåíèå êèñëîðîäîì öåíòðàëüíîé âåíîçíîé êðîâè (Central venous oxygen saturation)
  • SD — ñòàíäàðòíîå îòêëîíåíèå (standart deviation) SFTPA — ãåí ñóðôàêòàíòíîãî áåëêà A
  • SFTPB — ãåí ñóðôàêòàíòíîãî áåëêà Â
  • SFTPC — ãåí ñóðôàêòàíòíîãî áåëêà Ñ
  • SPINK — èíãèáèòîð ñåðèíîâîé ïðîòåàçû
  • SpO2 — íàñûùåíèå (ñàòóðàöèÿ) ãåìîãëîáèíà êèñëîðîäîì spp. — âèäû (ïðè ðîäîâîì èìåíè ìèêðîîðãàíèçìîâ)
  • Src. — èñòî÷íèê èíôîðìàöèè, áèáëèîãðàôè÷åñêàÿ ññûëêà (source)
  • STAT1 — ñèãíàëüíûé ïðåîáðàçîâàòåëü è àêòèâàòîð òðàíñêðèïöèè 1 (signal transducer and activator of transcription)
  • TA — ìåæäóíàðîäíàÿ àíàòîìè÷åñêàÿ òåðìèíîëîãèÿ TCR — T-êëåòî÷íûé ðåöåïòîð (T-cell receptor)
  • TLRs — Òîëë-ïîäîáíûå ðåöåïòîðû (Toll-like receptors) TNF — ôàêòîð íåêðîçà îïóõîëè (tumor necrosis factor)
  • TORCH — òîêñîïëàçìîç, êðàñíóõà, öèòîìåãàëîâèðóñíàÿ èíôåêöèÿ, ãåðïåñ è äðóãèå èíôåêöèè (Toxoplasmosis, Other infections, Rubella, Cytomegalovirus Herpes simplex)
  • TPM — ìóòàöèÿ òðîïîìèîçèíà (mutation of the tropomyosin)
  • TRAP — ñèíäðîì îáðàòíîé àðòåðèàëüíîé ïåðôóçèè áëèçíåöîâ (twin reversed arterial perfusion)
  • TRAPS — ïåðèîäè÷åñêèé ñèíäðîì, àññîöèèðîâàííûé ñ ðåöåïòîðîì ôàêòîðà íåêðîçà îïóõîëè (Tumor Necrosis Factor Receptor-Associated Periodic Syndrome)
  • ™ — òîðãîâàÿ ìàðêà
  • URL — èíòåðíåò-ññûëêà, àäðåñ èíòåðíåò-ðåñóðñà (Uniform Resource Locator)
  • VEGF — ôàêòîð ðîñòà ýíäîòåëèÿ ñîñóäîâ (Vascular Endothelial Growth Factor)
  • WPW — ñèíäðîì Âîëüôà-Ïàðêèíñîíà-Óàéòà (Wolff-Parkinson-White)
  • XLA — Õ-ñöåïëåííàÿ àãàììàãëîáóëèíåìèÿ (X-linked agammaglobulinemia)
  • aDG-RD — äèñòðîôèè, ñâÿçàííûå ñ a-äèñòðîãëèêàíàìè (alpha dystroglycan-related dystrophies)
  • β-ÕÃ× — β-ñóáúåäèíèöà õîðèîíè÷åñêîãî ãîíàäîòðîïèíà ÷åëîâåêà

 õîäå ïîäãîòîâêè ñòàòåé ïî äåòñêîé îðòîïåäèè â ïåäèàòðèè äëÿ ïîëüçîâàòåëåé ñàéòà ÌåäÓíèâåð èñïîëüçîâàíû òðóäû ñëåäóþùèõ àâòîðîâ:

  1. Davids JR: Normal gait and assessment of gait disorders. In Morrissy R, Weinstein S, editors: Lovell and Winter’s pediatric orthopedics, ed 5, Philadelphia, 2001, Lippincott Williams & Wilkins.
  2. Dimeglio A: Growth in pediatric orthopedics. In Weinstein S, Flynn JM, editors: Lovell and Winter’s pediatric orthopedics, ed 7, Philadelphia, 2013, Lippincott Williams & Wilkins, pp 33–62.
  3. Engstr?m P, Tedroff K: The prevalence and course of idiopathic toe-walking in 5-year-old children, Pediatrics 130:279–284, 2012.
  4. Frick SL: Normal growth and development in pediatric orthopedics. In Dormans JP, editor: Pediatric orthopedics: core knowledge in orthopedics, Philadelphia, 2005, Mosby, pp 1–14.
  5. Mackie EJ, Tatarczuch L, Mirams M: The skeleton: a multifunctional complex organ.
  6. The growth plate and endochondral ossification, J Endocrinol 211(2):109–121, 2011. Ogden J: Anatomy and physiology of skeletal development. In Catterall A, editor:
  7. Skeletal injury in the child, ed 3, New York, 2000, Springer-Verlag, pp 1–37. Song KM, Little DG: Peak height velocity as a maturity indicator for males with idiopathic scoliosis, J Pediatr Orthop 20:286–288, 2000.
  8. Topol GA, Podesta LA, Reeves KD, et al: Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease, Pediatrics 128:e1121–e1128, 2011.
  9. Bakhos LL, Lockhart GR, Myers R, et al: Emergency department visits for concussion in young child athletes, Pediatrics 126:e550–e556, 2010.
  10. Blinman TA, Houseknecht E, Snyder C, et al: Postconcussive symptoms in hospitalized pediatric patients after mild traumatic brain injury, J Pediatr Surg 44(6):1223–1228, 2009.
  11. Blume H, Hawash K: Subacute concussion-related symptoms and postconcussion syndrome in pediatrics, Curr Opin Pediatr 24:724–730, 2012.
  12. Brooks BL, Mannix R, Maxwell B, et al: Multiple past concussions in high school football players: are there differences in cognitive functioning and symptom reporting?, Am J Sports Med 44(12):3243–3251, 2016.
  13. Brown NJ, Mannix RC, O’Brien MJ, et al: Effect of cognitive activity level on duration of post-concussion symptoms, Pediatrics 133:e299–e304, 2014.
  14. Bryan MA, Rowhani-Rahbar A, Comstock RD, et al: Sports- and recreation-related concussions in US youth, Pediatrics 138(1):e20154635, 2016.
  15. Collins M, Lovell MR, Iverson GL, et al: Examining concussion rates and return to play in high school football players wearing newer helmet technology: a three-year prospective cohort study, Neurosurgery 58(2):275–286, 2006.
  16. Collins MW, Iverson GL, Lovell MR, et al: On-field predictors of neuropsychological and symptom deficit following sports-related concussion, Clin J Sport Med 13(4):222–229, 2003.
  17. Collins MW, Kontos AP, Reynolds E, et al: A comprehensive, targeted approach to the clinical care of athletes following sport-related concussion, Knee Surg Sports Traumatol Arthrosc 22(2):235–246, 2014.
  18. Colvin JD, Thurm C, Pate BM, et al: Diagnosis and acute management of patients with concussion at children’s hospitals, Arch Dis Child 98:934–938, 2013.
  19. Committee on Sports-Related Concussions in Youth: Sports-related concussions in youth: improving the science, changing the culture, Institute of Medicine of the National Academies Report Brief, October 2013, Washington, DC, 2014, National Academies Press.
  20. DeMatteo CA, Hanna SE, Mahoney WJ, et al: My child doesn’t have a brain injury, he only has a concussion, Pediatrics 125:327–334, 2010.
  21. Dick RW: Is there a gender difference in concussion incidence and outcomes?, Br J Sports Med 43(Suppl 1):i46–i50, 2009.
  22. Eisenberg MA, Andrea J, Meehan W, et al: Time interval between concussions and symptom duration, Pediatrics 132:8–17, 2013.
  23. Elbin RJ, Sufrinko A, Schatz P, et al: Removal from play after concussion and recovery time, Pediatrics 138(3):e20160910, 2016.
  24. Field M, Collins MW, Lovell MR, et al: Does age play a role in recovery from sports related concussion? A comparison of high school and collegiate athletes, J Pediatr 142:546–553, 2003.
  25. Giza CC, Hovda DA: The neurometabolic cascade of concussion, J Athl Train 36: 228–235, 2001.
  26. Giza CC, Kutcher JS, Barth J, et al: Summary of evidence-based guideline update: evaluation and management of concussion in sports. Report of the Guideline Development Subcommittee of the American Academy of Neurology, Neurology 80:2250–2257, 2013.
  27. Grool AM, Agilpay M, Momoli F, et al: Association between early participation in physical activity following acute concussion and persistent post-concussive symptoms in children and adolescents, JAMA 316(23):2504–2514, 2016.
  28. Grubenhoff JA, Currie D, Comstock RD, et al: Psychological factors associated with delayed symptom resolution in children with concussion, J Pediatr 174:27–32, 2016.
  29. Guerriero RM, Proctor MR, Mannix R, et al: Epidemiology, trends, assessment and management of sport-related concussion in United States high schools, Curr Opin Pediatr 24:696–701, 2012.
  30. Halstead ME, Walter KD, Moffatt K: Sport-related concussion in children and adolescents, Pediatrics 142(6):e20183074, 2018.
  31. Halstead ME, McAvoy K, Devore CD, et al: Returning to learning following a concussion, Pediatrics 132:948–957, 2013.
  32. Halstead ME, Walter KD: Council on Sports Medicine and Fitness. Sport-related concussion in children and adolescents, Pediatrics 126(3):597–615, 2010.
  33. Harmon KG, Drezner JA, Gammons M, et al: American Medical Society for Sports Medicine position statement: concussion in sport, Clin J Sport Med 23:1–18, 2013.
  34. Helmy A, Agarwal M, Hutchinson PJ: Concussion and sport, BMJ 347:f5748, 2013. Heyer GL, Schaffer CE, Rose SC, et al: Specific factors influence postconcussion symptom duration among youth referred to a sports concussion clinic, J Pediatr 174:33–38, 2016.
  35. Iverson GL, Gardner AJ, Terry DP, et al: Predictors of clinical recovery from concussion: a systematic review, Br J Sports Med 51(12):941–948, 2017.
  36. Jotwani V, Harmon KG: Postconcussion syndrome in athletes, Curr Sports Med Rep 9(1):21–26, 2010.
  37. Kontos AP, Elbin RJ, Fazio-Sumrock VC, et al: Incidence of sports-related concussion among youth football players aged 8-12 years, J Pediatr 163:717–720, 2013.
  38. Kucera KL, Yau RK, Register-Mihalik J, et al: Traumatic brain and spinal cord fatalities among high school and college football players—United States, 2005-2014, MMWR Morb Mortal Wkly Rep 65(52):1465–1469, 2017.
  39. Langlois JA, Rutland-Brown W, Wald MM: The epidemiology and impact of traumatic brain injury: a brief overview, J Head Trauma Rehabil 21:375–378, 2006.
  40. Lau BC, Kontos AP, Collins MW, et al: Which on-field signs/symptoms predict protracted recovery from sport-related concussion among high school football players?, Am J Sports Med 39:2311–2318, 2011.
  41. Makdissi M, Schneider KJ, Feddermann-Dermont N, et al: Approach to investigation and treatment of persistent symptoms following sport-related concussion: a systematic review, Br J Sports Med 2017. doi:10.1136/bjsports-2016-097470. Published Online First 8 May.
  42. Maugans TA, Farley C, Altaye M, et al: Pediatric sports-related concussion produces cerebral blood flow alterations, Pediatrics 129:28–37, 2012.
  43. McAllister TW, Flashman LA, Maerlender A, et al: Cognitive effects of one season of head impacts in a cohort of collegiate contact sport athletes, Neurology 78:1777–1784, 2012.
  44. McCrea M, Guskiewicz K, Randolph C, et al: Incidence, clinical course, and predictors of prolonged recovery time following sport-related concussion in high school and college athletes, J Int Neuropsychol Soc 19:22–33, 2013.
  45. McCrory P, Meeuwise W, Aubry M, et al: Consensus statement on concussion in sport: the 4th international conference on concussion in sport held in Zurich, November 2012, Br J Sports Med 47:250–258, 2013.
  46. McCrory P, Meeuwise WH, Dvorak J, et al: Consensus statement on concussion in sport—the 5th international conference on concussion in sport held in Berlin, October 2016, Br J Sports Med 51:838–847, 2017.
  47. Meehan WP III, d’Hemecourt P, Collins C, et al: Computerized neurocognitive testing for the management of sport-related concussions, Pediatrics 129:38–44, 2012.
  48. Moser RS, Glatts C, Schatz P: Efficacy of immediate and delayed cognitive and physical rest for treatment of sports-related concussion, J Pediatr 161:922–926, 2012.
  49. Moser RS, Schatz P: A case for mental and physical rest in youth sports concussion: it’s never too late, Front Neurol 3(171):1–7, 2012.
  50. Newcombe VFJ: Cognitive deficits and mild traumatic brain injury, BMJ 346:f1522, 2013.
  51. Pfaller AY, Nelson LD, Apps JN, et al: Frequency and outcomes of a symptom-free waiting period after sport-related concussion, Am J Sports Med 44(11):2941–2946, 2016.
  52. Rivara FP, Schiff MA, Chrisman SP, et al: The effect of coach education on reporting of concussions among high school athletes after passage of concussion law, Am J Sports Med 42(5):1197–1203, 2014.
  53. Root JM, Zuckerbraun NS, Wang L, et al: History of somatization is associated with prolonged recovery for concussion, J Pediatr 174:39–44, 2016.
  54. Schatz P, Moser RS, Covassin T, et al: Early indicators of enduring symptoms in high school athletes with multiple previous concussions, Neurosurgery 68(6):1562–1567, 2011.
  55. Schneider KJ, Leddy JJ, Guskiewicz KM, et al: Rest and treatment/rehabilitation following sport-related concussion: a systematic review, Br J Sports Med 51:930–934, 2017.
  56. Shahim P, Tegner Y, Wilson DH, et al: Blood biomarkers for brain injury in concussed professional ice hockey players, JAMA Neurol 71:684–692, 2014.
  57. Silverberg ND, Iverson GL, McCrea M, et al: Activity-related symptom exacerbations after pediatric concussion, JAMA Pediatr 170(10):946–953, 2016.
  58. Singh R, Meier TB, Kuplicki R, et al: Relationship of collegiate football experience and concussion with hippocampal volume and cognitive outcomes, JAMA 311:1883–1888, 2014.
  59. Sport concussion assessment tool—5th edition, Br J Sports Med 51:851–858, 2017.
  60. Sufrinko AM, Kontos AP, Apps JN, et al: The effectiveness of prescribed rest depends on initial presentation after concussion, J Pediatr 185:167–172, 2017.
  61. Taverez MM, Atabaki SM, Teach SJ: Acute evaluation of pediatric patients with minor traumatic brain injury, Curr Opin Pediatr 24:307–313, 2012.
  62. Taylor AM: Neuropsychological evaluation and management of sport-related concussion, Curr Opin Pediatr 24:717–723, 2012.
  63. Thomas DG, Apps JN, Hoffmann RG, et al: Benefits of strict rest after acute concussion: a randomized controlled trial, Pediatrics 135(2), 2015. doi:10.1542/peds.2014-0966. e-pub January.
  64. Yuh EL, Mukherjee P, Lingsma HF, et al: Magnetic resonance imaging improves 3-month outcome prediction in mild traumatic brain injury, Ann Neurol 73:224–235, 2013.
  65. Weiler R, Ingram M, Wolman R: Osgood-Schlatter disease, BMJ 343:d4535, 2011.
  66. Al-Hakim W, Jaiswal PK, Khan W, et al: The non-operative treatment of anterior knee pain, Open Orthop J 6:320–326, 2012.
  67. Hennrikus W, Pylawka T: Patellofemoral instability in skeletally immature athletes, J Bone Joint Surg Am 95(2):176–183, 2013.
  68. Hensler D, Sillanpaa PJ, Schoettle PB: Medial patellofemoral ligament: anatomy, injury and treatment in the adolescent knee, Curr Opin Pediatr 26:70–78, 2014.
  69. Beck NA, Lawrence JTR, Nordin JD, et al: ACL Tears in School-Aged Children and Adolescents Over 20 Years, Pediatrics 139(3):e20161877, 2017.
  70. Lawrence JT, Argawal N, Ganley TJ: Degeneration of the knee joint in skeletally immature patients with a diagnosis of an anterior cruciate ligament tear: is there harm in delay of treatment? Am J Sports Med 39:2582–2587, 2011.
  71. Milewski MD, Beck NA, Lawrence JT, et al: Anterior cruciate ligament reconstruction in the young athlete: a treatment algorithm for the skeletally immature, Clin Sports Med 30:801–810, 2011.
  72. Price MJ, Tuca M, Cordasco FA, Green DW: Nonmodifiable risk factors for anterior cruciate ligament injury, Curr Opin Pediatr 29:55–64, 2017.
  73. Shea KG, Grimm NL, Ewing CK, et al: Youth sports anterior cruciate ligament and knee injury epidemiology: who is getting injured? In what sports? When? Clin Sports Med 30:691–706, 2011.
  74. Bracken J, Tran T, Ditchfield M: Developmental dysplasia of the hip: controversies and current concepts, J Paediatr Child Health 48(11):963–972, 2012.
  75. Bruras KR, Aukland SM, Markestad T, et al: Newborns with sonographically dysplastic and potentially unstable hips: 6-year follow-up of an RCT, Pediatrics 127:e661–e666, 2011.
  76. Carroll KL, Schiffern AN, Murray KA, et al: The occurrence of occult acetabular dysplasia in relatives of individuals with developmental dysplasia of the hip, J Pediatr Orthop 36(1):96–100, 2016.
  77. Dezateux C, Rosendahl K: Developmental dysplasia of the hip, Lancet 369:1541–1552, 2007.
  78. Dogruel H, Atalar H, Yavuz OY, et al: Clinical examination versus ultrasonography in detecting developmental dysplasia of the hip, Int Orthop 32(3):415–419, 2008.
  79. Haynes DJ: Developmental dysplasia of the hip: etiology, pathogenesis and examination and physical findings in the newborn, Instr Course Lect 50:535–540, 2001.
  80. Laborie LB, Engesaeter IO, Lehmann TG, et al: Screening strategies for hip dysplasia: Long-term outcome of a randomized controlled trial, Pediatrics 132:492–501, 2013.
  81. Lowry CA, Donoghue VB, Murphy JF: Auditing hip ultrasound screening of infants at increased risk of developmental dysplasia of the hip, Arch Dis Child 90:579–581, 2005.
  82. Moseley CF: Developmental hip dysplasia and dislocation: management of the older child, Instr Course Lect 50:547–553, 2001.
  83. Mulpuri K, Song KM, Goldberg MJ, Sevarino K: Detection and nonoperative management of pediatric developmental dysplasia of the hip in infants up to 6 months of age, J Am Acad Orthopaedic Surg 23(3):202–205, 2015.
  84. Pacana MJ, Hennrikus WL, Slough J, Curtin W: Ultrasound examination for infants born breech by elective cesarean section with a normal hip exam for instability, J Pediatr Orthop 37(1):e15–e18, 2017.
  85. Pollet V, Percy V, Prior HJ: Relative risk and incidence for developmental dysplasia of the hip, J Pediatr 181:202–207, 2017.
  86. Roovers EA, Boere-Boonekamp MM, Castelein RM, et al: Effectiveness of ultrasound screening for developmental dysplasia of the hip, Arch Dis Child Fetal Neonatal Ed 90:F25–F30, 2005.
  87. Roy DR: Current concepts in Legg-Calv?-Perthes disease, Pediatr Ann 28:748–752, 1999.
  88. Shaw BA, Segal LS: Section on orthopaedics. Evaluation and referral for developmental dysplasia of the hip in infants, Pediatrics 138(6):e20163107, 2016.
  89. Shorter D, Hong T, Osborn DA: Screening programmes for developmental dysplasia of the hip in newborn infants, Cochrane Database Syst Rev (9):CD004595, 2011.
  90. U.S. Preventive Services Task Force: Screening for developmental dysplasia of the hip: recommendation statement, Pediatrics 117:898–902, 2006.
  91. West S, Witt J: Bilateral developmental dysplasia of the hips, BMJ 342:d2152, 2011.
  92. Woolacott NF, Puhan MA, Steurer J, et al: Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review, BMJ 330:1413–1415, 2005.
  93. Caird MS, Flynn JM, Leung YL, et al: Factors distinguishing septic arthritis from transient synovitis of the hip in children, J Bone Joint Surg Am 88:1251–1257, 2006.
  94. Cook PC: Transient synovitis, septic hip, and Legg-Calv?-Perthes disease: an approach to the correct diagnosis, Pediatr Clin North Am 61(6):1109–1118, 2014.
  95. Gough-Palmer A, McHugh K: Investigating hip pain in a well child, BMJ 334:1216–1220, 2007.
  96. Kochar MS, Mandiga R, Zurakowski D, et al: Validation of a clinical prediction rule for the differentiation between septic arthritis and transient synovitis of the hip in children, J Bone Joint Surg Am 86:1629–1635, 2004.
  97. Kocher MS, Zurakowski D, Kasser JR: Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm, J Bone Joint Surg Am 81:1662–1670, 1999.
  98. Perry DC, Bruce C: Evaluating the child who presents with an acute limp, BMJ 341:444–449, 2010.
  99. Taekema HC, Landham PR, Maconochine I: Distinguishing between transient synovitis and septic arthritis in the limping child: how useful are clinical prediction tools, Arch Dis Child 94:167–168, 2009.
  100. Yagupsky P, Dubnov-Raz G, Gene A, et al: Differentiating Kingella kingae septic arthritis of the hip from transient synovitis in young children, J Pediatr 165:985–989, 2014.
  101. Hailer YD, Montgomery S, Ekborn A, et al: Legg-Calv?-Perthes disease and the risk of injuries requiring hospitalization: a register study involving 2579 patients, Acta Orthop 83(6):572–576, 2012.
  102. Hamer AJ: Pain in the hip and knee, BMJ 328:1067–1069, 2004.
  103. Liu YF, Chen WM, Lin YF, et al: Type II collagen gene variants and inherited osteonecrosis of the femoral head, N Engl J Med 352:2294–2301, 2005.
  104. Metcalfe D, Van Dijck S, Parsons N, et al: A twin study of Perthes disease, Pediatrics 137(3):e20153542, 2016.
  105. Perry DC, Green DJ, Bruce CE, et al: Abnormalities of vascular structure and function in children with Perthes disease, Pediatrics 130:e126–e131, 2012.
  106. Perry DC, Machin DM, Pope D, et al: Racial and geographic factors in the incidence of Legg-Calv?-Perthes’ disease: a systematic review, Am J Epidemiol 175(3):159–166, 2012.
  107. Rich MM, Schoenecker PL: Management of Legg-Calv?-Perthes disease using ana-frame orthosis and hip range of motion: a 25-year experience, J Pediatr Orthop 33:112–119, 2013.
  108. Azzopardi T, Sharma S, Bennet GC: Slipped capital femoral epiphysis in children aged less than 10 years, J Pediatr Orthop B 19:13–18, 2010.
  109. Clement ND, Vats A, Duckworth AD, et al: Slipped capital femoral epiphysis: is it worth the risk and cost not to offer prophylactic fixation of the contralateral hip? Bone Joint J 97-B(10):1428–1434, 2015.
  110. Loder RT, Dietz FR: What is the best evidence for the treatment of slipped capital femoral epiphysis?, J Pediatr Orthop 32(Suppl 2):S158–S165, 2012.
  111. Novais EN, Millis MB: Slipped capital femoral epiphysis: prevalence, pathogenesis, and natural history, Clin Orthop Relat Res 470(12):3432–3438, 2012.
  112. Roaten J, Spence DD: Complications related to the treatment of slipped capital femoral epiphysis, Orthop Clin North Am 47(2):405–413, 2016.
  113. Souder CD, Boman JD, Wenger DR: The role of capital realignment versus in situ stabilization for the treatment of slipped capital femoral epiphysis, J Pediatr Orthop 34(8):791–798, 2014.
  114. Adobor RD, et al: School screening and point prevalence of adolescent idiopathic scoliosis in 4000 Norwegian children aged 12 years, Scoliosis 6:23, 2011.
  115. Altaf F, Gibson A, Dannawi A, et al: Adolescent idiopathic scoliosis, BMJ 346:f1585, 2013.
  116. Bekmez S, Dede O, Yazici M: Advances in growing rods treatment for early onset scoliosis, Curr Opin Pediatr 29:87–93, 2017.
  117. Carragee EJ, Lehman RA Jr: Spinal bracing in adolescent idiopathic scoliosis, N Engl J Med 369:1558–1560, 2013.
  118. Dede O, Demirkiran G, Yazici M: 2014 update on the “growing spine surgery” for young children with scoliosis, Curr Opin Pediatr 26:57–63, 2014.
  119. Do T, Fras C, Burke S, et al: Clinical value of routine preoperative magnetic resonance imaging in adolescent idiopathic scoliosis: a prospective study of three hundred and twenty-seven patients, J Bone Joint Surg Am 83:577–579, 2001.
  120. Dobbs M, Lenke LG, Szymanski DA, et al: Prevalence of neural axis abnormalities in patients with infantile idiopathic scoliosis, J Bone Joint Surg Am 84:2230–2234, 2002.
  121. Dunn J, Hennrikson NB, Morrison CC, et al: Screening for adolescent idiopathic scoliosis evidence report and systemic review for the US Preventive Services Task Force, JAMA 319(2):173–187, 2018.
  122. Goldberg CJ, Moore DP, Fogarty EE, et al: Adolescent idiopathic scoliosis: the effect of brace treatment on the incidence of surgery, Spine 26:42–47, 2001.
  123. Grivas TB, Hresko MT, Labelle H, et al: The pendulum swings back to scoliosis screening: screening policies for early detection and treatment of idiopathic scoliosis- current concepts and recommendations, Scoliosis 8(1):16, 2013. PMID: 24165694.
  124. Hresko MT: Idiopathic scoliosis in adolescents, N Engl J Med 368:834–841, 2013.
  125. Inoue M, Minami S, Nakata Y, et al: Prediction of curve progression in idiopathic scoliosis from gene polymorphic analysis, Stud Health Technol Inform 91:90–96, 2002.
  126. Kepler CK, Meredith DS, Green DW, et al: Long-term outcomes after posterior spine fusion for adolescent idiopathic scoliosis, Curr Opin Pediatr 24:68–75, 2012.
  127. Kruse LM, Buchan JG, Gurnett CA, et al: Polygenic threshold model with sex dimorphism in adolescent idiopathic scoliosis: the carter effect, J Bone Joint Surg Am 94(16):1485–1491, 2012.
  128. Little DG, Song KM, Katz D, et al: Relationship of peak height velocity to other maturity indicators in idiopathic scoliosis in girls, J Bone Joint Surg Am 82:685–693, 2000.
  129. Lykissas MG, Crawford AH, Jain VV: Complications of surgical treatment of pediatric spinal deformities, Orthop Clin North Am 44(3):357–370, 2013.
  130. Miller NH: Idiopathic scoliosis: cracking the genetic code and what does it mean?, J Pediatr Orthop 31:S49–S52, 2011.
  131. Nault ML, Mac-Thiong JM, Roy-Beaudry M, et al: Three-dimensional spine parameters can differentiate between progressive and nonprogressive patients with AIS at the initial visit: a retrospective analysis, J Pediatr Orthop 33:618–623, 2013.
  132. Negrini S, Minozzi S, Bettany-Saltikov J, et al: Cochrane Database Syst Rev (6):CD006850, 2015.
  133. Pollak L, Shlamkovic N, Minewicz A, et al: Otolith dysfunction as a possible cause for the development of idiopathic scoliosis, J Pediatr Orthop 33:293–297, 2013.
  134. Shi L, Wang D, Hui SC, et al: Volumetric changes in cerebellar regions in adolescent idiopathic scoliosis compared with healthy controls, Spine J 13(12):1904–1911, 2013.
  135. Song KM, Little DG: Peak height velocity as a maturity factor for males with idiopathic scoliosis, J Pediatr Orthop 20:286–288, 2000.
  136. Sponseller PD: Sizing up scoliosis, JAMA 289:608–609, 2003.
  137. Sponseller PD: Bracing for adolescent idiopathic scoliosis in practice today, J Pediatr Orthop 31:S53–S60, 2011.
  138. Sun X, Wu T, Liu Z, et al: Osteopenia predicts curve progression of adolescent idiopathic scoliosis in girls treated with brace treatment, J Pediatr Orthop 33:366–371, 2013.
  139. Ueno M, Takaso M, Nakazawa T, et al: A 5-year epidemiological study on the prevalence rate of idiopathic scoliosis in Tokyo: school screening of more than 250,000 children, J Orthop Sci 16:1–6, 2011.
  140. Wang WJ: Top theories for the etiopathogenesis of adolescent idiopathic scoliosis, J Pediatr Orthop 31:S14–S27, 2011.
  141. Weinstein SL, Dolan LA, Spratt KF, et al: Health and function of patients with untreated idiopathic scoliosis, JAMA 289:559–567, 2003.
  142. Weinstein SL, Dolan LA, Wright JG, et al: Effects of bracing in adolescents with idiopathic scoliosis, N Engl J Med 369:1512–1521, 2013.
  143. Yang S, Andras LAM, Redding GJ, et al: Early-onset scoliosis: a review of history, current treatment, and future directions, Pediatrics 137(1):e20150709, 2016.
  144. Yim AP, Yeung HY, Sun G, et al: Abnormal skeletal growth in adolescent idiopathic scoliosis is associated with abnormal quantitative expression of melatonin receptor, MT2, Int J Mol Sci 14:6345–6358, 2013.
  145. Basu PS, Elsebaie H, Noordeen MH: Congenital spinal deformity: a comprehensive assessment at presentation, Spine 27:2255–2259, 2002.
  146. Campbell RM, Hell-Vocke AK: Growth of the thoracic spine in congenital scoliosis after expansion thoracoplasty, J Bone Joint Surg Am 85:409–420, 2003.
  147. Campbell RM, Smith MD, Mayes TC, et al: The characteristics of thoracic insufficiency syndrome associated with fused ribs and congenital scoliosis, J Bone Joint Surg Am 85:399–408, 2003.
  148. Deviren V, Bervin S, Smith JA, et al: Excision of hemivertebrae in the management of congenital scoliosis involving the thoracic and thoracolumbar spine, J Bone Joint Surg Br 83:496–500, 2001.
  149. Gollogly S, Smith JT, Campbell RM: Determining lung volume with three-dimensional reconstructions of CT scan data, J Pediatr Orthop 24:323–328, 2004.
  150. Herring JA: Tachdjian’s pediatric orthopaedics, ed 5, 2014, Saunders/Elsevier Philadelphia.
  151. Pahys JM, Guille JT: What’s new in congenital scoliosis?, J Pediatr Orthop 2016. PMID: 28009797. ePub ahead of print.
  152. Phillips JH, Knapp DR Jr, Herrera-Soto J: Mortality and morbidity in early-onset scoliosis surgery, Spine 38(4):324–327, 2013.
  153. Shen H, Wang Z, Liu J, et al: Abnormalities associated with congenital scoliosis: a retrospective study of 226 Chinese surgical cases, Spine 38:814–818, 2013.
  154. Smith JT, Gollogly S, Dunn HK: Simultaneous anterior-posterior approach through a costotransversectomy for the treatment of congenital kyphosis and acquired kyphoscoliotic deformities, J Bone Joint Surg Am 87:2281–2289, 2005.
  155. Suh SW, Sarwark JF, Vora A, et al: Evaluating congenital spine deformities for intra- spinal anomalies with magnetic resonance imaging, J Pediatr Orthop 21:525–531, 2001.
  156. Wu N, Ming J, Xiao Z, et al: TBX6 null variants and a common hypomorphic allele in congenital scoliosis, N Engl J Med 372(4):341–350, 2015.
  157. Jones KB, Sponseller PD, Shindle MK, et al: Longitudinal parental perceptions of spinal fusion for neuromuscular spine deformity in patients with totally involved cerebral palsy, J Pediatr Orthop 23:143–149, 2003.
  158. Spiegel DA, Flynn JM, Stasikelis PJ, et al: Curve patterns in chiari I malformation and/or syringomyelia, Spine 28:2139–2146, 2003.
  159. Westerlund LE, Gill SS, Jjarosz TS, et al: Posterior-only unit rod instrumentation and fusion for neuromuscular scoliosis, Spine 26:1984–1989, 2001.
  160. Boseker EH, Moe JH, Winter RB, et al: Determination of “normal” thoracic kyphosis: a roentgenographic study of 121 “normal” children, J Pediatr Orthop 20:796–798, 2000.
  161. Herring JA: Tachdjian’s pediatric orthopaedics, ed 5, 2014, Saunders/Elsevier Philadelphia.
  162. Papegelopoulos PJ, Klassen RA, Peterson HA, et al: Surgical treatment of Scheuermann’s disease with segmental compression instrumentation, Clin Orthop 386:139–149, 2001.
  163. Poolman RW, Been HD, Ubags LH: Clinical outcome and radiographic results after operative treatment of Scheuermann’s disease, Eur Spine J 11:561–569, 2002.
  164. Ristolainen L, Kettunen JA, Kujala UM, et al: Progression of untreated mild thoracic Scheuermann’s kyphosis: radiographic and functional assessment after mean follow- up of 46 years, J Orthop Sci 22(4):652–657, 2017.
  165. Tsirikos AI, Jain AK: Scheuermann’s kyphosis; current controversies, J Bone Joint Surg Br 93:857–864, 2011.
  166. Balague F, Dudler J, Nordin M: Low-back pain in children, Lancet 361:1403–1404, 2003.
  167. Bhangle SD, Sapru S, Panush RS: Back pain made simple: an approach based on principles and evidence, Cleve Clin J Med 76(7):393–399, 2009.
  168. Bhatia NN, Chow G, Timon SJ, et al: Diagnostic modalities for the evaluation of pediatric back pain, J Pediatr Orthop 28:230–233, 2008.
  169. Feldman DS, Hedden DM, Wright JG: The use of bone scan to investigate back pain in children and adolescents, J Pediatr Orthop 20:790–795, 2000.
  170. Jones GT, Macfarlane GJ: Epidemiology of low back pain in children and adolescents, Arch Dis Child 90:312–316, 2005.
  171. Maher C, Underwood M, Buchbinder R: Non-specific low back pain, Lancet 389:736–744, 2017.
  172. Miller R, Beck NA, Sampson NR, et al: Imaging modalities for low back pain in children: a review of spondyloysis and undiagnosed mechanical back pain, J Pediatr Orthop 33:282–288, 2013.
  173. Miller P, Kendrick D, Bentley E, et al: Cost-effectiveness of lumbar spine radiography in primary care patients with low back pain, Spine 27(20):2291–2297, 2002.
  174. Parisini P, DiSilvestre M, Greggi T, et al: Lumbar disc excision in children and adolescents, Spine 26:1997–2000, 2001.
  175. Speed C: Low back pain, BMJ 328:1119–1121, 2004.
  176. Watson KD, Papageorgiou AC, Jones GT, et al: Low back pain in schoolchildren: the role of the mechanical and psychosocial factors, Arch Dis Child 88:12–17, 2003.
  177. Beck NA, Miller R, Baldwin K, et al: Do oblique views add value in the diagnosis of spondylolysis in adolescents?, J Bone Joint Surg Am 95(1–7):e65, 2013.
  178. Grzegorzewski A, Kumar SJ: In situ posterolateral spine arthrodesis for grades III, IV, and V spondylolisthesis in children and adolescents, J Pediatr Orthop 20:506–511, 2000.
  179. Herring JA: Tachdjian’s pediatric orthopaedics, ed 5, 2014, Saunders/Elsevier Philadelphia.
  180. Hioki A, Miyamoto K, Sadamasu A, et al: Repair of pars defects by segmental transverse wiring for athletes with symptomatic spondylolysis: relationship between bony union and postoperative symptoms, Spine 37(9):802–807, 2012.
  181. Lenke LG, Bridwell KW: Evaluation and surgical treatment of high-grade isthmic dysplastic spondylolisthesis, Instr Course Lect 52:525–532, 2003.
  182. Sairyo K, Sakai T, Yasui N, Dezawa A: Conservative treatment for pediatric lumbar spondylolysis to achieve bone healing using a hardbrace: what type and how long?, J Neurosurg Spine 16(6):610–614, 2012. [Epub 2012 Apr 20].
  183. Tsirikos AI, Garrido EG: Spondylolysis and spondylolisthesis in children and adolescents, J Bone Joint Surg Br 92-B:751–759, 2010.
  184. Chandrasenan J, Klezl Z, Bommireddy R, Calthorpe D: Spondylodiscitis in children: a retrospective series, J Bone Joint Surg Br 93(8):1122–1125, 2011.
  185. Garron E, Viehweger E, Luanay F, et al: Nontuberculous spondylodiscitis in children, J Pediatr Orthop 22(3):321–328, 2002.
  186. Kang HM, Choi EH, Lee HJ, et al: The etiology, clinical presentation and long-term outcomes of spondylodiscitis in children, Pediatr Infect Dis J 35(4):e102–e106, 2016.
  187. Keren R, Shah SS, Srivastava R, et al: Comparative effectiveness of intravenous vs. oral antibiotics for postdischarge treatment of acute osteomyelitis in children, JAMA Pediatr 169(2):120–128, 2015.
  188. Christman T, Li Y: Pediatric return to sports after spinal surgery, Sports Health 8(4):3331–3335, 2016.
  189. Low-dose meloxicam (vivlodex) for osteoarthritis pain, Med Lett Drugs Ther 58(1490):35–36, 2016.
  190. Ropper AH, Zafonte RD: Sciatica, N Engl J Med 372(13):1240–1248, 2015.
  191. Urrutia J, Zamora T, Prada C: The prevalence of degenerative or incidental findings in the lumbar spine of pediatric patients: a study using magnetic resonance imaging as a screening tool, Eur Spine J 25(2):596–601, 2016.
  192. Huisman TA: Pediatric tumors of the spine, Cancer Imaging 9 Spec No A:S45–S48, 2009. PMID 19965293.
  193. Adams SB Jr, Flynn JM, Hosalkar HS: Torticollis in an infant caused by hereditary muscle aplasia, Am J Orthop 32:556–558, 2003.
  194. Cheng JC, Tang SP, Chen TM, et al: The clinical presentation and outcome of treatment of congenital muscular torticollis in infants—a study of 1086 cases, J Pediatr Surg 35:1091–1096, 2000.
  195. Cheng JC, Wong MW, Tang SP, et al: Clinical determinants of the outcome of manual stretching in the treatment of congenital muscular torticollis in infants: a prospective study of eight hundred and twenty-one cases, J Bone Joint Surg Am 83:679–687, 2001.
  196. Collins A, Jankovic J: Botulinum toxin injection for congenital muscular torticollis presenting in children and adults, Neurology 67:1083–1085, 2006.
  197. Gupta AK, Roy DR, Conlon ES: Torticollis secondary to posterior fossa tumors, J Pediatr Orthop 16:505–507, 1996.
  198. Hosalkar HS, Gill IS, Gujar P, et al: Familial torticollis with polydactyly: manifestation in three generations, Am J Orthop 30:656–658, 2001.
  199. Kim SN, Shin YB, Kim W, et al: Screening for the coexistence of congenital muscular torticollis and developmental dysplasia of hip, Ann Rehabil Med. 35:485–490, 2011.
  200. Klippel M, Feil A: The classic: a case of absence of cervical vertebrae with the thoracic cage rising to the base of the cranium (cervical thoracic cage), Clin Orthop Relat Res 109:3–8, 1975.
  201. Mezue WC, Taha ZM, Bashir EM: Fever and acquired torticollis in hospitalized children, J Laryngol Otol 116:280–284, 2002.
  202. Nichter S: A clinical algorithm for early identification and intervention of cervical muscular torticollis, Clin Pediatr 55(6):532–536, 2016.
  203. Osiro S, Tiwari KJ, Matusz P, et al: Grisel’s syndrome: a comprehensive review with focus on pathogenesis, natural history, and current treatment options, Childs Nerv Syst 28:821–825, 2012.
  204. Park HK, Kang EY, Lee SH, et al: The utility of ultrasonography for the diagnosis of developmental dysplasia of hip joint in congenital muscular torticollis, Ann Rehabil Med. 37:26–32, 2013.
  205. Reichman EF, Shah J: Grisel syndrome: an unusual and often unrecognized cause of t-orticollis, Pediatr Emerg Care 31(8):577–580, 2015.
  206. Snyder EM, Coley BD: Limited value of plain radiographs in infant torticollis, Pediatrics 118:e1779–e1784, 2006.
  207. Suhr MC, Oledzka M: Considerations and intervention in congenital muscular torticollis, Curr Opin Pediatr 27(1):75–81, 2015.
  208. Clarke RA, Catalan G, Diwan AD, et al: Heterogeneity in Klippel-feil syndrome: a new classification, Pediatr Radiol 28:967–974, 1998.
  209. Hensinger RN, Lang JE, MacEwen GD: Klippel-feil syndrome: a constellation of associated anomalies, J Bone Joint Surg Am 56:1246–1253, 1974.
  210. Klippel M, Feil A: The classic: a case of absence of cervical vertebrae with the thoracic cage rising to the base of the cranium (cervical thoracic cage), Clin Orthop Relat Res 109:3–8, 1975.
  211. Pizzutillo PD, Woods M, Nicholson L, et al: Risk factors in Klippel-feil syndrome, Spine 19:2110–2116, 1994.
  212. Samartzis D, Kalluri P, Herman J, et al: Clinical triad findings in pediatric Klippel-feil patients, Scoliosis Spinal Disord 11:15, 2016. PMCID: PMC4922059.
  213. Thomsen MN, Schneider U, Weber M, et al: Scoliosis and congenital anomalies associated with Klippel-feil syndrome types I-III, Spine 22(4):396–401, 1997.
  214. Tracy MR, Dormans JP, Kusumi K: Klippel-feil syndrome: clinical features and current understanding of etiology, Clin Orthop Relat Res 424:183–190, 2004.
  215. Botto LD, May K, Fernhoff PM, et al: A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population, Pediatrics 112(1 Pt 1):101–107, 2003.
  216. Copley LA, Dormans JP: Cervical spine disorders in infants and children, J Am Acad Orthop Surg 6:204–214, 1998.
  217. Dai L, Yuan W, Ni B, et al: Os odontoideum: etiology, diagnosis and management, Surg Neurol 53:106–109, 2000.
  218. Drummond DS, Hosalkar HS: Treatment of cervical instability. Clark CR the cervical spine, ed 4, 2005, The Cervical Spine Research Society, pp 427–447.
  219. Fielding JW, Hensinger RN, Hawkins RJ: Os odontoideum, J Bone Joint Surg Am 62(3):376–383, 1980.
  220. Guille JT, Sherk HH: Congenital osseous anomalies of the upper and lower cervical spine in children, J Bone Joint Surg Am 84:277–288, 2002.
  221. Kim HJ: Cervical spine anomalies in children and adolescents, Curr Opin Pediatr 25:72–77, 2013.
  222. MacKenzie WG, Dhawale AA, Demczko MM, et al: Flexion-extension cervical spine MRI in children with skeletal dysplasia: is it safe and effective?, J Pediatr Orthop 33(1):91–98, 2013.
  223. Malik V, Verma RU, Joshi V, et al: An evidence-based approach to the 12-min consultation for a child with Down’s syndrome, Clin Otolaryngol 37(4):291–296, 2012.
  224. Martinez-Lage JF, Morales T, Fernandez Cornejo V: Inflammatory C2-3 subluxation:a Grisel’s syndrome variant, Arch Dis Child 88:628–629, 2003.
  225. McHugh BJ, Grant RA, Zupon AB, et al: Congenital os odontoideum arising from the secondary ossification center without prior fracture, J Neurosurg Spine 17(6):594–597, 2012.
  226. McKay SD, Al-Omari A, Tomlinson LA, et al: Review of cervical spine anomalies in genetic syndromes, Spine 37(5):E269–E277, 2012.
  227. McRae DL, Barnum AS: Occipitalization of the atlas, Am J Roentgenol Radium TherNucl Med 70(1):23–46, 1953.
  228. Pang D, Li V: Atlantoaxial rotatory fixation: part III of a prospective study of the clinical manifestation, diagnosis, management, and outcome of children with atlantoaxial rotatory fixation, Neurosurgery 57:952–972, 2005.
  229. Ricchetti ET, States L, Hosalkar HS, et al: Radiographic study of the upper cervical spine in the 22q11.2 deletion syndrome, J Bone Joint Surg Am 86:1751–1760, 2004.
  230. Segal LS, Drummond DS, Zarotti RM, et al: Complications of posterior arthrodesis of the cervical spine in patients who have down syndrome, J Bone Joint Surg Am 73(10):1547–1554, 1991.
  231. Ali M, Jackson T, Rayan GM: Closing wedge osteotomy of abnormal middle phalanx for clinodactyly, J Hand Surg Am 34(5):914–918, 2009.
  232. Altergott C, Garcia FJ, Nager AL: Pediatric fingertip injuries, Pediatr Emerg Med Pract 24:148–152, 2008.
  233. Bauer AS, Bae DS: Pediatric trigger digits, J Hand Surg Am 40:2304–2309, 2015.
  234. Bexkens R, Washburn FJ, Eygendaal D, et al: Effectiveness of reduction maneuvers in the treatment of nursemaid’s elbow: a systematic review and meta-analysis, Am J Emerg Med 35(1):159–163, 2017.
  235. Cheung JPY, Fung BKK, Mak KC, Leung KH: Multiple triggering in a girl with Ehlers-Danlos syndrome: case report, J Hand Surg Am 35A:1675–1677, 2010.
  236. Colberg RE, S?nchez CF, Lugo-Vicente H: Aspiration and triamcinolone acetonide injection of wrist synovial cysts in children, J Pediatr Surg 43(11):2087–2090, 2008.
  237. Kenniston JA, Beredjiklian PK, Bozentka DJ: Osteochondritis dissecans of the capitellum in fraternal twins: case report, J Hand Surg Am 33:1380–1383, 2008.
  238. Krul M, van der Wouden JC, Kruithof EJ, et al: Cochrane Database Syst Rev (7): CD007759, 2017.
  239. Lahiri A, Lester R: Hand anomalies in Russell Silver syndrome, J Plast Reconstr Aesthet Surg 62(4):462–465, 2009.
  240. Manske PR, Goldfarb CA: Congenital failure of formation of the upper limb, Hand Clin 25(2):157–170, 2009.
  241. Pill SG, Ganley TJ, Flynn JM, et al: Osteochondritis dissecans of the capitellum: arthroscopic-assisted treatment of large, full-thickness defects in young patients, Arthroscopy 19(2):222–225, 2003.
  242. Ty JM, James MA: Failure of differentiation: part II (arthrogryposis, camptodactyly, clinodactyly, Madelung deformity, trigger finger, and trigger thumb), Hand Clin 25(2):195–213, 2009.
  243. Van Heest AE, House J, Krivit W, Walker K: Surgical treatment of carpal tunnelsyndrome and trigger digits in children with mucopolysaccharide storage disorders, J Hand Surg Am. 23A:236-243, 1998.
  244. Wafa AM: Hourglass dorsal metacarpal island flap: a new design for syndactylized web reconstruction, J Hand Surg Am 33(6):905–908, 2008.
  245. Ahmed AA, Skaria P, Safina NP, et al: Arthrogryposis and pterygia as lethal end manifestations of genetically defined congenital myopathies, Am J Med Genet A 2017. PMID: 29274205. (ePub ahead of print).
  246. Bamshad M, Van Heest AE, Pleasure D: Arthrogryposis: a review and update, J Bone Joint Surg Am 91(Suppl 4):40–46, 2009.
  247. Bevan WP, Hall JG, Bamshad M, et al: Arthrogryposis multiplex congenita (amyoplasia): an orthopaedic perspective, J Pediatr Orthop 27(5):594–600, 2007.
  248. Boehm S, Limpaphayom N, Alaee F, et al: Early results of ponseti method for the treatment of clubfoot in distal arthrogryposis, J Bone Joint Surg Am 90(7):1501–1507, 2008.
  249. Dalton P, Clover L, Wallerstein R, et al: Fetal arthrogryposis and maternal serum antibodies, Neuromuscul Disord 16(8):481–491, 2006.
  250. Dillion E, Bjornson K, Jaffe K, et al: Ambulatory activity in youth with arthrogryposis, J Pediatr Orthop 214–217, 2009.
  251. Dimitraki M, Tsikouras P, Bouchlariotou S, et al: Prenatal assessment of arthrogryposis. A review of the literature, J Matern Fetal Neonatal Med 24:32–36, 2011.
  252. Drummond DS, Mackenzie DA: Scoliosis in arthrogryposis multiplex congenital, Spine (Phila 1976) 3(2):146–151, 1978.
  253. Hall JG: Arthrogryposis associated with unsuccessful attempts at termination of pregnancy, Am J Med Genet 63:292–300, 1996.
  254. Hall JG: Uterine structural anomalies and arthrogryposis—death of an urban legend, Am J Med Genet A 161A:82–88, 2012.
  255. Hall JG, Reed SD, Rosenbaum KN, et al: Limb pterygium syndrome: a review and report of eleven patients, Am J Med Genet 12:337–409, 1982.
  256. Hoff JM, Loane M, Gilhus NE, et al: Arthrogryposis multiplexa congenita: an epideiologic study of nearly 9 million births in 24 EUROCAT registers, Eur J Obstet Gynecol Reprod Biol 159:347–350, 2011.
  257. Kalampokas E, Kalampokas T, Sofoudis C, et al: Diagnosing arthrogryposis multiplex congenital: a review, ISRN Obstet Gynecol 1–6, 2012.
  258. Kimber E, Tajsharghi H, Kroksmark AK, et al: Distal arthrogryposis: clinical and genetic findings, Acta Paediatr 101:877–887, 2012.
  259. Kowalczyk B, Felu? J: Arthrogryposis: an update on clinical aspects, etiology, andtreatment strategies, Arch Med Sci 12(1):10–24, 2016.
  260. Mennen U, Van Heest A, Ezaki MB, et al: Arthrogryposis multiplex congenital, J Hand Surg 30(5):468–474, 2005.
  261. Rink BD: Arthrogryposis: a review and approach to prenatal diagnosis, Obstet Gynecol Surv 66(6):369–377, 2011.
  262. Shah NR, Limpaphayom N, Dobbs MB: A minimally invasive treatment protocol for congenital dislocation of the knee, J Pediatr Orthop 29(7):720–725, 2009.
  263. VanHeest AE, Waters PM, Simmons BP: Surgical treatment of arthrogryposis of the elbow, J Hand Surg 23A:1063–1070, 1998.
  264. Yingsakmongkol W, Kumar SJ: Scoliosis in arthrogryposis multiplex congenital: results after nonsurgical and surgical treatment, J Pediatr Orthop 20(5):656–661, 2000.
  265. Endele D, Jung C, Bauer G, et al: Value of MRI in diagnosing injuries after ankle sprains in children, Foot Ankle Int 33(12):1063–1068, 2012.
  266. Flynn JM, Skagggs DL, Waters PM, editors: Rockwood and Wilkins’ fractures. In Children, ed, 8th, Philadelphia, 2015, Lippincott Williams and Wilkins.
  267. Gorter EA, Oostdijk W, Felius A, et al: Vitamin D deficiency in pediatric fracture patients: prevalence, risk factors, and vitamin D supplementation, J Clin Res Pediatr Endocrinol 8(4):445–451, 2016.
  268. Larsen MC, Bohm KC, Rizkala AR, Ward CM: Outcomes of nonoperative treatment of Salter-harris II distal radius fractures: a systematic review, Hand 11(1):29–35, 2016.
  269. Olney RC, Mazur JM, Pike LM, et al: Healthy children with frequent fractures: how much evaluation is needed?, Pediatrics 121:890–897, 2008.
  270. Poolman RW: Adjunctive non-invasive ways of healing bone fractures, BMJ 338:611–612, 2009.
  271. Wren TAL, Shepherd JA, Kalkwarf HJ, et al: Racial disparity in fracture risk between white and nonwhite children in the United States, J Pediatr 161:1035–1040, 2012.
  272. Baldwin K, Pandya NK, Wolfgruber H, et al: Femur fractures in the pediatric population: abuse or accidental trauma, Clin Orthop Relat Res 469(3):798–804, 2011.
  273. Baldwin KD, Scherl SA: Instr Course Lect 62:399–403, 2013. Blatz AM, Gillespie CW, Katcher A, et al: Factors associated with nonaccidental trauma evaluation among patients below 36 months old presenting with femur fractures at a Level-1 pediatric trauma center, J Pediatr Orthop 2017.
  274. Drendel AL, Gorelick MH, Weisman SJ, et al: A randomized clinical trial of ibuprofenversus acetaminophen with codeine for acute pediatric arm fracture pain, Ann Emerg Med 54:553–560, 2009.
  275. Green NE, Swiontkowski MF, editors: Skeletal trauma in children, vol 3, ed 4, Philadelphia, 2009, W.B. Saunders.
  276. Jadhav SP, Swischuk LE: Commonly missed subtle skeletal injuries in children: a pictorial review, Emerg Radiol 15(6):391–398, 2008.
  277. Kemp AM, Dunstan F, Harrison S, et al: Patterns of skeletal fractures in child abuse: systematic review, BMJ 337:a1518, 2008.
  278. Leaman LA, Hennrikus WL, Bresnahan JJ: Identifying non-accidental fractures in children aged <2 years, J Child Orthop 10(4):335–341, 2016.
  279. Olney RC, Mazur JM, Pike LM, et al: Healthy children with frequent fractures: how much evaluation is needed?, Pediatrics 121:890–897, 2008.
  280. Pandya NK, Baldwin K, Wolfgruber H, et al: Child abuse and orthopaedic injury patterns: analysis at a level 1 pediatric trauma center, J Pediatr Orthop 29(6):618–625, 2009.
  281. Poolman RW: Adjunctive non-invasive ways of healing bone fractures, BMJ 338:611–612, 2009.
  282. Williams KG, Smith G, Luhmann SJ, et al: A randomized controlled trial of cast versus splint for distal radial buckle fracture: an evaluation of satisfaction, convenience, and preference, Pediatr Emerg Care 29(5):555–559, 2013.
  283. Appleboam A, Reuben AD, Benger JR, et al: Elbow extension test to rule out elbow fracture: multicentre, prospective validation and observational study of diagnostic accuracy in adults and children, BMJ 338:31–34, 2009.
  284. Baldwin K, Morrison MJ 3rd, Tomlinson LA, et al: Both bone forearm fractures in children and adolescents, which fixation strategy is superior–plates or nails? A systematic review and meta-analysis of observational studies, J Orthop Trauma 28(1):e8–e14, 2014.
  285. Crawford SN, Lee LS, Izuka BH: Closed treatment of overriding distal radial fractures without reduction in children, J Bone Joint Surg Am 94(3):246–252, 2012.
  286. Edmonds EW: How displaced are “nondisplaced” fractures of the medial humeral epicondyle in children? Results of a three-dimensional computed tomography analysis, J Bone Joint Surg Am 92(17):2785–2791, 2010.
  287. Green NE, Swiontkowski MF, editors: Skeletal trauma in children, vol 3, ed 4, Philadelphia, 2009, W.B. Saunders.
  288. Koelink E, Schuh S, Howard A, et al: Primary care physician follow-up of distal radius buckle fractures, Pediatrics 137(1):e21052262, 2016.
  289. Kropman RHJ, Bemelman M, Segers MJM, et al: Treatment of compacted greenstick forearm fractures in children using bandage or cast therapy: a prospective randomized trial, J Trauma 68:425–428, 2010.
  290. Ladenhauf HN, Schaffert M, Bauer J: The displaced supracondylar humerus fracture: indications for surgery and surgical options: a 2014 update, Curr Opin Pediatr 26:64–69, 2014.
  291. Pathy R, Dodwell ER: Medial epicondyle fractures in children, Curr Opin Pediatr 27:58–66, 2015.
  292. Plint AC, Perry JJ, Correll R, et al: A randomized, controlled trial of removable splinting versus casting for wrist buckle fractures in children, Pediatrics 117(3):691–697, 2006.
  293. Rangan A, Handoll H, Brealy S, et al: Surgical vs nonsurgical treatment of adults with displaced fractures of the proximal humerus, JAMA 313(10):1037–1046, 2015.
  294. Runyon RS, Doyle SM: When is it ok to use a splint versus cast and what remodeling can one expect for common pediatric forearm fractures, Curr Opin Pediatr 29:46–54, 2017.
  295. Soto F, Fiesseler F, Morales J, et al: Presentation, evaluation, and treatment of clavicle fractures in preschool children presenting to an emergency department, Pediatr Emerg Care 25:744–747, 2009.
  296. Baldwin K, Hsu JE, Wenger DR, et al: Treatment of femur fractures in school-aged children using elastic stable intramedullary nailing: a systematic review, J Pediatr Orthop B 20(5):303–308, 2011.
  297. Bhandari M, Jeray KJ, Petrisor BA, et al: A trial of wound irrigation in the initial management of open fracture wounds, N Engl J Med 327(27):2629–2640, 2015.
  298. Boutis K, Plint A, Stimec J, et al: Radiograph-negative lateral ankle injuries in children: occult growth plate fracture or sprain?, JAMA Pediatr 170(1):e154114, 2016.
  299. Brousil J, Hunter JB: Femoral fractures in children, Curr Opin Pediatr 25:52–56, 2013.
  300. Cummings RJ: Paediatric femoral fracture, Lancet 365:1116–1117, 2005.
  301. Flynn JM, Garner MR, Jones KJ, et al: The treatment of low-energy femoral shaft fractures: a prospective study comparing the “walking spica”: with the traditional spica cast, J Bone Joint Surg Am 93(23):2196–2202, 2011.
  302. Green NE, Swiontkowski MF, editors: Skeletal trauma in children, vol 3, ed 4, Philadelphia, 2009, W.B. Saunders.
  303. Heffernan MJ, Gordon JE, Sabatini CS, et al: Treatment of femur fractures in young children: a multicenter comparison of flexible intramedullary nails to spica casting in young children aged 2 to 6 years, J Pediatr Orthop 35(2):126–129, 2015.
  304. Hoeffe J, Trottier ED, Bailey B, et al: Intranasal fentanyl and inhaled nitrous oxide for fracture reduction: the FAN observational study, Am J Emerg Med 35(5):710–715, 2017.
  305. Loud KJ, Micheli LJ, Bristol S, et al: Family history predicts stress fracture in active female adolescents, Pediatrics 120:e364–e372, 2007.
  306. Malanga GA, Ramirez-Del Toro JA: Common injuries of the foot and ankle in the child and adolescent athlete, Phys Med Rehabil Clin N Am 19(2):347–371, ix, 2008.
  307. Patel S, Haddad F: Triplane fractures of the ankle, Br J Hosp Med (Lond) 70(1):34–40, 2009.
  308. Poonai N, Bhullar G, Lin K, et al: Oral administration of morphine versus ibuprophen to manage postfracture pain in children: a randomized trial, CMAJ 186(18):1358–1363, 2014.
  309. Wells L, Millman JE: Trauma related to the lower extremity. In Dormans JP, editor: Pediatric orthopaedics: core knowledge in orthopaedics, Philadelphia, 2005, Mosby, pp 85–115.
  310. Wright JG, Wang EEL, Owen JL, et al: Treatments for paediatric femoral fractures: a randomized trial, Lancet 365:1153–1162, 2005.
  311. Yeranosian M, Horneff JG, Baldwin K, et al: Factors affecting the outcome of fractures of the femoral neck in children and adolescents: a systematic review, Bone Joint J 95-B(1):135–142, 2013.
  312. Green NE, Swiontkowski MF, editors: Skeletal trauma in children, vol 3, ed 4, Philadelphia, 2009, W.B. Saunders.
  313. Bernard L, Dinh A, Ghout I, et al: Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial, Lancet 385:875–882, 2015.
  314. Calvo C, Nunez E, Camacho M, et al: Epidemiology and management of acute, uncomplicated septic arthritis and osteomyelitis: Spanish multicenter study, Pediatr Infect Dis J 35(12):1288–1293, 2016.
  315. Howard-Jones AR, Isaacs D: Systematic review of duration and choice of systemic antibiotic therapy for acute haematogenous bacterial ostomyelitis in children, J Paediatr Child Health 49:760–768, 2013.
  316. Keren R, Shah SS, Srivastava R, et al: Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children, JAMA Pediatr 169(2):120–128, 2015.
  317. Kumar J, Ramachandran M, Little D, Zenios M: Pelvic osteomyelitis in children, J Pediatr Orthop B 19:38–41, 2010.
  318. Lora-Tamayp J, Murillo O: Shorter treatments for vertebral osteomyelitis, Lancet 385:836–837, 2015.
  319. Mantadakis E, Plessa E, Vouloumanou EK, et al: Deep venous thrombosis in children with musculoskeletal infections: the clinical evidence, Int J Infect Dis 16:e236–e243, 2012.
  320. Martin AC, Anderson D, Lucey J, et al: Predictors of outcome in pediatric osteomyelitis: five years experience in a single tertiary center, Pediatr Infect Dis J 35(4):387–391, 2016.
  321. McNeil JC, Forbes AR, Vallejo JG, et al: Role of Operative or Interventional Radiology-Guided Cultures for Osteomyelitis, Pediatrics 137(5):e20154616, 2016.
  322. Principi N, Esposito S: Kingella kingae infections in children, BMC Infect Dis 15:260, 2015.
  323. Ratnayake K, Davis AJ, Brown L, Young TP: Pediatric acute osteomyelitis in the postvaccine, methicillin-resistant Staphylococcus aureus era, Am J Emerg Med 33:1420–1424, 2015.
  324. Section J, Gibbons SD, Barton T, et al: Microbiological culture methods for pediatric musculoskeletal infection: a guideline for optimal use, J Bone Joint Surg Am 97(6):441–449, 2015.
  325. Spyropoulou V, Dhouib Chargui A, Merlini L, et al: Primary subacute hematogenous osteomyelitis in children: a clearer bacteriological etiology, J Child Orthop 10(3):241–246, 2016.
  326. Tuason DA, Gheen T, Sun D, et al: Clinical and laboratory parameters associated with multiple surgeries in children with acute hematogenous osteomyelitis, J Pediatr Orthop 34(5):565–570, 2014.
  327. Wipff J, Adamsbaum C, Kahan A, Job-Deslandre C: Chronic recurrent multifocal osteomyelitis, Joint Bone Spine 78:555–560, 2011.
  328. Wood JB, Johnson DP: Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children, J Hosp Med 11(7):505–508, 2016.
  329. Zhorne DJ, Altobelli ME, Cruz AT: Impact of antibiotic pretreatment on bone biopsy yield for children with acute hematogenous osteomyelitis, Hosp Pediatr 5(6):337–341, 2015.
  330. Amit U, Dagan R, Yagupsky P: Prevalence of pharyngeal carriage of Kingella kingae in young children and risk factors for colonization, Pediatr Infect Dis J 32:191–193, 2013.
  331. Angelakis E, Edouard S, Lafranchi MA, et al: Emergence of Q fever arthritis in France, J Clin Microbiol 52(4):1064–1067, 2014.
  332. Aupiais C, Basmaci R, Ilharreborde B, et al: Arthritis in children: comparison of clinical and biological characteristics of septic arthritis and juvenile idiopathic arthritis, Arch Dis Child 102:316–322, 2017.
  333. Carter K, Doern C, Jo CH, Copley LA: The clinical usefulness of polymerase chain reaction as a supplemental diagnostic tool in the evaluation and the treatment of children with septic arthritis, J Pediatr Orthop 36(2):167–172, 2016.
  334. Cerit ET, Aydin M, Azap A: A case of brucellar monoarthritis and review of the literature, Rheumatol Int 32:1465–1468, 2012.
  335. Dubnov-Raz G, Scheuerman O, Chodick G, et al: Invasive kingella kingae infections in children: clinical and laboratory characteristics, Pediatrics 122(6):1305–1309, 2008.
  336. Farrow L: A systematic review and meta-analysis regarding the use of corticosteroids in septic arthritis, BMC Musculoskelet Disord 16:241, 2015.
  337. Fogel I, Amir J, Bar-On E, Harel L: Dexamethasone therapy for septic arthritis in children, Pediatrics 136(4):e776–e782, 2015.
  338. Gonzalez-Gay MA, Garcia-Porrua C, Afonso E, et al: Acute arthritis associated with acute Q fever, Clin Exp Rheumatol 18(1):109, 2000.
  339. Haldar M, Butler M, Quinn CD, et al: Evaluation of a real-time PCR assay for simultaneous detection of kingella kingae and staphylococcus aureus from synovial fluid in suspected septic arthritis, Ann Lab Med 34(4):313–316, 2014.
  340. Heyworth BE, Shore BJ, Donohue KS, et al: Management of pediatric patients with synovial fluid white blood-cell counts of 25,000 to 75,000 cells/mm(3) after aspiration of the hip, J Bone Joint Surg Am 97(5):389–395, 2015.
  341. Laine JC, Denning JR, Riccio AI, et al: The use of ultrasound in the management of septic arthritis of the hip, J Pediatr Orthop B 24(2):95–98, 2015.
  342. Mignemi ME, Menge TJ, Cole HA, et al: Epidemiology, diagnosis, and treatment of pericapsular pyomyositis of the hip in children, J Pediatr Orthop 34(3):316–325, 2014.
  343. Monsalve J, Kan JH, Schallert EK, et al: Septic arthritis in children: frequency of coexisting unsuspected osteomyelitis and implications on imaging work-up and management, AJR Am J Roentgenol 204(6):1289–1295, 2015.
  344. Rosenfeld S, Bernstein DT, Daram S, et al: Predicting the presence of adjacent infections in septic arthritis in children, J Pediatr Orthop 36(1):70–74, 2016.
  345. Sarkissian EJ, Gans I, Gunderson MA, et al: Community-acquired Methicillin-resistant staphylococcus aureus musculoskeletal infections: emerging trends over the past decade, J Pediatr Orthop 36(3):323–327, 2016.
  346. Tornero E, De Bergua-Domingo JM, Domenech P, et al: Knee arthritis in children: when can be safely treated with needle joint aspiration? A large Children’s tertiary hospital study, J Pediatr Orthop 2016. [ePub ahead of print]. PMID 27662387.
  347. Tran Quang V, Bidet P, Birgy A, et al: Susceptibility testing of Kingella kingae to cefazolin, Clin Microbiol Infect 2017. doi:10.1016/j.cmi.2017.10.003. [Epub ahead of print]. pii: S1198-743X(17)30540-2.
  348. Williams N, Cooper C, Cundy P: Kingella kingae septic arthritis in children: recognizing an elusive pathogen, J Child Orthop 8:91–95, 2014.
  349. Ackerman MJ, Zipes DP, Kovacs RJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies, Circulation 132:e326–e329, 2015.
  350. American Academy of Pediatrics, American Academy of Family Physicians, American Medical Society for Sports Medicine, et al: PPE preparticipation physical evaluation monograph, ed 4, Elk Grove Village, IL, 2010, American Academy of Pediatrics.
  351. American Academy of Pediatrics, Section on Cardiology and Cardiac Surgery Policy Statement: Pediatric sudden cardiac arrest, Pediatrics 129(4):e1094–e1102, 2012.
  352. Behm DG, Blazevich AJ, Kay AD, McHugh M: Acute effects of muscle stretching on physical performance, range of motion, and injury incidence in healthy active individuals: a systematic review, Appl Physiol Nutr Metab 41:1–11, 2016.
  353. Braverman AC, Harris KM, Kovacs RJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 7: aortic diseases, including marfan syndrome, Circulation 132(22):e303–e309, 2015.
  354. Brenner JS: Council on sports medicine and fitness. Sports specialization and intensive training in young athletes, Pediatrics 138(3):e20162148, 2016.
  355. Centers for Disease Control and Prevention: Nonfatal sports and recreation heat illness treated in hospital emergency departments–United States, 2001–2009, MMWR Morb Mortal Wkly Rep 60:977–980, 2011.
  356. Davies HD, Jackson MA, Rice SG: Infectious diseases associated with organized sports and outbreak control, Pediatrics 140(4):e20172477, 2017.
  357. Diokno E, Rowe D: Medical and orthopedic conditions and sports participation, Pediatr Clin North Am 57:839–847, 2010.
  358. Drezner JA, O’Connor FG, Harmon KG, et al: AMSSM position statement on cardiovascular preparticipation screening in athletes: current evidence, knowledge gaps, recommendations and future directions, Br J Sports Med 2016. PMID: 27660369. doi:10.1136/bjsports-2016-096781.
  359. Gallant F, O’Loughlin JL, Brunet J, et al: Childhood sports participation and adolescent sport profile, Pediatrics 140(6):e20171449, 2017.
  360. Knowles SB: Is there an injury epidemic in girls’ sports?, Br J Sports Med 44:38–44, 2010.
  361. Lehman PJ, Carl RL: The preparticipation physicial evaluation, Pediatr Ann 46(3): e85–e92, 2017.
  362. Levine BD, Baggish AL, Kovacs RJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and impact, Circulation 132(22):e262–e266, 2015.
  363. Link MS, Estes NA III, Maron BJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 13: commotion cordis, Circulation 132:e339–e342, 2015.
  364. Maron BJ, harris KM, Thompson PD, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 14: sickle cell trait, Circulation 132(22):e343–e345, 2015.
  365. Maron BJ, Levine BD, Washington RL, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: participation screening for cardiovascular disease in competitive athletes, Circulation 132(22):e267–e272, 2015.
  366. Maron BJ, Udelson JE, Bonow RO, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis, Circulation 132(22):e273–e280, 2015.
  367. Maron BJ, Zipes DP, Kovacs RJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations, Circulation 132(22):e256–e261, 2015.
  368. Meehan WP, Mannix R: A substantial proportion of life-threatening injuries are sport-related, Pediatr Emerg Care 29:624–627, 2013.
  369. Mitten MJ, Zipes DP, Maron BJ, et al: Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 15: legal aspects of medical eligibility and disqualification recommendations, Circulation 132(22):e346–e349, 2015.
  370. Rice SG: Council on sports medicine and fitness, American academy of pediatrics: medical conditions affecting sports participation, Pediatrics 121:841–848, 2008.
  371. Scurr J, Brown N, Smith J, et al: The influence of the breast on sport and exercise participation in school girls in the United Kingdom, J Adolesc Health 58:167–173, 2016.
  372. Sharma S, Estes NMA III, Vetter VL, et al: Cardiac screening before participation in sports, N Engl J Med 369:2049–2053, 2013.
  373. Sugimoto D, Myer GD, Foss KD, Hewett TE: Specific exercise effects of preventive neuromuscular training intervention on anterior cruciate ligament injury risk reduction in young females: meta-analyses and subgroup analysis, Br J Sports Med 49(5):282–289, 2015.
  374. Alter KE, Murphy KP: Guidance techniques for botulinum toxins and other injections.
  375. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  376. Bergeron MF, Mountjoy M, Armstrong N, et al: International olympic committee consensus statement on youth athletic development, Br J Sports Med 49(13):843–851, 2015.
  377. Brenner JS, COUNCIL ON SPORTS MEDICINE AND FITNESS: Sports specialization and intensive training in young athletes, Pediatrics 138(3):2016.
  378. Chang GH, Paz DA, Dwek JR, Chung CB: Lower extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 37(5):836–846, 2013.
  379. Finnoff JT, Hall MM, Adams E, et al: American medical society for sports medicine.
  380. American medical society for sports medicine position statement: interventional musculoskeletal ultrasound in sports medicine, Clin J Sport Med 25(1):6–22, 2015.
  381. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  382. Hryhorczuk AL, Restrepo R, Lee EY: Pediatric musculoskeletal ultrasound: practical imaging approach, AJR Am J Roentgenol 206(5):W62–W72, 2016.
  383. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  384. Kataura S, Suzuki S, Matsuo S, et al: Acute effects of the different intensity of static stretching on flexibility and isometric muscle force, J Strength Cond Res 2016. [Epub ahead of print].
  385. LaPrade RF, Agel J, Baker J, et al: AOSSM Early Sport specialization consensus statement, Orthop J Sports Med 4(4):2325967116644241, 2016.
  386. Lloyd RS, Faigenbaum AD, Stone MH, et al: Position statement on youth resistance training: the 2014 international consensus, Br J Sports Med 48:498–505, 2014.
  387. Marshall DA, Lopatina E, Lacny S, Emery CA: Economic impact study: neuromuscular training reduces the burden of injuries and costs compared to standard warm-up in youth soccer, Br J Sports Med 50(22):1388–1393, 2016.
  388. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  389. Mlynarek RA, Kuhn AW, Bedi A: Platelet-rich plasma (PRP) in orthopedic sports medicine, Am J Orthop 45(5):290–326, 2016.
  390. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  391. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  392. Myer GD, Jayanthi N, Difiori JP, et al: Sport Specialization, Part I: Does early sports specialization increase negative outcomes and reduce the opportunity for success in young athletes?, Sports Health 7(5):437–442, 2015.
  393. Myer GD, Jayanthi N, DiFiori JP, et al: Sports Specialization, Part II: Alternative solutions to early sport specialization in youth athletes, Sports Health 8(1):65–73, 2016.
  394. Paz DA, Chang GH, Yetto JM Jr, et al: Upper extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 39(6):954–964, 2015.
  395. Peck E, Jelsing E, Onishi K: Advanced Ultrasound-guided interventions for tendinopathy, Phys Med Rehabil Clin N Am 27(3):733–748, 2016.
  396. Piccolo CL, Galluzzo M, Ianniello S, et al: Pediatric musculoskeletal injuries: role of ultrasound and magnetic resonance imaging, Musculoskelet Surg 101:85–102, 2017.
  397. Simic L, Sarabon N, Markovic G: Does pre-exercise static stretching inhibit maximal muscular performance? A meta-analytical review, Scand J Med Sci Sports 23:131–148, 2013.
  398. Arnold A, Thigpen CA, Beattie PF, et al: Overuse physeal injuries in youth athletes, Sports Health 2017. doi:10.1177/1941738117690847. [Epub ahead of print]. 1941738117690847.
  399. Chang GH, Paz DA, Dwek JR, Chung CB: Lower extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 37(5):836–846, 2013.
  400. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  401. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  402. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  403. McInnis KC, Ramey LN: High-Risk Stress fractures: diagnosis and management, PM R 8(3 Suppl):S113–S124, 2016. doi:10.1016/j.pmrj.2015.09.019. PubMed PMID: 26972260. Review.
  404. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  405. Paz DA, Chang GH, Yetto JM Jr, et al: Upper extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 39(6):954–964, 2015.
  406. Rauck RC, LaMont LE, Doyle SM: Pediatric upper extremity stress injuries, Curr Opin Pediatr 25:40–44, 2013.
  407. Braithwaite KA, Marshall KW: The skeletally immature and newly mature throwing athlete, Radiol Clin North Am 54(5):841–855, 2016.
  408. Dong W, Goost H, Lin XB, et al: Treatments for shoulder impingement syndrome: a PRISMA systematic review and network meta-analysis, Medicine (Baltimore) 94(10):e510, 2015.
  409. Fountain LB: Sports medicine in children: common overuse injuries, FP Essent 417:22–25, 2014.
  410. Gismervik S?, Drogset JO, Granviken F, et al: Physical examination tests of the shoulder: a systematic review and meta-analysis of diagnostic test performance, BMC Musculoskelet Disord 18(1):41, 2017.
  411. Hermans J, Luine JJ, Meuffels DE, et al: Does this patient with shoulder pain have rotator cuff disease? The rational clinical examination systematic review, JAMA 310:837–847, 2013.
  412. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  413. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  414. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  415. Moyer JE, Brey JM: Shoulder injuries in pediatric athletes, Orthop Clin North Am 47(4):749–762, 2016.
  416. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  417. Paz DA, Chang GH, Yetto JM Jr, et al: Upper extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 39(6):954–964, 2015.
  418. Peck E, Jelsing E, Onishi K: Advanced Ultrasound-guided interventions for tendinopathy, Phys Med Rehabil Clin N Am 27(3):733–748, 2016. doi:10.1016/j.pmr.2016.04.008. PubMed PMID: 27468675. Review.
  419. Rauck RC, LaMont LE, Doyle SM: Pediatric upper extremity stress injuries, Curr Opin Pediatr 25(1):40–45, 2013.
  420. Smucny M, Kolmodin J, Saluan P: Shoulder And elbow injuries in the adolescent athlete, Sports Med Arthrosc 24(4):188–194, 2016.
  421. Alter KE, Murphy KP: Guidance techniques for botulinum toxins and other injections.
  422. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  423. Braithwaite KA, Marshall KW: The skeletally immature and newly mature throwing athlete, Radiol Clin North Am 54(5):841–855, 2016.
  424. Coombes BK, Bisset L, Brooks P, et al: Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia, JAMA 309:461–469, 2013.
  425. Ellington MD, Edmonds EW: Pediatric elbow and wrist pathology related to sports participation, Orthop Clin North Am 47(4):743–748, 2016.
  426. Fountain LB: Sports medicine in children: common overuse injuries, FP Essent 417:22–25, 2014.
  427. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  428. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  429. Krogh TP, Fredberg U, Stengaard-Pedersen K, et al: Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline, Am J Sports Med 41:625–635, 2013.
  430. Leahy I, Schorpion M, Ganley T: Common medial elbow injuries in the adolescent athlete, J Hand Ther 28(2):201–210, 2015.
  431. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  432. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  433. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  434. Murray DJ, Javed S, Jain N, et al: Platelet—rich—plasma injections in treating lateral epicondylosis: a review of the recent evidence, J Hand Microsurg 7(2):320–325, 2015.
  435. Paz DA, Chang GH, Yetto JM Jr, et al: Upper extremity overuse injuries in pediatric athletes: clinical presentation, imaging findings, and treatment, Clin Imaging 39(6):954–964, 2015.
  436. Peck E, Jelsing E, Onishi K: Advanced Ultrasound-guided interventions for tendinopathy, Phys Med Rehabil Clin N Am 27(3):733–748, 2016. doi:10.1016/j.pmr.2016.04.008. PubMed PMID: 27468675. Review.
  437. Rauck RC, LaMont LE, Doyle SM: Pediatric upper extremity stress injuries, Curr Opin Pediatr 25(1):40–45, 2013.
  438. Smucny M, Kolmodin J, Saluan P: Shoulder and elbow injuries in the adolescent athlete, Sports Med Arthrosc 24(4):188–194, 2016.
  439. Tisano BK, Estes AR: Overuse injuries of the pediatric and adolescent throwing athlete, Med Sci Sports Exerc 48(10):1898–1905, 2016.
  440. Dizdarevic I, Bishop M, Sgromolo N, et al: Approach to the pediatric athlete with back pain: more than just the pars, Phys Sportsmed 43(4):421–431, 2015.
  441. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  442. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  443. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  444. Miller R, Beck NA, Sampson NR, et al: Imaging modalities for low back pain in children: a review of spondyloysis and undiagnosed mechanical back pain, J Pediatr Orthop 33(3):282–288, 2013.
  445. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  446. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  447. Shah SA, Saller J: Evaluation and diagnosis of back pain in children and adolescents, J Am Acad Orthop Surg 24(1):37–45, 2016.
  448. Taxter AJ, Chauvin NA, Weiss PF: Diagnosis and treatment of low back pain in the pediatric population, Phys Sportsmed 42(1):94–104, 2014.
  449. Alter KE, Murphy KP: Guidance techniques for botulinum toxins and other injections.
  450. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  451. Broadley P, Offiah AC: Hip and groin pain in the child athlete, Semin Musculoskelet Radiol 18(5):478–488, 2014.
  452. Cohen B, Kleinhenz D, Schiller J, Tabaddor R: Understanding Athletic Pubalgia: A Review, R I Med J (2013) 99(10):31–35, 2016.
  453. Fountain LB: Sports medicine in children: common overuse injuries, FP Essent 417:22–25, 2014.
  454. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  455. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  456. Krabak BJ, Snitily B, Milani CJ: Running injuries during adolescence and childhood, Phys Med Rehabil Clin N Am 27(1):179–202, 2016.
  457. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  458. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  459. Stoev I, Powers AK, Puglisi JA, et al: Sacroiliac joint pain in the pediatric population, J Neurosurg Pediatr 9(6):602–607, 2012.
  460. Tammareddi K, Morelli V, Reyes M Jr: The athlete’s hip and groin, Prim Care 40(2):313–333, 2013.
  461. Dekker TJ, Rush JK, Schmitz MR: What’s new in pediatric and adolescent anterior cruciate ligament injuries?, J Pediatr Orthop 2016. [Epub ahead of print].
  462. Everhart JS, Cole D, Sojka JH, et al: Treatment options for patellar tendinopathy: A systematic review, Arthroscopy 2017. doi:10.1016/j.arthro.2016.11.007. [Epub ahead of print]. PubMed PMID: 28110807. pii: S0749-8063(16)30928-8, Review.
  463. Fabricant PD, Kocher MS: Anterior cruciate ligament injuries in children and adolescents, Orthop Clin North Am 47(4):777–788, 2016.
  464. Gorman McNerney ML, Arendt EA: Anterior knee pain in the active and athletic adolescent, Curr Sports Med Rep 12(6):404–410, 2013.
  465. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  466. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  467. Krabak BJ, Snitily B, Milani CJ: Running injuries during adolescence and childhood, Phys Med Rehabil Clin N Am 27(1):179–202, 2016.
  468. Launay F: Sports-related overuse injuries in children, Orthop Traumatol Surg Res 101(1 Suppl):S139–S147, 2015.
  469. Ludwig M, Atanda A Jr: Management of anterior cruciate ligament tears in skeletally immature athletes, Phys Sportsmed 43(4):440–447, 2015.
  470. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  471. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  472. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  473. Orth RC: The pediatric knee, Pediatr Radiol 43(Suppl 1):S90–S98, 2013.
  474. Peck E, Jelsing E, Onishi K: Advanced Ultrasound-guided interventions for tendinopathy, Phys Med Rehabil Clin N Am 27(3):733–748, 2016. doi:10.1016/j.pmr.2016.04.008. PubMed PMID: 27468675. Review.
  475. Pengel KB: Common overuse injuries in the young athlete, Pediatr Ann 43(12):e297–e308, 2014.
  476. Rathleff MS, Vicenzino B, Middelkoop M, et al: Patellofemoral pain in adolescence and adulthood: same same, but different?, Sports Med 45(11):1489–1495, 2015.
  477. Van Der Heijden RA, Lankhorst NE, Van Linschoten R, et al: Exercise for treating patellofemoral pain syndrome: an abridged version of cochrane systematic review, Eur J Phys Rehabil Med 52(1):110–133, 2016.
  478. Wegmann H, Tschauner S, Singer G, et al: The pediatric knee: diagnosis and management of ligament injuries, Semin Musculoskelet Radiol 18(5):489–497, 2014.
  479. Yen YM: Assessment and treatment of knee pain in the child and adolescent athlete, Pediatr Clin North Am 61(6):1155–1173, 2014.
  480. Bresnahan JJ, Hennrikus WL: Chronic exertional compartment syndrome in a high school soccer player, Case Rep Orthop 2015:965257, 2015.
  481. Fountain LB: Sports medicine in children: common overuse injuries, FP Essent 417:22–25, 2014.
  482. Gaunder C, McKinney B, Rivera J: Popliteal artery entrapment or chronic exertional compartment syndrome?, Case Rep Med 698:1047, 2017.
  483. Henry HT, Szolomayer LK, Sumpio BE, Sutton KM: Popliteal artery entrapment syndrome: bilateral lower extremity involvement, Orthopedics 1-4:2017. doi:10.3928/ 01477447-20170918-10. [Epub ahead of print].
  484. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  485. Jarraya M, Simmons S, Farber A, et al: Uncommon diseases of the popliteal artery: a pictorial review, Insights Imaging 7:679–688, 2016.
  486. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  487. Krabak BJ, Snitily B, Milani CJ: Running injuries during adolescence and childhood, Phys Med Rehabil Clin N Am 27(1):179–202, 2016.
  488. Launay F: Sports-related overuse injuries in children, Orthop Traumatol Surg Res 101(1 Suppl):S139–S147, 2015.
  489. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  490. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  491. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  492. Pengel KB: Common overuse injuries in the young athlete, Pediatr Ann 43(12):e297–e308, 2014.
  493. Rajasekaran S, Finnoff JT: Exertional leg pain, Phys Med Rehabil Clin N Am 27:91–119, 2016.
  494. Alter KE, Murphy KP: Guidance techniques for botulinum toxins and other injections.
  495. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  496. Brison RJ, Day AG, Pelland L, et al: Effect of early supervised physiotherapy on recovery from acute ankle sprain: randomized controlled trial, BMJ 355:i5650, 2016.
  497. David S, Gray K, Russell JA, Starkey C: Validation of the ottawa ankle rules for acute foot and ankle injuries, J Sport Rehabil 25(1):48–51, 2016.
  498. Spiegel DA, Dormans JP: Neuromuscular disorders. In Dormans JP, editor: Core knowledge in orthopaedics: pediatric orthopaedics, Philadelphia, 2005, Elsevier, pp 418–453.
  499. Westh RN, Menelaus MB: A simple calculation for the timing of the epiphyseal arrest, J Bone Joint Surg Br 63:117–119, 1981.
  500. Ey EH: Medical imaging of common orthopedic conditions in childhood, Curr Probl Pediatr Adolesc Health Care 41(1):29–32, 2011.
  501. Foster HE, Kay LJ, Friswell M, et al: Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen, Arthritis Rheum 55(5):709–716, 2006.
  502. Goff I, Rowan A, Bateman BJ, Foster HE: Poor sensitivity of musculoskeletal history in children, Arch Dis Child 97(7):644–646, 2012.
  503. Herring JA: The orthopedic examination: a comprehensive overview. In Herring JA, editor: Tachdjian’s pediatric orthopedics, ed 3, Philadelphia, 2002, W.B. Saunders, pp 25–61.
  504. Hosalkar HS, Garg S, Pollack A, et al: The diagnostic accuracy of MRI vs. CT imaging for osteoid osteoma in children, Clin Orthop 433:171–177, 2005.
  505. Maurer K: Musculoskeletal ultrasound in childhood, Eur J Radiol 83(9):1529–1537, 2014.
  506. Milla SS, Coley BD, Karmazyn B, et al: ACR appropriateness criteria limping child — ages 0 to 5 years, J Am Coll Radiol 9:545–553, 2012.
  507. Naranje S, Kelly DM: A systematic approach to the evaluation of a limping child, Am Fam Physician 92(10):908–916, 2015.
  508. Nemeth B: The diagnosis and management of common childhood orthopedic disorders, Curr Probl Pediatr Adolesc Health Care 41(1):2–28, 2011.
  509. Ruzbarsky JJ, Scher D, Dodwell E: Toe walking: causes, epidemiology, assessment, and treatment, Curr Opin Pediatr 28:40–46, 2016.
  510. Staheli LT: Normative data in pediatric orthopaedics, J Pediatr Orthop 16:561–562, 1996.
  511. Sutherland DH, Olsten R, Cooper L, et al: The development of gait, J Bone Joint Surg Am 62:336–353, 1980.
  512. Herzenberg JE, Burghardt RD: Resistant metatarsus adductus: prospective randomized trial of casting versus orthosis, J Orthop Sci 19:250–256, 2014.
  513. Paton RW, Choudry QA, Jugdey R, Hughes S: Is congenital talipes equinovarus a risk factor for pathological dysplasia of the hip? A 21-year prospective, longitudinal observational study, Bone Joint J 96-B(11):1553–1555, 2014.
  514. Shaw BA, Segal LS, Section on Orthopaedics: Evaluation and referral for developmental dysplasia of the hip in infants, Pediatrics 138(6):e20163107, 2016.
  515. Shorter D, Hong T, Osborn DA: Cochrane review: screening programmes for developmental dysplasia of the hip in newborn infants, Evid Based Child Health 8(1):11–54, 2013.
  516. Dobbs MB, Gurnett CA: Genetics of clubfoot, J Pediatr Orthop B 21(1):7–9, 2012.
  517. Gray K, Pacey V, Gibbons P, et al: Interventions for congenital talipes equinovarus (clubfoot), Cochrane Database Syst Rev (8):CD008602, 2014.
  518. Hsu LP, Dias LS, Swaroop VT: Long-term retrospective study of patients with idiopathic clubfoot treated with posterior medial-lateral release, J Bone Joint Surg 95(5):e271–e278, 2013.
  519. Jeans KA, Erdman AL, Karol LA: Plantar pressures after nonoperative treatment for clubfoot: intermediate follow-up at age 5 years, J Pediatr Orthop 37(1):53–58, 2017.
  520. Marquez E, Pacey V, Chivers A, et al: The Ponseti technique and improved ankle dorsiflexion in children with relapsed clubfoot: a retrospective analysis, J Pediatr Orthop B 26(2):116–121, 2017.
  521. Miller NH, Carry PM, Mark BJ, et al: Does strict adherence to the Ponseti method improve isolated clubfoot treatment outcomes? A two institutions review, Clin Orthop Relat Res 474(1):237–243, 2016.
  522. Richards BS, Faulks S, Razi O, et al: Nonoperatively corrected clubfoot at age 2 years: radiographs are not helpful in predicting future relapse, J Bone Joint Surg Am 99(2):155–160, 2017.
  523. Sala DA, Chu A, Lehman WB, et al: Achievement of gross motor milestones in children with idiopathic clubfoot treated with Ponseti method, J Pediatr Orthop 33(1):55–58, 2013.
  524. Singh AK, Roshan A, Ram S: Outpatient taping in the treatment of idiopathic congenital talipes equinovarus, Bone Joint J 95-B(2):271–278, 2013.
  525. Merrill LJ, Gurnett CA, Connolly AM, et al: Skeletal muscle abnormalities and genetic factors associated related to congenital vertical talus, Clin Orthop Relat Res 469(4):1167–1174, 2011.
  526. Miller M, Dobbs MB: Congenital vertical talus: etiology and management, J Am Acad Orthop Surg 23(1):604–611, 2015.
  527. Yang JS, Dobbs MB: Treatment of congenital vertical talus: comparison of minimally invasive and extensive soft-tissue release procedures at minimum five-year follow-up, J Bone Joint Surg Am 97(16):1354–1365, 2015.
  528. Carr JB II, Yang S, Lather LA: Pediatric pes planus: a state-of-the-art review, Pediatrics 137(3):e21051230, 2016.
  529. Dare DM, Dodwell ER: Pediatric flatfoot: cause, epidemiology, assessment, and treatment, Curr Opin Pediatr 26:93–100, 2014.
  530. Jane MacKenzie A, Rome K, Evans AM: The efficacy of nonsurgical interventions for pediatric flexible flat foot: a critical review, J Pediatr Orthop 32(8):830–834, 2012.
  531. Moraleda L, Salcedo M, Bastrom TP, et al: Comparison of the calcaneo-cuboidcuneiform osteotomies and the calcaneal lengthening osteotomy in the surgical treatment of symptomatic flexible flatfoot, J Pediatr Orthop 32(8):225–232, 2012.
  532. Roth S, Roth A, Jotanovic Z, Madarevic T: Navicular index for differentiation of flatfoot from normal foot, Int Orthop 37(6):1107–1112, 2013.
  533. Crim J: Imaging of tarsal coalitions, Radiol Clin North Am 46(6):1017–1026, 2008.
  534. Guignard D, Journeau P, Mainard-Simard L, et al: Child calcaneonavicular coalitions: MRI diagnostic value in a 19-case series, Orthop Traumatol Surg Res 97(1):67–72, 2011.
  535. Mahan ST, Spencer SA, Vezeridis PS, Kasser JR: Patient-reported outcomes of tarsal coalitions treated with surgical excision, J Pediatr Orthop 35(6):583–588, 2015.
  536. Mosca VS, Bevan WP: Talocalcaneal tarsal coalitions and the calcaneal lengthening osteotomy: the role of deformity correction, J Bone Joint Surg 94(17):1584–1594, 2012
  537. Karakis I, Gregas M, Darras BT, et al: Clinical correlates of Charcot-Marie-Tooth disease in patients with pes cavus deformities, Muscle Nerve 47(4):488–492, 2013.
  538. Wicart P: Cavus foot, from neonates to adolescents, Orthop Traumatol Surg Res 98(7):813–828, 2012.
  539. Atanda A Jr, Shah SA, O’Brien K: Osteochondrosis: common causes of pain in growing bones, Am Fam Physician 83(3):258–291, 2011.
  540. Kean JR: Foot problems in the adolescent, Adolesc Med State Art Rev 18(1):182–191, 2007.
  541. Kose O: Do we really need radiographic assessment for the diagnosis of non-specific heel pain (calcaneal apophysitis) in children?, Skeletal Radiol 39(4):359–361, 2010.
  542. Rachel JN, Williams JB, Sawyer JR, et al: Is radiographic evaluation necessary in children with a clinical diagnosis of calcaneal apophysitis (Sever disease), J Pediatr Orthop 31(5):548–550, 2011.
  543. Davis J, Czerniski B, Au A, et al: Diagnostic accuracy of ultrasonography in retained soft tissue foreign bodies: a systematic review and meta-analysis, Acad Emerg Med 22(7):777–787, 2015.
  544. Haverstock BD: Puncture wounds of the foot, Clin Podiatr Med Surg 29(2):311–322, ix, 2012.
  545. Niall DM, Murphy PG, Fogarty EE, et al: Puncture wound related Pseudomonas infections of the foot in children, Ir J Med Sci 166(2):98–101, 1997.
  546. Edmonds EW, Ek D, Bomar JD, et al: Preliminary radiographic outcomes of surgical correction in juvenile hallux valgus: single proximal, single distal versus double osteotomies, J Pediatr Orthop 35(3):307–313, 2015.
  547. Shirzad K, Kiesau CD, DeOrio JK, et al: Lesser toe deformities, J Am Acad Orthop Surg 19:505–514, 2011.
  548. Kurup HV, Clark CIM, Dega RK: Footwear and orthopaedics, Foot Ankle Surg 18(2):79–83, 2012.
  549. Mauch M, Grau S, Krauss I, et al: A new approach to children’s footwear based on foot type classification, Ergonomics 52(8):999–1008, 2009.
  550. Wolf S, Simon J, Patikas D, et al: Foot motion in children’s shoes: a comparison of barefoot walking with shod walking in conventional and flexible shoes, Gait Posture 27(1):51–59, 2008.
  551. Arazi M, Ogun TC, Memik R: Normal development of the tibiofemoral angle in children: a clinical study of 590 normal subjects from 3 to 17 years of age, J Pediatr Orthop 21:264–267, 2001.
  552. Cahuzac JP, Vardon D, Sales de Gauzy J: Development of the clinical tibiofemoral angle in normal adolescents: a study of 427 normal subjects from 10 to 16 years of age, J Bone Joint Surg Br 77:729–732, 1995.
  553. Heath CH, Staheli LT: Normal limits of knee angle in white children—genu varum and genu valgum, J Pediatr Orthop 13:259–262, 1993.
  554. Ruwe PA, Gage JR, Ozonoff MB, et al: Clinical determination of femoral anteversion: a comparison of established techniques, J Bone Joint Surg Am 74:820–830, 1992.
  555. Thompson GH: Gait disturbances. In Kliegman RM, editor: Practical strategies in pediatric diagnosis and therapy, ed 2, Philadelphia, 2003, W.B. Saunders, pp 823–843.
  556. Lincoln TL, Suen PW: Common rotational variations in children, J Am Acad Orthop Surg 11(5):312–320, 2003.
  557. Staheli LT: Rotational problems in children, Instr Course Lect 43:199–209, 1994.
  558. Cheema JI, Grissom LE, Harcke HT: Radiographic characteristics of lower-extremity bowing in children, Radiographics 23(4):871–880, 2003.
  559. Davids JR, Blackhurst DW, Allen BL Jr: Radiographic evaluation of bowed legs in children, J Pediatr Orthop 21:257–263, 2001.
  560. Do TT: Clinical and radiographic evaluation of bowlegs, Curr Opin Pediatr 13:42–46, 2001.
  561. Doyle BS, Volk G, Smith CI: Infantile Blount’s disease: long-term follow-up of surgically treated patients at skeletal maturity, J Pediatr Orthop 16:469–476, 1996.
  562. Feldman MD, Schoenecker PL: Use of metaphyseal-diaphyseal angle in the evaluation of bowed legs, J Bone Joint Surg Am 75:1602–1609, 1993.
  563. Mayer SW, Hubbard EW, Sun D, et al: Gradual deformity correction in Blount disease, J Pediatr Orthop 2016. [Epub ahead of print]. PMID: 28027146.
  564. Sabharwal S: Treatment of infantile Blount disease: an update, J Pediatr Orthop 37(Suppl 2):S26–S31, 2017.
  565. Scott AC: Treatment of infantile Blount disease with lateral tension band plating, J Pediatr Orthop 32:29–34, 2012.
  566. Stevens PM, Maguire M, Dales MD, et al: Physeal stapling for idiopathic genu valgum, J Pediatr Orthop 19:645–649, 1999.
  567. Stevenson DA, Viskochil DH, Schorry EK, et al: The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1, Genet Med 9(7):409–412, 2007.
  568. Abdlslam KM, Oleksak M, Saleh M: Tibial shortening for correction of leg length discrepancy and deformity: a new technique, J Pediatr Orthop B 12(4):264–268, 2003.
  569. Babu LV, Evans O, Sankar A, et al: Epiphysiodesis for limb length discrepancy: a comparison of two methods, Strategies Trauma Limb Reconstr 9(1):1–3, 2014.
  570. Beresford-Cleary N, Craig RS, Wainwright A: Principles of skeletal growth and correction for leg length discrepancies in children, Orthop Trauma 30(6):471–481, 2016.
  571. Cardoso HF, Abrantes J, Humphrey LT: Age estimation of immature human skeletal remains from the diaphyseal length of the long bones in the postnatal period, Int J Legal Med 128(5):809–824, 2014.
  572. Cunningham C, Scheuer L, Black S: Developmental juvenile osteology, 2016, Academic Press.
  573. Gruelich WW, Pyle SI: Radiographic atlas of skeletal development of the hand and wrist, ed 2, Stanford, CA, 1959, Stanford University Press.
  574. Inan M, Chan G, Littleton AG, et al: Efficacy and safety of percutaneous epiphysiodesis, J Pediatr Orthop 28(6):648–651, 2008.
  575. Lee SC, Shim JS, Seo SW, et al: The accuracy of current methods in determining the timing of epiphysiodesis, Bone Joint J 95(7):993–1000, 2013.
  576. Tsuchiya H, Uehara K, Abdel-Wanis ME, et al: Deformity correction followed by lengthening with the Ilizarov method, Clin Orthop Relat Res 402:176–183, 2002.
  577. Kushare I, Klingele K, Samora W: Discoid meniscus: diagnosis and management, Orthop Clin North Am 46(4):533–540, 2015.
  578. Akagi R, Saisu T, Segawa Y, et al: Natural history of popliteal cysts in the pediatric population, J Pediatr Orthop 33(3):262–268, 2013.
  579. Herman AM, Marzo JM: Popliteal cysts: a current review, Orthopedics 37(8):e678–e684, 2014.
  580. Neubauer H, Morbach H, Schwarz T, et al: Popliteal cysts in paediatric patients: clinical characteristics and imaging features on ultrasound and MRI, Arthritis 2011:751593, 2011.
  581. Chambers HG, Shea KG, Anderson AF, et al: American Academy of Orthopaedic Surgeons. Diagnosis and treatment of osteochondritis dissecans, J Am Acad Orthop Surg 19(5):297–306, 2011.
  582. Gunton MJ, Carey JL, Shaw CR, et al: Drilling juvenile osteochondritis dissecans: retro- or transarticular? Clin Orthop Relat Res 471(4):1144–1151, 2013.
  583. Pascual-Garrido C, Moran CJ, Green D, et al: Osteochondritis dissecans of the knee in children and adolescents, Curr Opin Pediatr 25:46–51, 2013.
  584. Uppstrom TJ, Gausden EB, Green DW: Classification and assessment of juvenile osteochondritis dissecans knee lesions, Curr Opin Pediatr 28:60–67, 2016.
  585. Arnold A, Thigpen CA, Beattie PF, et al: Overuse physeal injuries in youth athletes, Sports Health 9(2):139–147, 2017.
  586. Atanda A Jr, Shah SA, O’Brien K: Osteochondrosis: common causes of pain in growing bones, Am Fam Physician 83(3):285–291, 2011.
  587. Doherty C, Bleakley C, Hertel J, et al: Recovery from a first-time lateral ankle sprain and the predictors of chronic ankle stability, Am J Sports Med 44(4):955–1003, 2016.
  588. Erickson JB, Samora WP, Klingele KE: Ankle injuries in the pediatric athlete, Sports Med Arthrosc 24(4):170–177, 2016.
  589. Halstead ME: Pediatric ankle sprains and their imitators, Pediatr Ann 43(12):e291–e296, 2014.
  590. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  591. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  592. Krabak BJ, Snitily B, Milani CJ: Running injuries during adolescence and childhood, Phys Med Rehabil Clin N Am 27(1):179–202, 2016.
  593. Launay F: Sports-related overuse injuries in children, Orthop Traumatol Surg Res 101(1 Suppl):S139–S147, 2015.
  594. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orhtopedic Surgeons, Rosemont, IL, 2016.
  595. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  596. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  597. Pengel KB: Common overuse injuries in the young athlete, Pediatr Ann 43(12):e297–e308, 2014.
  598. Shore BJ, Kramer DE: Management of syndesmotic ankle injuries in children and adolescents, J Pediatr Orthop 36(Suppl 1):S11–S14, 2016.
  599. Asplund CA, Best TM: Achilles tendon disorders, BMJ 346:f1262, 2013.
  600. Azevedo RR, da Rocha ES, Franco PS, Carpes FP: Plantar pressure asymmetry and risk of stress injuries in the foot of young soccer players, Phys Ther Sport 24:39–43, 2017.
  601. Davison MJ, David-West SK, Duncan R: Careful assessment the key to diagnosing adolescent heel pain, Practitioner 260(1793):30–32, 2016.
  602. Herring JA, editor: Tachdjian’s pediatric orthopedics, Philadelphia, PA, 2014, Elsevier Sanders.
  603. James AM, Williams CM, Haines TP: Effectiveness of footwear and foot orthoses for calcaneal apophysitis: a 12-month factorial randomised trial, Br J Sports Med 50(20):1268–1275, 2016.
  604. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  605. Lee HJ, Lim KB, Yoo J, et al: Effect of Custom-molded foot orthoses on foot pain and balance in children with symptomatic flexible flat feet, Ann Rehabil Med 39(6):905–913, 2015.
  606. Lewis RD, Wright P, McCarthy LH: Orthotics compared to conventional therapy and other Non-surgical treatments for plantar fasciitis, J Okla State Med Assoc 108(12):596–598, 2015.
  607. Martus JE, editor: Orthopaedic knowledge update: pediatrics 5, American Academy of Orthopedic Surgeons, Rosemont, IL, 2016.
  608. Murphy KP, Wunderlich CA, Pico EL, et al: Orthopedic & musculoskeletal conditions.
  609. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  610. Roth J, Neumann J, Tao M: Orthopaedic perspective on barefoot and minimalist running, J Am Acad Orthop Surg 24(3):180–187, 2016.
  611. Vahdatpour B, Kianimehr L, Ahrar MH: Autologous platelet-rich plasma compared with whole blood for the treatment of chronic plantar fasciitis; a comparative clinical trial, Adv Biomed Res 5:84, 2016.
  612. Alsalaheen BA, Mucha A, Morris LO, et al: Vestibular rehabilitation for dizziness and balance disorders after concussion, J Neurol Phys Ther 34:87–93, 2010.
  613. Babcock L, Kurowski BG: Identifying children and adolescents at risk for persistent postconcussion symptoms, JAMA 315(10):987–988, 2016.
  614. Zemek R, Barrowman N, Freedman SB, et al: Clinical risk score for persistent postconcussion symptoms among children with acute concussion in the ED, JAMA 315(10):1014–1025, 2016.
  615. Zhang AL, Sing DC, Rugg CM, et al: The rise of concussions in the adolescent population, Orthop J Sports Med 4(8):1–7, 2016.
  616. Zuckerman SL, Lee YM, Odom MJ, et al: Recovery from sports-related concussion: days to return to neurocognitive baseline in adolescents versus young adults, Surg Neurol Int 3:130, 2012.
  617. Aebli N, Wicki AG, R?egg TB, et al: The Torg-Pavlov ratio for the prediction of acute spinal cord injury after a minor trauma to the cervical spine, Spine J 13(6):605–612, 2013.
  618. Alpayci M, ?enk?y E, Delen V, et al: Decreased neck muscle strength in patients with the loss of cervical lordosis, Clin Biomech (Bristol, Avon) 33:98–102, 2016.
  619. Cantu RC, Li YM, Abdulhamid M, Chin LS: Return to play after cervical spine injury in sports, Curr Sports Med Rep 12(1):14–17, 2013.
  620. France JC, Karsy M, Harrop JS, Dailey AT: Return to play after cervical spine injuries: a consensus of opinion, Global Spine J 6(8):792–797, 2016.
  621. Green J, Zuckerman SL, Dalton SL, et al: A 6-year surveillance study of “stingers” in NCAA American football, Res Sports Med 25(1):26–36, 2016.
  622. Hrysomallis C: Neck muscular strength, training, performance and sport injury risk: a review, Sports Med 46(8):1111–1124, 2016.
  623. Huang P, Anissipour A, Mcgee W, Lemak L: Return-to-play recommendations after cervical, thoracic, and lumbar spine injuries, Sports Health 8(1):19–25, 2015.
  624. Hutton MJ, Mcguire RA, Dunn R, et al: Catastrophic cervical spine injuries in contact sports, Global Spine J 6(7):721–734, 2016.
  625. Rosenthal BD, Boody BS, Hsu WK: Return to play for athletes, Neurosurg Clin N Am 28(1):163–171, 2017.
  626. Schroeder GD, Vaccaro AR: Cervical spine injuries in the athlete, Instr Course Lect 66:391–402, 2017.
  627. Almond CSD, Shin AY, Fortescue EB: Hyponatremia among runners in the Boston marathon, N Engl J Med 15:1150–1156, 2005.
  628. Boden BP, Breit I, Beachler JA, et al: Fatalities in high school and college football players, Am J Sports Med 41(5):1108–1116, 2013.
  629. Bytomski JR, Squire DL: Heat illness in children, Curr Sports Med Rep 2:320–324, 2003.
  630. Casa DJ, Armstrong LE, Kenny GP, et al: Exertional heat stroke: new concepts regarding cause and care, Curr Sports Med Rep 11(3):115–123, 2012.
  631. Centers for Disease Control and Prevention: Heat illness among high school athletes—United States, 2005-2009, MMWR Morb Mortal Wkly Rep 59:1009–1013, 2010.
  632. Council on Sports Medicine and Fitness and Council on School Health, Bergeron MF, Devore C, et al: Policy statement—climatic heat stress and exercising children and adolescents, Pediatrics 128(3): e741–e747, 2011.
  633. Hew-Butler T, Rosner MH, Fowkes-Godek S, et al: Statement of the third international exercise-associated hyponatremia consensus development conference, Carlsbad, California, 2015, Clin J Sport Med 25(4):303–320, 2015.
  634. American Psychiatric Publishing: Feeding and eating disorders.
  635. Birch K: Female athlete triad, BMJ 330:244–246, 2005.
  636. Deimel JF, Dunlap BJ: The female athlete triad, Clin Sports Med 31(2):247–254, 2012.
  637. De Souza MJ, Nattiv A, Joy E, et al: 2014 female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad, Br J Sports Med 48:289, 2014.
  638. Gordon CM, Ackerman KE, Berga SL, et al: Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline, J Clin Endocrinol Metab 102(5):1–27, 2017.
  639. Greydanus DE, Omar H, Pratt HD: The adolescent athlete: current concepts andconundrums, Pediatr Clin North Am 57(3):697–718, 2010.
  640. House S, Loud K, Shubkin C: Female athlete triad for the primary care pediatrician, Curr Opin Pediatr 25:755–761, 2013.
  641. Kelly AKW, Hecht S, Council on sports medicine and fitness: The female athletic triad, Pediatrics 138(2):e20160922, 2016.
  642. Nemet D, Eliakim A: Pediatric sports nutrition: an update, Curr Opin Clin Nutr Metab Care 12(3):304–309, 2009.
  643. Vo M, Accurso EC, Goldschmidt AB, LeGrange D: The impact of DSM-5 on eating disorder diagnoses, International J Eating Disorders 2016. doi:10.1002/eat.22628. (Epub ahead of print).
  644. Bishop D: Dietary supplements and team-sport performance, Sports Med 40(12):995–1017, 2010.
  645. Calfee R, Fadale P: Popular ergogenic drugs and supplements in young athletes, Pediatrics 117:e577–e589, 2006.
  646. Eisenberg ME, Wall M, Neumark-Sztainer D: Muscle-enhancing behaviors among adolescent girls and boys, Pediatrics 130:1019–1026, 2012.
  647. Elsharkawy AE, McPherson S, Masson S, et al: Cholestasis secondary to anabolic steroid use in young men, BMJ 344:e468, 2012.
  648. Hatton CK, Green GA, Ambrose PJ: Performance-enhancing drugs: understanding the risks, Phys Med Rehabil Clin N Am 25:897–913, 2014.
  649. Jain P, Hall-May E, Golabek K, et al: A comparison of sports and energy drinks–physiochemical properties and enamel dissolution, Gen Dent 60(3):190–197, 2012.
  650. LaBots M, Griesemer BA: Council on sports medicine and fitness: use of performance-enhancing substances, Pediatrics 138(1):e20163100, 2016.
  651. Meinhardt U, Nelson AE, Hansen JL, et al: The effects of growth hormone on body composition and physical performance in recreational athletes, Ann Intern Med 152:568–577, 2010.
  652. Momaya A, Fawal M, Estes R: Performance-enhancing substances in sports: a review of the literature, Sports Med 45:517–531, 2015.
  653. Schneider MB, Benjamin HJ: AAP committee on nutrition 2010-2011: clinical report—sports drinks and energy drinks for children and adolescents: are they appropriate, Pediatrics 127:1182–1189, 2011.
  654. Seifert SM, Schaechter JL, Hershorin ER, et al: Health effects of energy drinks on children, adolescents, and young adults, Pediatrics 127(3):511–528, 2011.
  655. Sjoqvist F, Garle M, Rane A: Use of doping agents, particularly anabolic steroids in sports and society, Lancet 371:1872–1882, 2008.
  656. Thevis M, Kuuranne T, Geyer H, Sch?nzer W: Annual banned-substance review: analytical approaches in human sports drug testing, Drug Test Anal 9:6–29, 2017.
  657. Toblin RL, Clarke-Walper K, Kok BC, et al: Energy drink consumption and its association with sleep problems among US service members on a combat deploy-ment–Afghanistan, 2010, MMWR Morb Mortal Wkly Rep 61:895–898, 2012.
  658. Van Wagoner RM, Eichner A, Bhasin S, et al: Chemical composition and labeling of substances marketed as selective androgen receptor modulators and solid via the internet, JAMA 381(20):2004–2010, 2017.
  659. Wolk BJ, Ganetsky M, Babu KM: Toxicity of energy drinks, Curr Opin Pediatr 24:243–251, 2012.
  660. World Anti-Doping Agency: The world anti-doping code international standard prohibited list. Jan 2018.
  661. Brenner JS: Council on sports medicine and fitness: sports specialization and intensive training in young adults, Pediatrics 138(3):e20162158, 2016.
  662. DiFiori JP, et al: Overuse injuries and burnout in youth sports: a position statement from the American medical society for sports medicine, Br J Sports Med 48(4):287–288, 2014.
  663. Jayanthi N, et al: Sports specialization in young athletes: evidence-based recommendations. Sports health, 2013, Sports Health 5(3):251–257, 2013.
  664. Logan K: Overuse and underutilization in youth sports: time to seek equipoise, J Pediatr 166(3):517–518, 2015.
  665. Myer GD, et al: Sport specialization, Part I: does early sports specialization increase negative outcomes and reduce the opportunity for success in young athletes? Sports Health 7(5):437–442, 2015.
  666. Myer GD, et al: Sports specialization, Part II: alternative solutions to early sport specialization in youth athletes, Sports Health 8(1):65–73, 2016.
  667. Babcock L, et al: Cervical spine injuries in children associated with sports and recreational activities, Pediatr Emerg Care 00(00):1–10, 2016.
  668. Council on sports medicine and fitness: tackling in youth football, Pediatrics 136(5): e1419–e1430, 2015.
  669. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  670. Lykissas M: Trends in pediatric Sports-related and Recreation-related injuries in the United States in the last decade, J Pediatr Orthop 33(8):803–810, 2013.
  671. Magrini D, Dahab KS: Musculoskeletal overuse injuries in the pediatric population, Curr Sports Med Rep 15(6):392–399, 2016.
  672. Olson D, Singh Sikka R, et al: Football injuries: current concepts, Curr Sports Med Rep 10(5):290–298, 2011.
  673. Salata M, Gibbs AE, Sekiya JK: The effectiveness of prophylactic knee bracing in American football: a systematic review, Sports Health 2(5):375–379, 2010.
  674. DiFiori JP, et al: Overuse injuries and burnout in youth sports: a position statement from the American medical society for sports medicine, Br J Sports Med 48(4):287–288, 2014.
  675. Magrini D, Dahab KS: Musculoskeletal overuse injuries in the pediatric population, Curr Sports Med Rep 15(6):392–399, 2016.
  676. Smith MV, et al: Prospective Player-reported injuries in female youth Fast-pitch softball players, Sports Health 7(6):497–503, 2015.
  677. Karlin AM, Murphy KP: Acute management and rehabilitation of Sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  678. Magrini D, Dahab KS: Musculoskeletal overuse injuries in the pediatric population, Curr Sports Med Rep 15(6):392–399, 2016.
  679. Pollard KA, Shields BJ, Smith GA: Pediatric volleyball-related injuries treated in US emergency departments, 1990-2009, Clin Pediatr (Phila) 50(9):844–852, 2011.
  680. Chung KC, Lark ME: Upper extremity injuries in tennis players: diagnosis, treatment, and management, Hand Clin 33(1):175–186, 2017.
  681. Gaw CE, Chounthirath T, Smith GA: Tennis-related injuries treated in United States emergency departments, 1990 to 2011, Clin J Sport Med 24(3):226–232, 2014.
  682. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  683. Putukian M, Linciln AE, Crisco JJ: Sports-specific issues in Men’s and Women’s lacrosse, Curr Sports Med Rep 13(5):334–340, 2014.
  684. Vincent HK, Zdziarski LA, Vincent KR: Review of lacrosse-related musculoskeletal injuries in high school and collegiate players, Sports Health 7(5):448–451, 2015.
  685. Xiang J, et al: Lacrosse injuries among high school boys and girls in the United States: academic years 2008-2009 through 2011-2012, Am J Sports Med 42(9):2082–2088, 2014.
  686. Babcock L, et al: Cervical spine injuries in children associated with sports and recreational activities, Pediatr Emerg Care 00(00):1–10, 2016.
  687. Kerr ZY, et al: Epidemiology of national collegiate athletic association men’s and women’s swimming and diving injuries from 2009/2010 to 2013/2014, Br J Sports Med 49:465–471, 2015.
  688. Narita T, et al: Critical factors for the prevention of low back pain in elite junior divers, Br J Sports Med 48:919–923, 2014.
  689. Zaina F, Donzelli S, Lusini M, et al: Swimming and spinal deformities: a cross-sectional study, J Pediatr 166:163–167, 2015.
  690. Read PJ, et al: Neuromuscular risk factors for knee and ankle ligament injuries in male youth soccer players, Sports Med 46(8):1059–1066, 2016.
  691. Rossler R, et al: Soccer injuries in players aged 7 to 12 years: a descriptive epidemiological study over 2 seasons, Am J Sports Med 44(2):309–317, 2016.
  692. Smith NA, Chounthirath T, Xiang H: Soccer-related injuries treated in emergency departments: 1990-2014, Pediatrics 138(4):2016.
  693. Black AM, et al: Policy change eliminating body checking in non-elite ice hockey leads to a threefold reduction in injury and concussion risk in 11- and 12-year-old players, Br J Sports Med 50(1):55–61, 2016.
  694. Matic GT, et al: Ice hockey injuries among United States high school athletes from 2008/2009-2012/2013, Phys Sportsmed 43(2):119–125, 2015.
  695. Polites SF, et al: Youth ice hockey injuries over 16 years at a pediatric trauma center, Pediatrics 133(6):e1601–e1607, 2014.
  696. Murtaugh K: Field hockey injuries, Curr Sports Med Rep 8(5):267–272, 2009.
  697. Hume PA, et al: Recreational snow-sports injury risk factors and countermeasures: a meta-analysis review and haddon matrix evaluation, Sports Med 45(8):1175–1190, 2015.
  698. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  699. Kim S, et al: Snowboarding injuries: trends over time and comparisons with alpine skiing injuries, Am J Sports Med 40(4):770–776, 2012.
  700. Steenstrup SE, Bere T, Bahr R: Head injuries among FIS world cup alpine and freestyle skiers and snowboarders: a 7-year cohort study, Br J Sports Med 48(1):41–45, 2014.
  701. Hunter J: The epidemiology of injury in skateboarding, Med Sport Sci 58:142–157, 2012.
  702. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  703. Kroncke EL, et al: Use of protective equipment by adolescents in inline skating, skateboarding, and snowboarding, Clin J Sport Med 18(1):38–43, 2008.
  704. Lustenberger T, et al: Skateboard-related injuries: not to be taken lightly. A national trauma databank analysis, J Trauma 69(4):924–927, 2010.
  705. Nathanson B, et al: An analysis of US emergency department visits from falls from skiing, snowboarding, skateboarding, roller-skating, and Using Nonmotorized Scooters, Clin Pediatr (Phila) 55(8):738–744, 2016.
  706. Daniels DJ, et al: High occurrence of head and spine injuries in the pediatric population following motocross accidents, J Neurosurg Pediatr 15(3):261–265, 2015.
  707. Embree TE, Romanow NTR, Djerboua MS, et al: Risk factors for bicycling injuries in children and adolescents: a systematic review, Pediatrics 138(5):e20160282, 2016.
  708. Jospeh B, Azim A, Haider AA, et al: Bicycle helmets work when it matters the most, Am J Surg 213(2):413–417, 2017.
  709. Romanow NT, Hagel BE, Nguyen M, et al: Mountain bike terrain park-related injuries: an emerging cause of morbidity, Int J Inj Contr Saf Promot 21(1):29–46, 2014.
  710. Centers for Disease Control: Outbreak of skin lesions among high school wrestlers—Arizona, 2014, MMWR Morb Mortal Wkly Rep 64(20):559–560, 2015.
  711. Demorest RA, Koutures C: Council on sports medicine and fitness, Pediatrics 138(6):e20163022, 2016.
  712. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  713. Khalili-Borna D, Honsik K: Wrestling and sports medicine, Curr Sports Med Rep 4:144–149, 2005.
  714. Myers RJ, Linakis SW, Mello MJ, Linakis JG: Competitive wrestling related injuries in school aged athletes in U.S. emergency departments, West J Emerg Med 11(5):442–449, 2010.
  715. DiFiori JP, et al: Overuse injuries and burnout in youth sports: a position statement from the American medical society for sports medicine, Br J Sports Med 48(4):287–288, 2014.
  716. Krabak BJ, Snitily B, Milani CJ: Running injuries during adolescence and childhood, Phys Med Rehabil Clin N Am 27(1):179–202, 2016.
  717. Roth J, et al: Orthopaedic perspective on barefoot and minimalist running, J Am Acad Orthop Surg 24(3):180–187, 2016.
  718. Currie DW, et al: Cheerleading injuries in United States high schools, Pediatrics 137(1):2016.
  719. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  720. Magrini D, Dahab KS: Musculoskeletal overuse injuries in the pediatric population, Curr Sports Med Rep 15(6):392–399, 2016.
  721. Saluan P, et al: Injury types and incidence rates in precollegiate female gymnasts: a 21-year experience at a single training facility, Orthop J Sports Med 3(4):2015.
  722. Westermann RW, et al: Evaluation of men’s and women’s gymnastics injuries: a 10-year observational study, Sports Health 7(2):161–165, 2015.
  723. Giannini S, et al: Posterior ankle impingement, Foot Ankle Int 34(3):459–465, 2013.
  724. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific musculoskeletal injuries. In Alexander MA, Matthews BJ, Murphy KP, editors: Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  725. Smith PJ, et al: Incidence and prevalence of musculoskeletal injury in ballet: a systematic review, Orthop J Sports Med 3(7): p. 2325967115592621, 2015.
  726. Sobrino FJ, de la Cuadra C, Guillen P: Overuse injuries in professional ballet: Injury-based differences among ballet disciplines, Orthop J Sports Med 3(6): p. 2325967115590114, 2015.
  727. Karlin AM, Murphy KP: Acute management and rehabilitation of sport-specific injuries. In Alexander MA, Matthews BJ, Murphy KP, editors:
  728. Pediatric rehabilitation principles and practice, ed 5, New York, 2015, Demos Medical.
  729. Murphy NA, et al: American academy of pediatrics council on children with, promoting the participation of children with disabilities in sports, recreation, and physical activities, Pediatrics 121(5):1057–1061, 2008.
  730. Patel DR, Greydanus DE: Sport participation by physically and cognitively challenged young athletes, Pediatr Clin North Am 57(3):795–817, 2010.
  731. Apajasalo M, Sintonen H, Rautonen J, et al: Health-related quality of life of patients with genetic skeletal dysplasias, Eur J Pediatr 157:114–121, 1998.
  732. Bonafe L, Cormier-Daire V, Hall C, et al: Nosology and classification of genetic skeletal disorders: 2015 revision, Am J Med Genet A 167A(12):2869–2892, 2015.
  733. Gripp K, Slavotinek A, Hall JG, et al: Handbook of normal physical measurements, ed 2, Oxford, UK, 2006, Oxford University Press.
  734. Hoover-Fong JE, McGready J, Schulze KJ, et al: Weight for age charts for children with achondroplasia, Am J Med Genet A 143:2227–2235, 2007.
  735. Hoover-Fong JE, Schulze KJ, McGready J, et al: Age-appropriate body mass index in children with achondroplasia: interpretation in relation to indexes of height, Am J Clin Nutr 88(3):64–71, 2008.
  736. Horton WA, Hecht JT: Chondrodysplasias: general concepts and diagnostic and management considerations. In Royce PM, Steinmann B, editors: Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, ed 2, New York, 2002, Wiley-Liss, pp 901–908.
  737. Horton WA: Skeletal development: insights from targeting the mouse genome, Lancet 362:560–569, 2003.
  738. Kozlowski K, Masel J, Sillence DO, et al: Gracile bone dysplasias, Pediatr Radiol 32:629–634, 2002.
  739. Krakow D, Lachman RS, Rimoin DL: Guidelines for the prenatal diagnosis of fetal skeletal dysplasias, Genet Med 11:127–133, 2009.
  740. Krakow D, Rimoin DL: The skeletal dysplasias, Genet Med 12(6):327–341, 2010.
  741. Lachman RS: Neurologic abnormalities in the skeletal dysplasias: a clinical andradiological perspective, Am J Med Genet 69:33–43, 1997.
  742. Lachman RS: Taybi and Lachman’s radiology of syndromes, metabolic disorders and skeletal dysplasias, ed 2, New York, 2007, Elsevier.
  743. Masi L, Agnusdei D, Bilezikian J, et al: Taxonomy of rare genetic metabolic bone disorders, Osteoporos Int 26:2529–2558, 2015.
  744. Schramm T, Gloning KP, Minderer S, et al: Prenatal sonographic diagnosis of skeletal dysplasias, Ultrasound Obstet Gynecol 34(2):160–170, 2009.
  745. Smits P, Bolton AD, Funari V, et al: Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210, N Engl J Med 362:206–216, 2010.
  746. Spranger J, Brill PW, Poznanski A: Bone dysplasias. An atlas of genetic disorders of skeletal development, ed 2, New York, 2002, Oxford University Press.
  747. Spranger J, Maroteaux P: The lethal osteochondrodysplasias, Adv Hum Genet 19:1–103, 331–332, 1990.
  748. Tunkel DE, Kerkavaz R, Smith B, et al: Hearing screening in children with skeletal dysplasia, Arch Otolaryngol Head Neck Surg 137:1236–1239, 2011.
  749. Boerkoel CF, O’Neill S, Andre JL, et al: Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature, Eur J Pediatr 159:1–7, 2000.
  750. Couchouron T, Masson C: Early-onset progressive osteoarthritis with hereditary progressive ophthalmology or Stickler syndrome, Joint Bone Spine 78:45–49, 2011.
  751. Horton WA, Hecht JT: Chondrodysplasias: disorders of cartilage matrix proteins. In Royce PM, Steinmann B, editors: Connective tissue and its heritable disorders, New York, 2002, Wiley-Liss, pp 909–938.
  752. Jackson GC, Mittaz-Crettol L, Taylor JA, et al: Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution, Hum Mut 33:144–157, 2012.
  753. Kennedy J, Jackson G, Ramsden S, et al: Comp mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis o pseudoachondroplasia or multiple epiphyseal dysplasia, Eur J Hum Genet 13:547–555, 2005.
  754. Posey KL, Alcorn JL, Hecht JT: Pseudoachondroplasia/COMP—translating from the bench to the bedside, Matrix Biol 37:167–173, 2014.
  755. Stattin E-L, Wiklund F, Lindblom K, et al: A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans, Am J Hum Genet 86:126–137, 2010.
  756. Tompson SW, Merriman B, Funari VA, et al: A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the c-type lectin domain of aggrecan, Am J Hum Genet 84:72–79, 2009.
  757. American Academy of Pediatrics Committee on Genetics: Health supervision for children with achondroplasia, Pediatrics 116:771–783, 2005.
  758. Collins WO, Choi SS: Otolaryngologic manifestations of achondroplasia, Arch Otolaryngol Head Neck Surg 133:237–244, 2007.
  759. Ho NC, Guarnieri M, Brant LJ, et al: Living with achondroplasia: quality of life evaluation following cervico-medullary decompression, Am J Med Genet A 131:163–167, 2004.
  760. Hoover-Fong JE, McGready J, Schulze KJ, et al: Weight for age charts for children with achondroplasia, Am J Med Genet A 143:2227–2235, 2007.
  761. Hoover-Fong JE, Schulze KJ, McGready J, et al: Age-appropriate body mass index in children with achondroplasia: interpretation in relation to indexes of height, Am J Clin Nutr 88:64–71, 2008.
  762. Horton WA, Hall JG, Hecht JT: Achondroplasia, Lancet 370:162–172, 2007.
  763. Ireland PJ, Donaghey S, McGill J, et al: Development in children with achondroplasia: a prospective clinical cohort study, Dev Med Child Neurol 54(6):532–537, 2012.
  764. Jelin AC, O’Hare E, Blakemore K, et al: Skeletal dysplasias: growing therapy for growing bones, Front Pharmacol 8(79):2017.
  765. Julliand S, Boule M, Baujat G, et al: Lung function, diagnosis, and treatment of sleep-disordered breathing in children with achondroplasia, Am J Med Genet A 158A:1987–1993, 2012.
  766. Lorget F, Kaci N, Peng J, et al: Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia, Am J Hum Genet 91:1108–1114, 2012.
  767. Nikkel S, Major N, King W: Growth and development in thanatophoric dysplasia—an update 25 years later, Clin Case Rep 1(2):75–78, 2013.
  768. Ornitz D, Legeai-Mallet L: Achondroplasia: development, pathogenesis and therapy, Dev Dyn 246(4):291–309, 2017.
  769. Rothenbuhler A, Linglart A, Piquard C, et al: A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N54OK-mutated hypochondroplasia, J Pediatr 160:849–853, 2012.
  770. Schipani E, Langman CB, Parfitt AM, et al: Constitutively activated receptors for parathyroid hormone and parathyroid hormone–related peptide in Jansen’s metaphyseal chondrodysplasia, N Engl J Med 335:708–714, 1996.
  771. Sciubba DM, Noggle JC, Marupudi NI, et al: Spinal stenosis surgery in pediatric patients with achondroplasia, J Neurosurg 106:372–378, 2007.
  772. White KK, Bompadre V, Goldberg MJ, et al: Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy, Am J Med Genet A 170A(1):42–51, 2016.
  773. Bonafe L, Cormier-Daire V, Hall C, et al: Nosology and classification of genetic skeletal disorders: 2015 revision, Am J Med Genet A 167A(12):2869–2892, 2015.
  774. Barbosa M, Sousa AB, Medeira A, et al: Clinical and molecular characterization of diastrophic dysplasia in the Portuguese population, Clin Genet 80:550–557, 2011.
  775. Hall BD: Diastrophic dysplasia: extreme variability within a sibship, Am J Med Genet 63:28–33, 1996.
  776. Makitie O, Kaitila I: Growth in diastrophic dysplasia, J Pediatr 130:641–646, 1997.
  777. Newbury-Ecob R: Atelosteogenesis type 2, J Med Genet 35:49–53, 1998.
  778. Rossi A, Superti-Furga A: Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance, Hum Mutat 17:159–171, 2001.
  779. Bonafe L, Cormier-Daire V, Hall C, et al: Nosology and classification of genetic skeletal disorders: 2015 revision, Am J Med Genet A 167A(12):2869–2892, 2015.
  780. Dreyer SD, Zhou G, Baldini A, et al: Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome, Nat Genet 19:47–50, 1998.
  781. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017a. Gimovsky M, Rosa E, Tolbert T, et al: Campomelic dysplasia: case report and review, J Perinatol 28:71–73, 2008.
  782. Granata A, Nori G, Ravazzolo R, et al: Nail-patella syndrome and renal involvement. Description of three cases and literature review, Clin Nephrol 69:377–382, 2008.
  783. Lefebvre V, Dvir-Ginzberg M: SOX9 and the many facets of its regulation in the chondrocyte lineage, Connect Tissue Res 58(1):2–14, 2017.
  784. Mansour S, Offiah AC, McDowall S, et al: The phenotype of survivors of campomelic dysplasia, J Med Genet 39:597–602, 2002.
  785. Mendoza-Londono R, Lee B: Cleidocranial dysplasia. In Pagon RA, Adam MP, Ardinger HH, et al, editors: GeneReviews® [Internet]. Seattle (WA), Seattle, 1993–2017, 2006, University of Washington. [updated 2013 Aug 29].
  786. Mundlos S, Otto F, Mundlos C, et al: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia, Cell 89:773–779, 1997.
  787. Nelson ME, Griffin GR, Innis JW, Green GE: Campomelic dysplasia: airway management in two patients and an update on clinical-molecular correlations in the head and neck, Ann Otol Rhinol Laryngol 120:682–685, 2011.
  788. Sweeney E, Hoover-Fong JE, McIntosh I: In Pagon RA, Adam MP, Ardinger HH, et al, editors: Nail-patella syndrome, 2003. [updated 2014 Nov 13].
  789. Wada Y, Nishimura G, Nagal T, et al: Mutation analysis of SOX9 and single copy number variant analysis of the upstream region in eight patients with campomelic and acampomelic campomelic dysplasia, Am J Med Genet A 149A:2882–2885, 2009.
  790. Askmyr MK, Fasth A, Richter J: Towards a better understanding and new therapeutics of osteopetrosis, Br J Haematol 140:597–609, 2008.
  791. Bollerslev J, Henriksen K, Nielsen MF, et al: Autosomal dominant osteopetrosis revisited: lessons from recent studies, Eur J Endocrinol 169:R39–R57, 2013.
  792. Charles JM, Key LL: Developmental spectrum of children with congenital osteopetrosis, J Pediatr 132:371–374, 1998.
  793. de Vernejoul MC: Sclerosing bone disorders, Best Pract Res Clin Rheumatol 22:71–83, 2008.
  794. Gelb BD, Shi GP, Chapman HA, et al: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency, Science 273:1236–1238, 1996.
  795. Sobacchi C, Schultz A, Coxon FP, et al: Osteopetrosis: genetics, treatment and new insights into osteoclast function, Nat Rev Endocrinol 9(9):522–536, 2013.
  796. Stark Z, Savarirayan R: Osteopetrosis, Orphanet J Rare Dis 4:5, 2009.
  797. Tolar J, Teitelbaum SL, Orchard PJ: Osteopetrosis, N Engl J Med 351:2839–2849, 2004.
  798. Baujat G, Huber C, El Hokayem J, et al: Asphysiating thoracic dysplasia: clinical and molecular review of 39 families, J Med Genet 50:91–98, 2013.
  799. Bonafe L, Cormier-Daire V, Hall C, et al: Nosology and classification of genetic skeletal disorders: 2015 revision, Am J Med Genet A 167A(12):2869–2892, 2015.
  800. Caparris-Martin JA, Valencia M, Reytor E, et al: The ciliary Evc/evc2 complex interacts with smo and controls hedgehog pathway activity in chondrocytes by regulating Sufu/gli3 dissociation and gli3 trafficking in primary cilia, Hum Mol Genet 22:124–139, 2013.
  801. D’Asdia MD, Torrente I, Consoli F, et al: Novel and recurrent EVC and EVC2 mutations in Ellis-van creveld syndrome and weyers acrofacial dysostosis, Eur J Med Genet 56:80–87, 2013.
  802. Dagoneau N, Goulet M, Genevieve D, et al: DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III, Am J Hum Genet 84:706–711, 2009.
  803. Dai J, Kim OH, Cho TJ, et al: Novel and recurrent TRPV4 mutations and their association with distinct phenotypes with the TRPV4 dysplasia family, J Med Genet 47:704–709, 2010.
  804. de Vries J, Yntema JL, van Die CE, et al: Jeune syndrome: description of 13 cases and a proposal for follow-up protocol, Eur J Pediatr 169(1):77–88, 2010.
  805. Dorn KV, Hughes CE, Rohatgi R: A Smoothened-evc2 complex transduces the hedgehog signal at primary cilia, Dev Cell 23:823–835, 2012.
  806. Genevieve D, le Merrer M, Feingold J, et al: Revisiting metatropic dysplasia: presentation of a series of 19 novel patients and review of the literature, Am J Med Genet A 146:992–996, 2008.
  807. Glorieux FH: Caffey disease: an unlikely collagenopathy, J Clin Invest 115:1142–1144, 2005.
  808. Kamoun-Goldrat A, le Merrer M: Infantile cortical hyperostosis (caffey disease): a review, J Oral Maxillofac Surg 66:2145–2150, 2008.
  809. Krakow D, Robertson SP, King LM, et al: Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis, Nat Genet 36:405–410, 2004.
  810. Makitie O, Sulisalo T, de la Chapelle A, et al: Cartilage-hair hypoplasia, J Med Genet 32:39–43, 1995.
  811. Makitie O, Martinnen E, Kaitila I: Skeletal growth in cartilage hair hypoplasia. A radiological study of 82 patients, Pediatr Radiol 22:434–439, 1992.
  812. Nishimura G, Lausch E, Savarirayan R, et al: TRPV4-associated skeletal dysplasias, Am J Med Genet C Semin Med Genet 160C:190–204, 2012.
  813. Pascual-Garrido C, Moran CJ, Green DW, et al: Osteochondritis dissecans of the knee in children and adolescents, Curr Opin Pediatr 25:46–51, 2013.
  814. Pignolo RJ, Shore EM, Kaplan FS: Fibrodysplasia ossificans progressive: clinical and genetic aspects, Orphanet J Rare Dis 6:80, 2011.
  815. Ridanpaa M, van Eenennaam H, Pelin K, et al: Mutations in the RNa component of rnase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia, Cell 104:195–203, 2001.
  816. Restrepo S, Sanchez AM, Palacios E: Infantile cortical hyperostosis of the mandible, Ear Nose Throat J 83:454–455, 2004.
  817. Ruiz-Perez VL, Ide SE, Strom TM, et al: Mutations in a new gene in Ellis-van creveld syndrome and weyers acrodental dysostosis, Nat Genet 24:283–286, 2000.
  818. Schmidts M, Arts HH, Bongers EM, et al: Exome sequencing identifies DYNC2H1 mutations as a common cause of asphyxiating thoracic dystrophy (jeune syndrome) without major polydactyly, renal or retinal involvement, J Med Genet 50:309–323, 2013.
  819. Sharrard WJW: Abnormalities of the epiphyses and limb inequality. In Sharrard WJW, editor: Paediatric orthopaedics and fracture, Oxford, UK, 1993, Blackwell Scientific Publications.
  820. Shimono K, Tung W, Macolino C, et al: Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor ? agonists, Nat Med 17:454–460, 2011.
  821. Taskinen M, Ranki A, Pukkala E, et al: Extended follow-up of the finnish cartilage-hair hypoplasia cohort confirms high incidence of non-hodgkin lymphoma and basal cell carcinoma, Am J Med Genet A 146:2370–2375, 2008.
  822. Thiel CT, Mortier G, Kaitila I, et al: Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum, Am J Hum Genet 81:519–529, 2007.
  823. Zhang H, Kamiya N, Tsuji T, et al: Elevated fibroblast growth factor signaling is critical for the pathogenesis of the dwarfism in Evc2/limbin mutant mice, PLoS Genet 12:e1006510, 2016.
  824. Antoniazzi F, Bertoldo F, Mottes M, et al: Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis, J Pediatr 129:432–439, 1996.
  825. Bishop N, Adami S, Ahmed SF, et al: Risedronate in children with osteogenesis imperfecta: a randomized, double-blind, placebo-controlled trial, Lancet 382:1424–1432, 2013.
  826. Cho TJ, Lee KE, Lee SK, et al: A single recurrent mutation in the 5’-UTR of IFITM5 causes osteogenesis imperfecta type V, Am J Hum Genet 91:343–348, 2012.
  827. Dwan K, Phillipi CA, Steiner RD, et al: Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev (10):CD005088, 2016.
  828. Forlino A, Cabral WA, Barnes AM, et al: New Perspectives on osteogenesis imperfecta, Nat Rev Endocrinol 7:540–547, 2011.
  829. Forlino A, Marini JC: Osteogenesis imperfecta, Lancet 387:1657–1668, 2016.
  830. Glorieux FH, Rauch F, Ward LM, et al: Alendronate in the treatment of pediatric osteogenesis imperfecta, J Bone Miner Res 19(Suppl 1):S12, 2004.
  831. Homan E, Rauch F, Grafe I, et al: Mutations in SERPINF1 cause osteogenesis imperfecta type VI, J Bone Miner Res 26:2798–2803, 2011.
  832. Kang H, Aryal ACS, Marini JC: Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia, Transl Res 181:27–48, 2017.
  833. Letocha A, Cintas HL, Troendle JF, et al: Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement, J Bone Miner Res 20:977–986, 2005.
  834. Lindert U, Cabral WA, Ausavarat S, et al: MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta, Nat Commun 7:11920, 2016.
  835. Marini JC: Should children with osteogenesis imperfecta be treated with bisphosphonates? Nat Clin Pract Endocrinol Metab 2:14–15, 2006.
  836. Marini JC, Blissett AR: New genes in bone development: what’s new in osteogenesis imperfecta, J Clin Endocrinol Metab 98:3095–3103, 2013.
  837. Marini JC, Hopkins E, Glorieux FH, et al: Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta, J Bone Miner Res 18:237–243, 2003.
  838. Marini JC, Reich A, Smith SM: Osteogenesis imperfecta due to mutations in noncollagenous genes: lessons in the biology of bone formation, Curr Opin Pediatr 26:500–507, 2014.
  839. Martinez-Glez V, Valencia M, Caparr?s-Mart?n JA, et al: Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta, Hum Mutat 3:343–350, 2012.
  840. Plotkin H, Rauch F, Bishop NJ: Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age, J Clin Endocrinol Metab 85:1846–1850, 2000.
  841. Rauch F, Husseini A, Roughley P, et al: Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI, J Clin Endocrinol Metab 97:E1550–E1556, 2012.
  842. Sakkers R, Kok D, Engelbert R, et al: Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomized placebo-controlled study, Lancet 363:1427–1431, 2004.
  843. Sato A, Ouellet J, Muneta T, et al: Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations — genotype-phenotype correlations and effect of bisphosphonate treatment, Bone 86:53–57, 2016.
  844. Starr SR, Roberts TT, Fischer PR: Osteogenesis imperfecta: primary care, Pediatr Rev 31:e54–e64, 2010.
  845. Ward LM, Rauch F: Oral bisphosphonates for paediatric osteogenesis imperfecta? Lancet 382:1388–1389, 2013.
  846. Abraham PA, Perejda AJ, Carnes WH, Uitto J: Marfan syndrome. Demonstration of abnormal elastin in aorta, J Clin Invest 70:1245–1252, 1982.
  847. Ades LC, Holman KJ, Brett MS, et al: Ectopia lentis phenotypes and the FBN1 gene, Am J Med Genet A 126A:284–289, 2004.
  848. Ahimastos AA, et al: Effect of perindopril on large artery stiffness and aortic root diameter in patients with marfan syndrome: a randomized controlled trial, JAMA 298:1539–1547, 2007.
  849. Aragon-Martin JA, et al: Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients, Hum Mutat 31:E1622–E1631, 2010.
  850. Boileau C, et al: TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of marfan syndrome, Nat Genet 44:916–921, 2012.
  851. Brooke BS, et al: Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome, N Engl J Med 358:2787–2795, 2008.
  852. Carmignac V, et al: In-frame mutations in exon 1 of SKI cause dominant Shprintzengoldberg syndrome, Am J Hum Genet 91:950–957, 2012.
  853. Chandra A, et al: A genotype-phenotype comparison of ADAMTSL4 and FBN1 in isolated ectopia lentis, Invest Ophthalmol Vis Sci 53:4889–4896, 2012.
  854. Chaudhry SS, et al: Fibrillin-1 regulates the bioavailability of TGFbeta1, J Cell Biol 176:355–367, 2007.
  855. Chen S, Fagan LF, Nouri S, Donahoe JL: Ventricular dysrhythmias in children with Marfan’s syndrome, Am J Dis Child 139:273–276, 1985.
  856. Chiu HH, et al: Losartan added to beta-blockade therapy for aortic root dilation in marfan syndrome: a randomized, open-label pilot study, Mayo Clin Proc 88:271–276, 2013.
  857. Cohn RD, et al: Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states, Nat Med 13:204–210, 2007.
  858. Comeglio P, Evans AL, Brice G, et al: Identification of FBN1 gene mutations in patients with ectopia lentis and marfanoid habitus, Br J Ophthalmol 86:1359–1362, 2002.
  859. Dagoneau N, et al: ADAMTS10 mutations in autosomal recessive Weill-marchesani syndrome, Am J Hum Genet 75:801–806, 2004.
  860. Davies RR, et al: Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size, Ann Thorac Surg 73:17–27, discussion 27–28, 2002.
  861. Debakey ME, et al: Surgical management of dissecting aneurysms of the aorta, J Thorac Cardiovasc Surg 49:130–149, 1965.
  862. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling, Nature 425:577–584, 2003.
  863. Doyle AJ, et al: Mutations in the TGF-beta repressor SKI cause Shprintzen-goldberg syndrome with aortic aneurysm, Nat Genet 44:1249–1254, 2012.
  864. Doyle JJ, et al: A deleterious gene-by-environment interaction imposed by calcium channel blockers in marfan syndrome, Elife 27:pii: e08648, 2015.
  865. Faivre L, et al: Clinical homogeneity and genetic heterogeneity in Weill-marchesani syndrome, Am J Med Genet A 123A:204–207, 2003.
  866. Faivre L, et al: Effect of mutation type and location on clinical outcome in 1,013 probands with marfan syndrome or related phenotypes and FBN1 mutations: an international study, Am J Hum Genet 81:454–466, 2007.
  867. Faivre L, et al: In frame fibrillin-1 gene deletion in autosomal dominant Weill-marchesani syndrome, J Med Genet 40:34–36, 2003.
  868. Fattori R, et al: Importance of dural ectasia in phenotypic assessment of Marfan’s syndrome, Lancet 354:910–913, 1999.
  869. Gaustadnes M, et al: The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment, Hum Mutat 20:117–126, 2002.
  870. Glesby MJ, Pyeritz RE: Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum, JAMA 262:523–528, 1989.
  871. Gott VL, et al: Aortic root replacement in 271 marfan patients: a 24-year experience, Ann Thorac Surg 73:438–443, 2002.
  872. Gott VL, et al: Replacement of the aortic root in patients with Marfan’s syndrome, N Engl J Med 340:1307–1313, 1999.
  873. Grahame R, Pyeritz RE: The marfan syndrome: joint and skin manifestations are prevalent and correlated, Br J Rheumatol 34:126–131, 1995.
  874. Gray JR, et al: Ascertainment and severity of marfan syndrome in a Scottish population, J Med Genet 31:51–54, 1994.
  875. Groenink M, et al: Losartan reduces aortic dilatation rate in adults with marfan syndrome: a randomized controlled trial, Eur Heart J 2013.
  876. Guo DC, et al: Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections, Nat Genet 39:1488–1493, 2007.
  877. Habashi JP, et al: Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism, Science 332:361–365, 2011.
  878. Habashi JP, et al: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of marfan syndrome, Science 312:117–121, 2006.
  879. Haji-Seyed-Javadi R, et al: LTBP2 mutations cause Weill-marchesani and Weill-marchesani-like syndrome and affect disruptions in the extracellular matrix, Hum Mutat 33:1182–1187, 2012.
  880. Hirani R, Hanssen E, Gibson MA: LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein, Matrix Biol 26:213–223, 2007.
  881. Hirata K, et al: The marfan syndrome: abnormal aortic elastic properties, J Am Coll Cardiol 18:57–63, 1991.
  882. Holm TM, et al: Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in marfan syndrome mice, Science 332:358–361, 2011.
  883. Isogai Z, et al: Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein, J Biol Chem 278:2750–2757, 2003.
  884. Judge DP, et al: Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of marfan syndrome, J Clin Invest 114:172–181, 2004.
  885. Kainulainen K, et al: Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene, Am J Hum Genet 49:662–667, 1991.
  886. Koenigsberg M, et al: Fetal marfan syndrome: prenatal ultrasound diagnosis with pathological confirmation of skeletal and aortic lesions, Prenat Diagn 1:241–247, 1981.
  887. Kojuri J, Razeghinejad MR, Aslani A: Cardiac findings in Weill-marchesani syndrome, Am J Med Genet A 143A:2062–2064, 2007.
  888. Korkko J, Kaitila I, Lonnqvist L, et al: Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in marfan syndrome and related conditions, J Med Genet 39:34–41, 2002.
  889. Kutz WE, et al: Functional analysis of an ADAMTS10 signal peptide mutation in Weill-marchesani syndrome demonstrates a long-range effect on secretion of the full-length enzyme, Hum Mutat 29:1425–1434, 2008.
  890. Lacro RV, et al: Atenolol versus losartan in children and young adults with Marfan’s syndrome, N Engl J Med 27:2061–2071, 2014.
  891. Lee MK, et al: TGF-beta activates erk MAP kinase signalling through direct phosphorylation of ShcA, EMBO J 26:3957–3967, 2007.
  892. Lindsay ME, et al: Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm, Nat Genet 44:922–927, 2012.
  893. Loeys B, et al: Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical marfan syndrome, Hum Mutat 24:140–146, 2004.
  894. Loeys B, Nuytinck L, Delvaux I, et al: Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected marfan syndrome, Arch Intern Med 161:2447–2454, 2001.
  895. Loeys BL, et al: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2, Nat Genet 37:275–281, 2005.
  896. Loeys BL, et al: Aneurysm syndromes caused by mutations in the TGF-beta receptor, N Engl J Med 355:788–798, 2006.
  897. Loeys BL, et al: The revised ghent nosology for the marfan syndrome, J Med Genet 47:476–485, 2010.
  898. Lynas MA: Marfan’s syndrome in northern Ireland; an account of thirteen families, Ann Hum Genet 22:289–309, 1958.
  899. Maumenee IH: The eye in the marfan syndrome, Trans Am Ophthalmol Soc 79:684–733, 1981.
  900. McKusick VA: Heritable disorders of connective tissue. III. The marfan syndrome, J Chronic Dis 2:609–644, 1955.
  901. Meijboom LJ, et al: Pregnancy and aortic root growth in the marfan syndrome: a prospective study, Eur Heart J 26:914–920, 2005.
  902. Milewicz DM, Pyeritz RE, Crawford ES, Byers PH: Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts, J Clin Invest 89:79–86, 1992.
  903. Morse RP, et al: Diagnosis and management of infantile marfan syndrome, Pediatrics 86:888–895, 1990.
  904. Murdoch JL, Walker BA, McKusick VA: Parental age effects on the occurrence of new mutations for the marfan syndrome, Ann Hum Genet 35:331–336, 1972.
  905. Murdoch JL, Walker BA, Halpern BL, et al: Life expectancy and causes of death in the marfan syndrome, N Engl J Med 286:804–808, 1972.
  906. Neptune ER, et al: Dysregulation of TGF-beta activation contributes to pathogenesis in marfan syndrome, Nat Genet 33:407–411, 2003.
  907. Ng CM, et al: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of marfan syndrome, J Clin Invest 114:1586–1592, 2004.
  908. Pees C, et al: Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, Adolescents, and young adults with marfan syndrome, Am J Cardiol 2013.
  909. Pereira L, et al: Genomic organization of the sequence coding for fibrillin, the defective gene product in marfan syndrome, Hum Mol Genet 2:1993, 1762.
  910. Putnam EA, Zhang H, Ramirez F, Milewicz DM: Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly, Nat Genet 11:456–458, 1995.
  911. Pyeritz RE: Maternal and fetal complications of pregnancy in the marfan syndrome, Am J Med 71:784–790, 1981.
  912. Pyeritz RE, Fishman EK, Bernhardt BA, Siegelman SS: Dural ectasia is a common feature of the marfan syndrome, Am J Hum Genet 43:726–732, 1988.
  913. Pyeritz RE, Murphy EA, McKusick VA: Clinical variability in the marfan syndrome(s), Birth Defects Orig Artic Ser 15:155–178, 1979.
  914. Ramos Arroyo MA, Weaver DD, Beals RK: Congenital contractural arachnodactyly. Report of four additional families and review of literature, Clin Genet 27:570–581, 1985.
  915. Rienhoff HY, et al: A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with marfan and Loeys-dietz syndrome, Am J Med Genet 161:2040–2046, 2013.
  916. Robinson PN, et al: Mutations of FBN1 and genotype-phenotype correlations in marfan syndrome and related fibrillinopathies, Hum Mutat 20:153–161, 2002.
  917. Roman MJ, Devereux RB, Kramer-Fox R, O’Loughlin J: Two-dimensional echocardiographic aortic root dimensions in normal children and adults, Am J Cardiol 64:507–512, 1989.
  918. Rossi-Foulkes R, et al: Phenotypic features and impact of beta blocker or calcium ntagonist therapy on aortic lumen size in the marfan syndrome, Am J Cardiol 83:1364–1368, 1999.
  919. Rossi-Foulkes R, et al: Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the marfan syndrome, Am J Cardiol 83:1364–1368, 1999.
  920. Rossiter JP, Repke JT, Morales AJ, et al: A prospective longitudinal evaluation of pregnancy in the marfan syndrome, Am J Obstet Gynecol 173:1599–1606, 1995.
  921. Sakai LY, Keene DR, Engvall E: Fibrillin, a new 350-kd glycoprotein, is a component of extracellular microfibrils, J Cell Biol 103:2499–2509, 1986.
  922. Salim MA, Alpert BS, Ward JC, Pyeritz RE: Effect of beta-adrenergic blockade on aortic root rate of dilation in the marfan syndrome, Am J Cardiol 74:629–633, 1994.
  923. Savolainen A, Kupari M, Toivonen L, et al: Abnormal ambulatory electrocardiographic findings in patients with the marfan syndrome, J Intern Med 241:221–226, 1997.
  924. Shores J, Berger KR, Murphy EA, Pyeritz RE: Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome, N Engl J Med 330:1335–1341, 1994.
  925. Shprintzen RJ, Goldberg RB: A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias, J Craniofac Genet Dev Biol 2:65–74, 1982.
  926. Silverman DI, et al: Family history of severe cardiovascular disease in marfan syndrome is associated with increased aortic diameter and decreased survival, J Am Coll Cardiol 26:1062–1067, 1995.
  927. Silverman DI, et al: Life expectancy in the marfan syndrome, Am J Cardiol 75:157–160, 1995.
  928. Sisk HE, Zahka KG, Pyeritz RE: The marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age, Am J Cardiol 52:353–358, 1983.
  929. Spittell PC, et al: Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990), Mayo Clin Proc 68:642–651, 1993.
  930. Streeten EA, Murphy EA, Pyeritz RE: Pulmonary function in the marfan syndrome, Chest 91:408–412, 1987.
  931. Testai FD, Gorelick PB: Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders, Arch Neurol 67:148–153, 2010.
  932. Tsuji T: Marfan syndrome: demonstration of abnormal elastic fibers in skin, J Cutan Pathol 13:144–153, 1986.
  933. van de Laar IM, et al: Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis, Nat Genet 43:121–126, 2011.
  934. van de Laar IM, et al: Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome, J Med Genet 49:47–57, 2012.
  935. Villeirs GM, Van Tongerloo AJ, Verstraete KL, et al: Widening of the spinal canal and dural ectasia in Marfan’s syndrome: assessment by CT, Neuroradiology 41:850–854, 1999.
  936. Wang L, et al: Mutations in myosin light chain kinase cause familial aortic dissections, Am J Hum Genet 87:701–707, 2010.
  937. Wang M, Clericuzio CL, Godfrey M: Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2, Am J Hum Genet 59:1027–1034, 1996.
  938. Wang M, et al: Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal marfan syndrome, Hum Mol Genet 4:607–613, 1995.
  939. Wood JR, Bellamy D, Child AH, Citron KM: Pulmonary disease in patients with marfan syndrome, Thorax 39:780–784, 1984.
  940. Yamashita M, et al: TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta, Mol Cell 31:918–924, 2008.
  941. Yetman AT, Bornemeier RA, McCrindle BW: Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the marfan syndrome, Am J Cardiol 95:1125–1127, 2005.
  942. Zhu L, et al: Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus, Nat Genet 38:343–349, 2006.
  943. Berndt T, Kumar R: Novel mechanisms in the regulation of phosphorus homeostasis, Physiology (Bethesda) 24:17–25, 2009.
  944. Bonewald LF, Wacker MJ: FGF23 production by osteocytes, J Bone Miner Res 28: 563–568, 2013.
  945. Boyden LM, Mao J, Belsky J, et al: High bone density due to a mutation in LDL-receptor related protein 5, N Engl J Med 346:1513–1521, 2002.
  946. Crabtree NJ, Arabi A, Bachrach LK, et al: Dual energy x-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD pediatric official positions, J Clin Densitom 17(2):225–242, 2014.
  947. Jonsson KB, Zahradnik R, Larsson T, et al: Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypophosphatemia, N Engl J Med 348:1656–1663, 2003.
  948. Loud KJ, Gordon CM: Adolescent bone health, Arch Pediatr Adolesc Med 160:1026–1032, 2006.
  949. Ma NS, Gordon CM: Pediatric osteoporosis: where are we now?, J Pediatr 161(6): 983–990, 2012.
  950. Matlik L, Savaiano D, McCabe G, et al: Perceived milk intolerance is related to bone mineral content in 10- to 13-year-old female adolescents, Pediatrics 120:e669–e677, 2007.
  951. Razzaque MS: FGF23-mediated regulation of systemic homeostasis: is klotho an essential player?, Am J Physiol 296:F470–F476, 2009.
  952. Shore RM, Chesney RW: Rickets: part I, Pediatr Radiol 43:140–151, 2013.
  953. Shore RM, Chesney RW: Rickets: part II, Pediatr Radiol 43:152–172, 2013.
  954. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al: Multiple genetic loci for bone mineral density and fractures, N Engl J Med 358:2355–2365, 2008.
  955. Wang Q, Seeman E: Skeletal growth and peak bone strength. In Rosen CJ, editor: Primer on the metabolic bone diseases and disorders of mineral metabolism, Washington, DC, 2013, American Society for Bone and Mineral Research, pp 349–353.
  956. Zemel BS, Kalkwarf HJ, Gilsanz V, et al: Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study, J Clin Endocrinol Metab 96(10):3160–3169, 2011.
  957. Bianchi ML: Hypophosphatasia: an overview of the disease and its treatment, Osteoporos Int. 26(12):2743–2757, 2015.
  958. Bishop N, Munns CF, Ozono K: Transformative therapy in hypophosphatasia, Arch Dis Child 101(6):514–515, 2016.
  959. Saraff V, Narayanan VK, Lawson AJ, et al: A diagnostic algorithm for children with low alkaline phosphatase activities: lessons learned from laboratory screening for hypophosphatasia, J Pediatr 172:181–186, 2016.
  960. Sheikh Z, Ali S, Hussain A, et al: A newborn with no bones: neonatal hypophosphatasia with respiratory distress, J Pediatr 188:306, 2017.
  961. Whyte MP: Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges, J Bone Miner Res 32(4):667–675, 2017.
  962. Whyte MP: Enzyme defects and the skeleton. In Rosen CJ, editor: Primer on the metabolic bone diseases and disorders of mineral metabolism, Eighth ed, John Wiley & Sons, Inc}, Ames USA., 2013, American Society for Bone and Mineral Research, pp 838–842.
  963. Whyte MP, Zhang F, Wenkert D, et al: Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years-experience with 173 pediatric patients, Bone 75:229–239, 2015.
  964. Chu AS, Rothschild JG: Update on benign transient hyperphosphatasemia: recognizing an underappreciated condition, Clin Pediatr (Phila) 55(6):564–566, 2016.
  965. Naot D, Choi A, Musson DS, et al: Novel homozygous mutatios in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget’s disease, Bone 68:6–10, 2014.
  966. Ridefelt P, Gustafsson J, Aldrimer M, Heilberg D: Alkaline phosphatase in healthy children: reference intervals and prevalence of elevated levels, Horm Res Paediatr 82:399–404, 2014.
  967. Abinun M: Successful hematopoietic stem cell transplantation for osteopetrosis due to TCRIG1 mutation, Arch Dis Child 95(12):984–985, 2010.
  968. Bacchetta J, Wesseling-Perry K, Gilsanz V, et al: Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography, Pediatr Rheumatol Online J 11:6, 2013.
  969. Bachrach LK, Gordon CM: Bone densitometry in children and adolescents, Pediatrics 138(4): e20162398, 2016.
  970. Bowden SA, Robinson RF, Carr R, et al: Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic, Pediatrics 121:e1585–e1590, 2008.
  971. Buckley L, Guyatt G, Fink HA, et al: 2017 American college of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis, Arthritis Care Res (Hoboken) 69(8):1095–1110, 2017.
  972. Burnham JM: Inflammatory disease and bone health in Children, Curr Opin Rheumatol 24(5):548–553, 2012.
  973. Compston JE, McClung MR, Leslie WD: Osteoporosis, Lancet 393:364–376, 2019.
  974. Crabtree NJ, Arabi A, Bachrach LK, et al: Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions, J Clin Densitom 17(2):225–242, 2014.
  975. Favus MJ: Bisphosphonates for osteoporosis, N Engl J Med 33(21):2027–2034, 2010.
  976. Ferrari SL: Prevention of fractures in patients with osteoporosis, Lancet 391:184–186, 2018.
  977. Gennari L, Bilezikian JP: Glucosteroid-induced osteoporosis: hope on the horizon,Lancet 373:1225–1226, 2009.
  978. Harrington J, Sochett E: The child with multiple fractures, what next? Pediatr Clin North Am 62(4):841–855, 2015.
  979. Heikkili K, Pearce J, M?ki M, Kaukinen K: Celiac disease and bone fracture: a systematic review and meta-analysis, J Clin Endocrinol Metab 100(1):25–34, 2015.
  980. Ioannidis JPA, Ralston SH, Bennett ST, et al: Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes, JAMA 292:2105–2114, 2004.
  981. Kyriakou A, Shepherd S, Mason A, Ahmed SF: Prevalence of vertebral fractures in children with suspected osteoporosis, J Pediatr 179:219–225, 2016.
  982. Laine CM, Joeng KS, Campeau PM, et al: WNT1 mutations in early-onset osteoporosis and osteogenesis imperfect, N Engl J Med 368:1809–1818, 2013.
  983. Lausch E, Janecke A, Bros M, et al: Genetic deficiency of tartrate-resistant acid phosphate associated with skeletal dysplasia, cerebral calcifications and autoimmunity, Nat Genet 43(2):132–137, 2011.
  984. Ma NS, Gordon CM: Pediatric osteoporosis: where are we now? J Pediatr 161:983–990, 2012.
  985. Nakhla M, Scuccimarri R, Duffy KNW, et al: Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia, J Pediatr 154:438–443, 2009.
  986. Richards JB, Rivadeneira F, Inouye M, et al: Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, Lancet 371:1505–1512, 2008.
  987. Rijks EB, Bongers BC, Vlemmix MJ, et al: Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review, Horm Res Paediatr 84(1):26–42, 2015.
  988. Scholes D, LaCroix AZ, Ichikawa LE, et al: Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception, Arch Pediatr Adolesc Med 159:139–144, 2005.
  989. Shaw NJ: Osteoporosis in paediatrics, Arch Dis Child 92:ep169–ep175, 2007.
  990. Stenson WF, Newberry R, Lorenz R, et al: Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis, Arch Intern Med 165:393–399, 2005.
  991. Van Dijk FS, Zillikens C, Micha D, et al: PLS3 mutations in X-linked osteoporosis with fractures, N Engl J Med 369:1529–1536, 2013.
  992. Van Meurs JBJ, Trikalinos TA, Ralston SH, et al: Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis, JAMA 209:1277–1290, 2008.
  993. Whyte MP: Hypophosphatasia: Enzyme replacement therapy brings new opportunities and new challenges, J Bone Miner Res 32(4):667–675, 2017.
  994. Whyte MP, Wenkert D, Clements KL, et al: Bisphosphonate-induced osteopetrosis, N Engl J Med 349:457–463, 2003.

Òðóäû îòå÷åñòâåííûõ àâòîðîâ ïðè ïîäãîòîâêå ñòàòåé ïî ïåäèàòðèè äëÿ ïîëüçîâàòåëåé ñàéòà - íå èñïîëüçîâàëèñü, òàê êàê èõ âû âñåãäà ìîæåòå íàéòè â áèáëèîòåêàõ.

- Âåðíóòüñÿ â ðàçäåë "Ïåäèàòðèÿ"

Ðåäàêòîð: Èñêàíäåð Ìèëåâñêè. Äàòà îáíîâëåíèÿ ïóáëèêàöèè: 7.8.2024

Ìåäóíèâåð Ìû â Telegram Ìû â YouTube Ìû â VK Ôîðóì êîíñóëüòàöèé âðà÷åé Êîíòàêòû, ðåêëàìà
Èíôîðìàöèÿ íà ñàéòå ïîäëåæèò êîíñóëüòàöèè ëå÷àùèì âðà÷îì è íå çàìåíÿåò î÷íîé êîíñóëüòàöèè ñ íèì.
Ñì. ïîäðîáíåå â ïîëüçîâàòåëüñêîì ñîãëàøåíèè.